WP1422	Sphingolipid pathway	8877	29956	64781	56848	56624	253782	7357	427	91012	204219	9517	8879	9514	166929	9331	79603	55304	8611	259230	2531	10558	57515	125981	10087	130367
WP4174	Metabolism of tetrahydrocannabinol (THC)	1576	1559
WP561	Heme biosynthesis	210	211	5498	212	7389	3145	2235	1371	7390
WP4818	Conversion of angiotensinogen to angiotensin II 	1215	1511	1636
WP5234	Bardet-Biedl syndrome	27130	80199	1406	79809	91147	22954	23432	51057	201163	55212	7546	54903	583	6102	6608	374654	26160	200894	123016	55112	4750	51098	157657	5311	56623	406	84100	92482	80258	166379	80173	8239	89891	57539	132884	585	79659	9657	22858	284086	51626	5727	84314	51259	403	4952	4117	2121	9731	2737	1259	9742	5147	114327	49855	5314	129880	388939	28981	51684	1258	5310	755	51473	55081	51715	11020	80184	57728	167691	132320	10806	582	168507	23059	57560	255758	27031	27241	112752	55764	54585	22897	26146	79738	95681	8195
WP3407	FTO obesity variant mechanism	7350	63976	79068	10891	6899	10265	84159	79191
WP4966	Fluoroacetic acid toxicity	217	1431	224	223
WP3865	Novel intracellular components of RIG-I-like receptor pathway	80143	6300	7706	10010	8737	7187	22938	8717	6387	340061	7186	6885	4214	23586	3661	9474	4793	3458	55593	64135	1654	79671	64343	8517	5601	5603	29110	5970	3576	79132	3627	3665	3439	5300	9641	56832	4792	5600	54941	26007	9636	1147	4790	5602	1540	7189	3456	57506	8772	843	338376	8653	3551	9755	9140	1432	10521	5599	841
WP5265	Neurogenesis regulation in the olfactory epithelium	65078	182	81565	6657	23462	351	5979	64218	57142	6774	2932	1020	23028	8851	28514	375790
WP2884	NRF2 pathway	1969	3326	3082	3303	154091	874	218	54657	2947	6535	7040	200010	8878	10057	144195	340024	2939	140809	2512	6528	3320	221074	4780	348932	283848	6517	4097	155184	6534	54600	6536	54577	6523	6530	28968	57181	8884	6529	2877	9588	6256	2938	2952	54659	6513	8714	7364	1728	6540	5226	1579	8824	2948	283375	5265	2953	22949	29985	6527	2495	201266	221357	2941	6518	60482	2949	873	1548	23516	3337	2042	7922	159963	2878	125206	7042	2946	81031	2944	27173	54578	3084	7296	9152	7039	131	2940	1066	6515	64116	6514	29986	6532	177	160728	55630	645	1958	2950	9817	7295	2729	54658	54716	2730	5052	5155	55334	7048	2258	11182	114134	23491	6533	6531	114112	6524	5467	6526	23764	6649	29988	4258	2678	115584	6538	66035	1839	25800	1244	55117	23657	221223	11254	2936	388662	2539	10257	91252	56606	4199	4259	3162
WP5437	GNAQ pathways in port-wine stain	5595	5879	5605	7204	10413	5609	112476	2475	5170	2776	5294	387	5608	4790	5607	6416	3339	5604	154796	5606	5894	207	5594
WP3527	Pre-implantation embryo	57504	5460	353238	476	2101	360	201516	1875	94234	359787	7080	7004	7021	360030	6496	126206	4306	10265	2297	5087	2624	284355	8570	6664	1746	11189	6657	366	503834	30812	9314	326340	3159	55506	4342	55509	999	503582	6597	4603	1994	79923	4084	1045	132625	342900	29947	1958	678	7538	83439	3182	1649	3662	2354	6926	8538	2625
WP5102	Familial partial lipodystrophy	687	63924	5396	2625	1149	6720	2167	6777	5346	3991	84823	4001	5465	23463	4000	2339	5468	688	1050	57104	10269	2624	4023	8815	10365	11343
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling	3675	3991	6514	55844	5562	5747	5605	7060	6794	2787	2149	3454	2782	3456	5518	2846	1943	3667	1902	5287	2247	5170	5295	3561	56034	1290	57521	2264	2309	2257	2252	2790	5154	2034	5156	53918	1435	3909	23566	92335	10319	3681	1282	5290	5527	3689	3444	64344	3169	5522	3910	2253	7010	200186	2788	5523	23533	22801	4193	9586	2248	6198	3791	8516	2783	8660	2056	2258	7450	5563	3696	3694	3915	113791	1128	1288	5594	7059	1440	5528	1942	2786	2784	285	1441	3693	6517	7249	5210	2475	1302	3551	6194	1278	5286	2246	10488	3559	64223	9623	2254	2256	50509	84699	5526	284	572	3911	5649	1385	1284	1286	90993	3320	1994	2263	51764	5516	3643	5291	1956	5728	2885	9965	3479	26281	2321	3680	51719	3480	57121	7148	1975	8517	3679	9470	2791	1277	3560	6009	94235	6513	2335	253314	5209	2057	3685	1946	1944	59345	10890	468	7143	5008	3716	148327	2308	1026	3908	2277	8823	30849	4233	1436	7057	4846	8817	5155	84335	208	3563	3688	7423	5296	1978	8471	5294	5519	2324	5228	5617	3655	3455	31	3683	5604	3381	6515	51378	3676	3674	2260	2259	3570	3815	2251	8115	1388	7422	5595	3630	7058	5521	1289	54541	1129	3914	3695	64764	5529	1281	3687	3682	10161	8515	1977	8822	3575	9180	1311	5618	23216	6199	3091	63923	2249	3690	8408	23035	4804	51552	1027	7448	1386	5207	3717	9170	3691	1292	5525	3265	2255	55970	4842	3918	4803	10000	9230	2998	3326	1969	27006	11140	3082	1280	7248	6654	4218	284217	4254	5894	2792	3913	3558	81617	4893	10891	3845	2785	1101	2261	7424	5293	80310	5862	5159	5208	3718	1945	6720	3684	3371	55012	6696	3912	2932	2793	1950	3673	2997	7184	842	1442	23239	26291	54331	3678	207	4843	1301	2690	5515	3566
WP690	Polyol pathway	6652	229	231
WP2805	exRNA mechanism of action and biogenesis	27161	23405	57510	29102	90459	54487
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	4792	27035	1728	3661	2974	2939	1147	4790	2977	59272	2983	23657	4312	4314	3592	7113	4780	4094	2982	65125	6347	3162	3576	2730	43740578	5970	8517	3553	3569	9817	5593	7124	3551	2729
WP4352	Ciliary landscape	203286	57136	4790	26160	80232	55212	54903	4698	583	54994	10421	9343	64795	149371	83657	1892	9882	55036	64792	1387	51646	10939	5879	4173	11336	10432	128239	2717	64072	801	51668	116225	51552	23265	30845	23404	9883	585	1778	5048	10987	4172	10982	5925	1857	25852	3065	80258	25904	55388	2040	1345	4637	26286	3020	5866	9342	10296	10413	55112	6990	140735	9859	11020	8636	140465	4218	10726	23549	7022	396	79699	4289	9669	5719	9742	23016	4741	10788	9255	9318	8100	2873	26146	83741	4236	2181	8826	54585	4174	4176	57560	27429	255758	27241	51138	3934	4436	51143	582	5862	55207	2077	85456	7020	4927	10048	22981	10238	54536	8533	8526	10920	25980	10128	7328	1039	25861	80005	2664	23019	23011	80199	815	55763	4171	4704	10083	64777	79989	9657	5714	63929	89891	140609	1655	80173	79874	11018	10980	27183	3066	92482	5899	7322	1488	6103	84515	5476	10640	64708	51314	339488	55812	123016	51098	6993	55081	57610	5718	1781	90410	129880	324	57414	28981	124401	246175	254394	83658	5713	56912	50813	875	284086	9217	55746	80344	79018	6629	5393	261726	54512	10051	23233	23301	25804	55764	5706	5704	4747	8732	60412	112752	55245	2720	7431	92104	65125	4175	10555	79598	27152	23059	7465	150737	8655	10424	80184	7260	167691	1499	55770	7021
WP5321	Prostaglandin and leukotriene metabolism in senescence 	5925	3488	240	10800	5743	4048	23411	5730	247	3265	9536	241	2770	239	246	2687	5321	64174	2678	4056
WP4320	Effect of progerin on genes involved in progeria	23028	10951	1107	1108	6720	5928	3065	126961333932;653604;	53615	51176	5931	1869	80309	23468	8932	11335	9112	9219	83508351;8352;8353;8354;8355;8356;8357;8358;8968;	3066	7157	5925	6839	57504	30203021;
WP2032	Thyroid stimulating hormone (TSH) signaling	5608	5908	1017	54331	109	2770	207	5594	2776	23236	5925	328	6774	7252	23513	6772	10672	2775	3480	5909	6198	108	5595	896	1385	5290	5906	6714	7253	5606	5894	5604	5337	5934	2778	5900	6195	5296	30818	6194	5295	1432	3265	5144	2475	1019	5170	1081	3717	103910	2773	2782	2771	673	3716	898	1027	2768
WP1995	Effects of nitric oxide	7498	4846	4843	4842	4151	4512
WP4792	Purine metabolism	1716	3614	4860	100	158	3704	159	7498	471	353	5631	3251	270
WP2276	Glial cell differentiation	11076	5354	2596	4155	1267	4478	4099
WP3580	Methionine de novo and salvage pathway	58478	4953	4552	6723	55256	55349	4507	191	6898	27430	4144	51074	22921	253827	84245	6611	4482	262	4143	259307	4548	635
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	472	10111	1653	29102	4683	4361	54487
WP3878	ATM signaling in development and disease 	2475	1020	5591	10155	8243	1432	84823	9212	9810	993	1386	6794	9025	7249	10111	7157	56254	23300	4683	3014	55183	5600	1111	64421	5932	2539	3316	5603	8517	472	9759	3150	79840	80254	11200	545	1017	10524	9656	165918	5515	699	6300	7158	4361
WP3890	Nanomaterial-induced inflammasome activation	3553	4790	29108	7099
WP5228	Arsenic liver toxicity pathway	
WP4872	MAP3K1 role in promoting and blocking gonadal determination	8312	4214	4216	2932	5594	6736	668	54361	6093	2254	6662	5600	10912	387	2263	10023
WP4758	Nephrotic syndrome	1493	2013	27235	7225	4643	81	4565	1585	5420	8029	4567	11346	54443	4868	23607	55988	56052	950	84942	7827	3675	1285	3691	57107	791226	5800	83478	79809	7490	1871	8565	51196	8542	64423	51004	4010	10269	2262	5373	396	4627	1287	3913	50485	1286	977	4000	79934	5076
WP4969	RAS and bradykinin pathways in COVID-19	7124	4846	185	183	3553	624	5054	186	4842	1576	3827	5972	1636	6093	710	3818	5594	1591	59272	4790	5592	3552	2161	3816	623	7421	1369	387
WP4194	Hormonal control of pubertal growth spurt	5351	6046	2688	2691	3479	2796	6750
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	39	2181	1593	6307	3422	50814	7108	1595	6721	2194	19	3157	2224	8435	1717	10682	4598	3158	6309	1718	4597	9023	6720	9619	3156	2182	6713	10965	29116	10858	6646	2222	7376	4047	2180	10062	10654	51478	9453
WP1603	Nicotine effect on chromaffin cells	1136	8913	775	1143
WP231	TNF-alpha signaling	3265	4893	3845
WP5405	13q12 or CRYL1 copy number variation 	51084
WP4312	Rett syndrome	6334	3064	3615	222183	23224	55869	79718	8831	1398	6907	23314	6323	2556	3766	9014	10014	2904	6812	9568	2775	27443	3065	9611	8892	6925	4208	2903	56949	9612	6594	9001	3785	85358	8295	23221	673	51412	2874	8243	2563	1108	6326	3097
WP5153	N-glycan biosynthesis	2821	146664	4351	6480	56052	4249	29880	1603	3703	4124	7991	8704	84920	4122	8813	440138	54344	79868	10195	29929	29926	4248	8818	1650	57134	57171	91869	6184	11320	1798	11253	2530	79053	5373	201595	79644	9526	29925	199857	22845	4245	2683	152586	144245	10905	85365	84620	4247	79796	25834	79087	23193	11282	8703	4121	7841	6185
WP106	Alanine and aspartate metabolism	189	2875	5091	445	2806	18	443	1615	2572	2805	2571	435
WP2485	NAD biosynthesis II from tryptophan	64802	8564	23475	23498	55191	125061	6999	8942
WP5287	17q12 copy number variation syndrome	284098	93210	124842	101060351	100170841	7006	284106	782	388381	5409	11056	246176	6871	390790	256957	26574	22806	79154	414060729873;	2064	79893	2886	80725	91608	440435	10693	79148	494188	414060	3883726351;	3975	3883729560;	146853	8396	6355	84299	54475	729877	11276	6346	3927	30837	6362	162394	6354	6356	57125	414059	5193	400591	11072	163	84961	729873	6359	8148	9326	91607	6351	3980	54883	6348	4302	100124696	146857	117584	6928	6358	4140626349;	342618	80179	84311	57151	51755	57636	101060376	6349	55106	84152	79922	91603	342667	54752	7703	9560	8557	6347	10948	40	5469	201299	6352	101060321	6357	9349	284099	101060321414060;729873;	102724862	5892	31	6360	4761	146861	146862
WP254	Apoptosis	7133	8772	8739	3660	54205	666	841	8837	3664	27242	598	7124	3551	407021	4792	4049	7157	3665	56616	8738	5602	407024	581	1147	572	355	3479	836	578	317	4793	3070	10018	9169	5970	3480	8517	596	7185	7186	5366	842	1677	5551	8737	329	1029	7132	4170	3659	330	8743	207	840	5295	332	665	843	3662	8718	3481	4794	599	3002	839	4790	4609	637	407025	27113	8626	3725	356	835	7161	4193	331	8795	8717	837	7187	1676	3661	3663	4214	6416	834
WP4542	Leukocyte-intrinsic Hippo pathway functions	83593	3683	4303	90417	55233	10397	1236	7005	100132074	6788	5906	406991	60485	2309	4023	7003	639	10971	4485	387	83706	5872	9113	26524	2533	6901	1432	930	8463	7004	10413	2308	5879	50943	23012
WP4582	Cancer immunotherapy by CTLA4 blockade	6957	8503	940	1493	942	5296	5293	5291	5515	941	5290	5295	6955	5781	5777
WP5444	Acetaminophen in analgesia and antipyresis	5743	3785	7442	3350	8989	2166	3786	5742	8912
WP4722	Glycerolipids and glycerophospholipids	5130	55500	1040	23761	137964	9791	8525	56895	56994	10400	10423	5337	8694	81490	57104	5833	1120	54675	84649	5319	57678
WP5220	Metabolic reprogramming in pancreatic cancer	5160	5211	3939	1431	2746	47	3099	22934	10498	6675	3845	7157	5162	2806	2821	6513	2875	2194	8501	4190	3158	2673	8140	8050	5238	5315	64841	6510	6646	2805	1737	4199	1738	27165	593	3156	3098	587	6120	6566	3949	9122
WP550	Biogenic amine synthesis	2571	5053	438	1621	1103	7054	2572	1644	4128	15	1312	5409	43	7166	3067
WP4271	Vitamin B12 disorders	326625	51293	6948	81693	6947	8029	4548	27249	4594	2694	166785	25974	4552
WP3656	Interleukin-1 induced activation of NF-kB	84962	3553	7189	92610	8878	3654	7335	7334
WP289	Myometrial relaxation and contraction pathways	3708	488	2869	2982	7529	5998	22809	2788	3725	8601	784	1388	5587	3487	71	26575	7534	5582	27297	2868	801	10636	3709	6013	85366	2353	5999	808	11318	111	23764	109	2776	5569	2697	5590	2783	10971	10267	8787	5575	3710	5335	2114	2551	2553	6000	467	4846	1902	3569	5144	5997	8525	5567	2782	2787	2870	6004	815	408	5588	3488	112	4790	1394	5570	60	2981	5020	5583	5581	817	4633	107	3489	5336	5576	9446	10268	2791	796	10681	5580	3486	5021	3484	1265	7532	108	2980	5579	818	5573	51764	5333	5331	6546	113	468	4635	59350	6263	59345	6261	10699	70	3485	54331	1264	64407	5578	800	2810	6001	8786	2985	489	94235	10488	57007	6262	5142	4842	5996	196883	55970	122042	3553	816	59	8490	114	1386	5566	9628	2784	2786	115	2785	133	409	1385	2792	805	1392	466	10266	6667	10287	5577	11142	58	7533	2778	7531
WP272	Blood clotting cascade	3816	5345	2244	5055	2243	2266	5054	5328	3818	7450
WP1531	Vitamin D metabolism	1591	2638	5741	1593	1594	6257	1717	7421	120227	6256
WP5055	Burn wound healing	4088	79148	207	4615	125113	43	50507	3146	2200	284004	6423	6387	8796	10468	6591	3600	3853	596	2162	6282	2312	3371	1950	3576	871	1277	2261	2263	6280	2304	7422	7178	836	7043	4312	5159	7852	7076	9314	2919	3579	7040	5175	113989832;	3383	2006	2260	4790	6277	581	259	7157	58	4313	57152	2264	6876	7042	3440	3082	79727	3624	5127	7124	3553	3569	6347	3956	1278	1634	4318	7099	3456	916	23476
WP5094	Orexin receptor pathway	5296	6513	2778	3061	5578	3062	5595	836	7428	5781	6506	5594	3091	2770	5295
WP4523	Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism	5447	1583	3283	1585	3284
WP4478	LTF danger signal response pathway	929	3439	7189	177	54210	7099	3456	7097	7124	4615	4057	5594	3553	3569	3654	4790	3552	3576	51135
WP2333	Trans-sulfuration pathway	51380	1786	4357	191	875	4548	1491	2805	27430	2730
WP5219	Diet-dependent trimethylamine/trimethylamine N-oxide metabolism 	
WP5344	Cardiomyocyte signaling converging on titin	27063	84675	2983	8048	5894	5604	200539	5594	84665	5578	2273	154	7273	8557	4077	23636	89869	153	5593	4193	83606	5567	84676	5568	5605	5566	815	2274	442206	26287	4881	5573	1410	6722
WP4316	miRNA degrading enzymes	54464	54512	87178
WP2637	Interleukin-1 (IL-1) structural pathway	4609	3556	4615	5594	10454	4155	3554	2002	5602	1326	5608	3552	4214	1977	3665	9261	23118	54472	3654	9448	3656	5601	3553	3316	51135	5599	7189	4215	257397	1386	5595	9252	3725
WP4799	Downregulation of ACE2 by SARS-CoV-2 spike protein	186	185	59272
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	2558	2566	2564	163	2557	2568	161	4804	2562	4915	2567	6464	2556	5290	1385	2554	5294	5296	387	1390	55879	160	2560	8503	57468	2559	2563	2561	112476	5335	6774	5295	2555	5291	5728	6093	2565	3717
WP5030	Ethylmalonic encephalopathy	23474	7263	6821
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	860	8091	1019	7088	4129	23592	23463	4654	1513	388585	83439	1387	1026	2660	1869	4087	7040	5468	2339	4000	8312	1052	4128	60	7480	7042	10269	324	27161	650	1050	6696	1051	6720	693120	3065	1452	7477	2932	51176	4851	4982	1499	8850	6895	4673	3726	4088	406884	122011	3280	6934	5925	23405	6932	7112
WP5180	DYRK1A involvement regarding cell proliferation in brain development	23385	3020	836	8893	1874	1408	91750	5933	7023	4851	286826	595	23132	26524	2932	55851	132660	842	51053	6598	3280	1875	1759	4772	63973	7249	2308	388585	5978	5663	1027	51107	3092	57521	84335	2247	10253	28514	5928	2475	7248	64223	64798	7157	5934	55957	273	2735	10238	1385	23621
WP5109	Familial hyperlipidemia type 2	7391	5360	26119	3990	2690	1071	3931	338	3949	335	2053	338328	4023	336	255738	337
WP4586	Metabolism of alpha-linolenic acid	9415	3992	240	239	5743	246
WP4726	Sphingolipid metabolism: integrated pathway	8612
WP585	Interferon type I signaling	1398	8554	3716	5777	5781	3932	10401	2534	5788	7535
WP325	Triacylglyceride synthesis	2819	8613	10555	8611	2710	56895	80168	8694	116255	56894	84649	2712	10554	3991	8513	3990	8443	8540	8612	57104	346606	57678	55326	4023
WP4658	Small cell lung cancer	3655	8503	3909	5296	1871	7188	4790	3674	5290	51426	1282	637	10319	1287	4609	7709	2272	3908	1026	5747	7189	898	3675	3688	208	5295	4149	79444	5915	6257	3915	1163	5925	7187	5743	1288	4616	3910	10912	595	3914	6258	112401	4792	7157	1147	581	22798	1284	1286	3913	3911	284217	6500	1869	1164	54205	1285	1027	598	10000	3918	1643	6256	841	3551	1019	3685	842	1021	7186	1030	2335	329	330	9134	207	9618	4843	1017	1647	317	578	836	5293	1028	5291	5728	4793	3673	1870	3912	596	7185	8517	5970
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	942	7248	7249	3122	5210	3101	3592	5564	7421	5294	65125	6515	941	3939	1591	5160	207	3586
WP241	One-carbon metabolism	1719	191	25902	1789	23382	275	27430	2346	7298	55349	471	10588	4552	10841	1786	6472	4522	123263	4548	10797	635	4524	6948	2618	10840	1788	4143	6470	2745
WP4155	Endometrial cancer	1647	207	2353	5594	6934	842	6932	2064	8313	369	1950	2932	595	2261	1499	2263	5293	2885	51176	5291	5728	1956	578	4616	5595	10912	4609	5894	5604	2002	572	4893	999	5290	51426	8312	2260	3611	3845	581	7157	2309	5296	1496	6654	324	8503	3265	6655	1495	2247	5170	208	1643	5295	2246	29119	10000	10297	1026	5605	83439	673
WP3670	Interactions between LOXL4 and oxidative stress pathway	7040	308	54536	4899	5310	1280	2252	23411	11140	4780	780	1728	51295	6839	84171	3490	650	2335
WP5256	COVID-19 and endothelial cell senescence	196527	84818	3605	23765	7099
WP3995	Prion disease pathway	5885	5621	2002	6908	10664	5594	5452	2534	5993	4790	2260	6688	4208	7184	1879	3309	53335	3662	5079	6256	6774	1106	4684	2033	9126	10538	100506742	5595	2923	836	5747
WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	5567	108	7422	5568	5176	5579	5566	434	1638	4157	408	7299	5331	3708	196883	6490	2776	23236	5332	2315	2778	5443	2769	115	5330	1385	409	7306	4935	4286
WP5216	Warburg effect modulated by deubiquitinating enzymes and their substrates	2475	10869	2203	3791	57646	84101	5230	5223	57695	2308	56957	7428	7422	51547	4609	3939	11338	3091	2538	207	78990	3099	6513	5294	51633	7874
WP5471	Receptor tyrosine kinase (RTK) family	2049	2260	2043	4058	2041	5754	4919	2324	114783	4920	780	2264	1969	5979	5156	2048	4233	7075	2051	4593	2050	4915	22853	6259	9625	238	2064	2066	285220	6098	2047	4486	2042	2065	3480	2044	4921	3791	2323	2321	5159	7010	2263	2261	4914	4916	3643	1956	3815
WP4883	SARS-CoV-2 and ACE2 receptor: molecular mechanisms	59272	4142	5972	185	7113	183
WP581	EPO receptor signaling	2885	10076	1154	5163	5595	3717	5605	6777	8651	3667	6772	6776	6774	5294	2056	8660	6654	2057	5604	5894	207	5594	5921	6714	5788	6464
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	5599	4835	10257	2730	1432	3162	5603	2729	9817	1244	3725	2950	4780	1066	9429	140809	2353	368	2052	5600	6300	8714	1728
WP5074	Kallmann syndrome	5594	5781	9723	429	207	3730	23129	3972	5290	10215	745	60675	6663	2885	128674	10818	5015	55636	5605	2253	26022
WP4284	Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer	7157	9134
WP4962	Airway smooth muscle cell contraction	94274	387	952	6261	2776	6093	23236	3710	5371	4638	9475
WP5066	FOXA2 pathway	10998	31	3667	6720	10257	3169	4547	2939	10599	2938	133522	338	2308	51085	8714	8660	2946	3170	1244	2194
WP306	Focal adhesion	5155	9564	208	83660	3688	394	4233	5880	7057	3908	4638	5879	2277	91807	857	93408	8711	6464	3381	60	3611	3674	3676	10298	5604	7294	3655	5228	7791	7423	387	4633	5296	2316	5058	640	7058	55359	3914	3695	824	5595	7422	5500	5582	55742	85366	63923	3690	54776	1311	331	29895	8515	23396	3918	10000	5599	29780	3265	5062	2318	3691	1292	7448	5602	2534	1101	284217	5501	3672	7414	3913	5894	6654	3082	340156	1280	10627	2932	3912	1950	3673	2317	64098	3371	6696	1399	3055	25759	5159	6093	10398	58498	7424	5293	80310	1729	4636	5063	330	6725	3678	207	7408	858	5578	5881	7094	5295	1290	56034	4660	2889	5170	7060	1793	5747	3675	998	5290	10319	1282	3909	8503	5156	5154	8516	595	22801	399694	56924	5753	3791	859	896	3910	2013	3725	87	71	5908	5594	1288	7059	3694	3915	3696	4659	10188	10420	7450	10451	5829	1278	3693	103910	673	1286	1284	6714	5923	5906	3911	572	2002	5649	7410	50509	2909	1277	3480	7148	3679	81	5601	596	5579	3479	2321	7409	3680	53358	1499	5291	1956	5728	2885	9475	106821730	7143	1398	894	2335	3685	2268	2064	329	5499
WP4487	Ophthalmate biosynthesis in hepatocytes	
WP3634	Insulin signaling in adipocytes (normal condition)	3667	2475	6198	3643	208	6194	9882	6517
WP5188	Retinol metabolism	216	112724	53630	54905	1008615401551;	316	10901	9227	8228	1548	124	158835	1543	145226	6121	195814	10170
WP4205	MET in type 1 papillary renal cell carcinoma	998	673	5879	5747	5605	1026	5062	5781	2889	3265	4233	112476	6655	5599	10000	6135	5335	6924	208	5295	2549	5296	3082	6654	8503	5604	5894	6801	572	10298	57144	5906	6714	3845	3640	4893	5546	5290	5293	2885	5291	7030	3718	3725	5595	7422	3791	1399	369	56924	5058	6774	867	238	207	5594	5908	116328	1398	106821730	2113	5063
WP4589	Major receptors targeted by epinephrine and norepinephrine	55811	150	114	108	152	112	154	107	146	151	115	113	109	111	153	196883
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	4087	207	4089	5594	860	3371	4088	6591	6615	1014	7431	5294	1004	2335	3397
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	598	581	1432	4170	10018	841	596	5603	7124	207	637	572	317	8772	842	836	840	5600	27113	6300	356
WP5038	Mitochondrial immune response to SARS-CoV-2	3661	23586	4790	4142	617	59272	7098	4715	148022	28976	340061	27035	51295	7187	9641	3665	1514	51284	186	29110	51103	5245	185	79671	64135	57506	1636	4791	7189	3438	7113	11331
WP4707	Aspirin and miRNAs	10257	5742	4790	5163	7422	4846	7471	5743	4597	5465
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling	836
WP2272	Pathogenic Escherichia coli infection	1499	7534	8440	10109	71	84790	10094	347733	6093	8976	10095	81873	10376	10382	10971	203068	4690	10092	84617	7100	653888	5578	10552	7846	7277	9475	7454	3059	998	81027	929	112714	113457	79861	347688	7099	7280	4950	51807	100506658	25	9181	4691	10383	3688	10381	2017	9076	3875	7430	387	10093	7278	56604	60	23643	2534	999
WP422	MAPK cascade	6654	8649	4133	6300	4214	3845	6416	10746	5602	7786	4893	5608	4155	2002	5594	5894	5606	5604	673	3725	5605	5595	6494	2885	5331	22821	4215	1432	5609	369	6655	6237	3265
WP262	Ebstein-Barr virus LMP1 signaling	65125	3576	5599	9448	3654	8517	7124	3551	7185	9260	115482723	3456	4215	7189	115482704	3320	1147	10454	6885	6352	6364	8717	26073	84164
WP4263	Pancreatic adenocarcinoma pathway	10912	7043	4616	7422	5595	56924	6198	4089	6774	5899	595	5058	5037	7048	5925	5594	6199	4088	5898	998	9459	3716	1026	5605	5879	1848	5880	5295	208	387	5296	7042	1871	8503	7039	4087	5604	10298	4790	5290	51426	1956	5291	5293	5888	675	578	8517	369	5601	5580	5970	6772	1870	1950	1029	5881	2064	842	1021	207	1647	106821730	5063	54101	673	1869	5062	3551	10928	2475	1019	10000	598	5599	1643	5900	7157	7046	5337	572	7040	5894	57144	7074	3845	581	1147	5602
WP5148	Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway)	718	729	727	735	59272	10747	728	730	719	2219	731
WP4876	Activation of NLRP3 inflammasome by SARS-CoV-2	114548	4790	7187	5970	3553	29108	834
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	7852	83439	7428	6932	7422	51176	6934	2034	5294	6714	7412	3371	9595
WP43	Oxidation by cytochrome P450	1581	66002	1572	1583	22952	1577	1589	51167	1576	10858	1565	51302	1544	4051	1555	199974	1562	260293	1557	1545	1727	1588	29785	1593	1591	51706	64816	1553	5447	339761	1551	9420	80777	1559	54905	285440	8529	1528	56603	120227	57834	1592	1594	1548	1585	57404	11283	340665	1584	1586	1579	1595	113612	1558	1571	126410	1582	1573	284541	1543	51700	1580	1549
WP4549	Fragile X syndrome	1374	4131	23236	1785	1977	2566	5594	2904	58512	5163	5825	6895	6566	84867	348980	2332	2890	3708	5530	6198	5909	1213	1211	26999	9894	1742	1605	10243	9524	3751	50944	224	3218	2549	2911	6464	1212	6457	1268	814	4763	2571	1915	5604	5605	1973	627	51256	1979	815	351	84335	5335	7915	57521	1175	9456	4204	5578	23405	1845	6009	1029	1981	9675	2915	5499	2554	3746	9743	4915	8831	8569	81631	207	116986	1173	8218	5573	2902	5291	5728	2885	8536	369	27161	7248	2903	160	6654	9495	23237	2891	64798	64223	1385	2534	3845	6714	2043	5526	163	5894	23426	6455	673	7249	4318	816	9463	18	5566	6529	2561	2475	2563	54869	80852	5781	23191
WP3925	Amino acid metabolism	5917	7166	4190	5166	7407	2058	3034	6999	4942	549	5160	6898	4128	30	8802	6611	6389	1373	875	5315	3158	7054	7453	4594	7173	216	501	4953	127	3067	1431	50	56922	586	26275	5409	1962	2752	1491	2937	5009	445	151742	6723	47	3376	131	3939	384	128	4357	10993	5832	4967	790	5091	92935	8050	2184	1621	2730	1738	635	2806	2271	34	3155	84532	23395	5831	2744	2746	10056	3176	84706	1644	440	1743	57818	5105	126	383	11112	3033	3417	2936	10841	4191	8974	8639	2805
WP5231	Hippocampal synaptogenesis and neurogenesis	1385
WP5037	Riboflavin and CoQ disorders	54840	23590	56997	27235	57107	51004	55312	79581	80308	57017	2108	10229	2110	55065
WP534	Glycolysis and gluconeogenesis	230	2538	5213	5211	25874	3099	6513	2821	2806	3948	3101	5224	229	4191	2027	3098	2026	2805	54858	1737	51660	5105	5313	6518	3939	5160	2023	6515	4190	7167	2203	2645	5315	5214	3945	5232	226	1738	92483	6514	5223	8789	5230	6517	2597	5091
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	8321	9509	64175	4041	5352	121340	5033	387733	5479	8600	649	60681	7471	90993	79709	5351	4982	375056	8720	5176	4015	51360	10491	5034	8974	4040	55151	1278	871	55214	3708	1277	8792
WP673	ErbB signaling	2069	815	2308	1026	5747	5605	5170	5295	208	5296	1978	2549	5336	27	8503	3084	9542	817	7039	5604	10298	4609	5290	6464	374	5582	1839	3725	5595	56924	6198	4193	399694	595	6776	5058	867	5594	6199	6416	1027	673	816	868	5062	25	6655	2475	3265	10000	5599	7157	6654	10718	2002	685	572	5894	57144	3845	6714	5602	4893	1956	5291	818	2885	5293	8440	25759	53358	5579	6777	369	5601	1399	2065	5609	2932	10018	1950	4690	2064	5578	2066	207	1398	145957	106821730	5063
WP183	Proteasome degradation	9861	3105	7321	7323	5718	5684	7317	5686	5695	3135	7316	6184	5687	7314	3014	5708	5682	5713	4734	3015	5711	5692	3134	6185	3136	5694	5696	5719	5720	5685	3137	3107	5701	5690	8335	5709	3106	5716	5699	5714	10197	3133	5691	5717	5693	5700	5706	5721	5704	7318	5707	5688	7345	5710	5702	7322	5698	7347	5705	5683	7320	5689	3458	5715
WP5187	mRNA vaccine activation of dendritic cell and induction of IFN-1	57506	51284	8792	64135	23586	7098	3661	3665	3140	51311
WP2881	Estrogen receptor pathway	6774	1543	1544	2099	8431	51	3725	6667	5166	1545	5465	5105	57678
WP3680	Physico-chemical features and toxicity-associated pathways	2876	6647	23209	5216	5599	345456	5217	4842	2535	91807	4741	5747	7039	23002	5524	4609	8312	5294	387	8323	58	8321	6654	324	6777	1855	644914	57379	2932	7481	2885	8324	1499	8326	7976	3725	8322	131096	115482696	8325	7855	6416	11211	9475	867	7114	4747	51384	4690	200315	4744	2335	375189
WP1602	Nicotine effect on dopaminergic neurons	8973	2770	54331	1020	1141	1815	1644	84152	7054	1136	6571	5499	5566	1813	1814	3777	51305	108	1137	1138	2782
WP2855	Dopaminergic neurogenesis	5309	2637	4487	6469	7054	6774	4929	1028	6571	2020	2019	2736	4760	4009	2253	7471	429	7040	63973	4821	2735	1644	216	5979	6657	4825	5015	4010	3170	6531
WP4921	Mitochondrial complex III assembly	7386	7384	7381	1537	7388	90624	55245	84300	27089	790955	10975	29796	54902	617	7385
WP3640	Imatinib and chronic myeloid leukemia	5159	2321	4839	5243	5292	9846	5156	3815	1027	2309	200734	613	9429	6502	4066	11040	25	1436	4609	1647
WP4564	Neural crest cell migration during development	4313	387	5294	8503	2151	375	10298	57144	7074	146850	2353	207	5290	5063	2049	2050	4804	1009	5291	5293	2051	7291	627	5879	4317	7204	30849	3725	4318	23533	56924	5062	2047	25791	208	2048	10000	5058	6774
WP5198	Inflammatory bowel disease signaling	50943	3596	30009	3594	3606	3725	7099	51561	3458	3565	4094	149233	8807	64127	6774	50616	3561	2625	6095	6778	6772	3569	59067	7124	50615	7100	7097	6775	6097	3459	4772	3558	3552	3566	4790	3605	3595	3586	4087	7040	3567
WP5120	Inclusion body myositis	4790	23385	2660	55851	23621	23411	4791	5664	5663	4137
WP5152	Iron-sulfur cluster biogenesis	2395	27247	3313	2230	4682	51218	9054	23479	10101	26502	51647	22	57128	2232	150274
WP4313	Ferroptosis	1536	3315	6520	5094	50507	1646	2879	81539	94033	2181	10533	81631	1491	23657	2643	5447	27235	8644	79643	84883	571	9474	1645	2495	1356	3162	55240	2937	3156	3658	7419	23516	7037	1803	7296	112483	27035	8031	51510	7157	55847	64116	2512	4891	7417	84557	51703	5261	5621	246	5093	2180	6510	23305	6303	2222	7018	2182	10162	2730	30061	2729	875	440738
WP3627	Gut-liver indole metabolism 	1571
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	4893	115	3845	79188	7040	5604	4087	1490	2010	4293	6654	8815	7042	107	387	6901	23592	3265	6655	196883	1072	55249	114	55811	5605	112	23345	163183	113	4088	109	111	5594	7112	23224	3799	4089	108	5595	5339	7043	161176	23353	6722	2885	3930
WP4746	Thyroid hormones production and peripheral downstream signaling effects	2885	10818	6567	5208	4193	1734	6469	6198	5346	7068	2932	9728	53919	4160	405753	6009	7270	4879	11343	842	389692	1735	26291	63976	7350	207	5594	51548	152831	64132	117247	389434	4881	1386	5172	2308	27330	7249	7200	51412	23028	155	6194	181	364	84335	7067	9882	1432	3710	7157	5443	5294	8458	64223	50506	7248	57104	51780	4852	1733	7253	5468	9572	5894	5604	572	6528	1385	9658	2260	6714
WP4971	Phosphoinositides metabolism	8898	23236	9107	3635	9110	5289	10903	90809	113026	54893	5293	6305	5291	5728	5333	55613	5331	5288	81846	5294	55529	79837	51196	54545	5336	4534	8897	5332	84812	200576	9108	66036	23007	5330	8395	5290	8394	8396	8776	4952	5305	30849	9651	5287	22908	5286	5335	89869	23396
WP4269	Ethanol metabolism production of ROS by CYP2E1	23764	5604	4780	1571	5605	5599	4097	7975	6667
WP111	Electron transport chain: OXPHOS system in mitochondria	291	7388	1340	4538	4722	4711	29796	4697	4713	1327	6341	1346	498	7350	9551	4508	4719	1355	7381	1345	4539	6834	509	4509	6392	522	518	4718	1350	9377	521	4514	4728	4537	4541	4698	6391	4705	4723	4704	4706	4729	10975	292	516	1329	55967	4717	4712	4700	4701	4724	4726	7352	1339	4709	293	27089	4696	4694	1347	4731	4720	4519	93974	6390	9016	4695	10063	4513	9481	4540	4708	374291	51079	513	4725	539	1353	506	1351	4512	4536	10476	7386	514	7384	4715	517	27109	1348	9167	10632	4707	1337	6389	7351	126328	4702	4710	4714	4716	7385	4535	1349	515
WP5366	NF1 copy number variation syndrome 	106480489	60412	121504554313;8294;8359;8360;8361;8362;8363;8364;8365;8366;8367;8368;8370;	6853	3198	4661	5883	5717	55803	9475	9134	4170	23586	84282	5888	5983	55770	1956	1876	545	51379	65078	5442	10988	596	2145	7398	1950	3632	106480943	8766	106481975	5982	6654	84440	51466	382	5894	6383	79736	1407	106479546	2123	100616248	8726	4803	890	8661	203068	106480065	83508351;8352;8353;8354;8355;8356;8357;8358;8968;	440423	106481273	100616266	5187	3720	2124	5594	23265	57599	4804	4214	5931	3205	406968	10419	5595	206	1786	10640	3984	6829	5984	4974	387	100616449	79915	149371	5937	27436	54536	4763	10746	898	6845	100126356	11336	55763	503645	55813	5111	3456	57506	23512	11282	1072	55352	126961333932;653604;	5985
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	3156	10891	3157	51548	2475	6720	51586	6721	10062	2194	5562	19	3949	23411	6319	5465
WP4583	Biomarkers for urea cycle disorders	445	5009	162417	2593	2155	2628	2875	383	435	27165	2805	2159
WP4723	Omega-3 / omega-6 fatty acid synthesis	51	60481	9415	54898	2180	2182	8310	3992	10965	641371	2181
WP3967	miR-509-3p alteration of YAP1/ECM axis	1277	7005	9564	1281	5090	1289	7058	6591	1909	6678	7291	2335	10413	7004	7003	10082	100126337	8463
WP3853	ERK pathway in Huntington's disease	3064	1956	840	836	5605	5595	627	9252	2002	5594	5894	5604	1385	2911	1950	4915
WP4661	Amino acid metabolism pathway excerpt: histidine catabolism extension	84706	2746	144193	3034	131669	10841
WP2261	Glioblastoma signaling	4893	5290	5607	2260	3845	6714	4763	4303	4194	5894	5606	5604	7248	5583	5336	7157	2309	5296	5294	2549	5156	208	5295	5335	5286	10000	3265	10253	3667	4233	1019	5170	1031	5287	2956	1869	1026	5605	7249	673	5588	898	1027	2308	5608	6416	54206	672	1017	207	894	5594	5590	1021	1030	2064	5578	5925	1029	867	472	5609	595	4193	5580	2065	5288	3480	369	5595	5579	675	5584	5159	5582	2263	2033	2885	5293	5728	1956	5291
WP5324	Octadecanoid formation from linoleic acid	2879	1579	1544	59344	246	79852	1576	1558	1559	1557	242
WP4808	Endochondral ossification with skeletal dysplasias	4256	7040	54407	445341	6660	2260	5745	4322	50515	4208	7042	1280	176	5167	11127	6662	3549	3481	2688	11096	5328	2247	55553	8817	860	7067	1473	5727	5744	5566	1300	2737	4318	579	207	655	2690	8100	7078	864	801	5741	4921	6772	3480	6696	3157	5327	6777	657	871	1515	2261	654	9759	9510	85477	9507	249	1028	7422	2487	3479	51719
WP1423	Ganglio sphingolipid metabolism	6489	2583	30815	6482	51046	6483	8869	29906	8705	127550	2523
WP268	Notch signaling	1856	182	8650	2648	5664	1857	3066	196403	3280	80309	6868	8850	171558	23220	23385	11317	3762	4853	4851	1840	1488	3065	10683	1855	9794	3955	55534	5986	9253	4854	3516	9612	1387	4242	388585	151636	3714	5663	83464	51107	4855	54567	1487	113878	7124	28514
WP5213	Amino acid metabolism in triple-negative breast cancer cells	5723	23657	6510	29968	6472	6513	2744	26227
WP2571	Polycystic kidney disease pathway	8325	6752	7855	11211	51422	2353	89780	2770	91544	53632	2776	2064	3783	7475	1080	1856	5136	80326	5563	6009	51384	1857	595	7477	2932	7481	7472	7483	1950	1855	7474	3791	7476	3480	5311	8322	81029	3725	3479	2321	5595	5571	8324	1499	8326	2767	7976	3845	7479	6714	5565	7484	4893	7471	7482	7473	5310	4609	7248	7423	7480	8321	8323	2778	5336	7478	3551	7124	2475	6197	54361	3265	7249	2771	673	2773	5562	5605	6794	2535	6558	5564	112
WP560	TGF-beta receptor signaling	7044	7046	3624	4790	4086	3976	10637	4087	7040	7471	4092	8928	1387	3716	7050	6498	4090	3265	5054	7124	9241	860	7057	3694	4091	7048	4093	9839	864	4088	4052	2280	25805	2353	5595	652	23090	3725	6497	7049	1499	3458	7030	2033	51176	1950	9372	6774	6772	10468	6696	2022	4089	5601	407028
WP1528	Physiological and pathological hypertrophy of the heart	4776	5606	5594	2353	3977	1489	387	2626	5581	817	5600	3572	183	5530	5599	6774	1432	1906	50804	5532	3725	5879	5579
WP716	Vitamin A and carotenoid metabolism	116362	5959	50700	1382	220	6817	6256	5948	56603	1592	158835	5947	9249	5915	8854	6017	6257	157506	948	6258	6820	127	64241	5914	5916	949	53630	4023	64240	1381	1571	83875	216	195814	5950	6121	145226	29881	124	54884	5594
WP428	Wnt signaling	5599	85409	57680	23401	4773	816	80319	59343	2535	6422	8312	81839	1459	5602	7473	283106	7471	23002	5533	324	4920	5332	4041	7480	8323	8321	7477	1452	2932	1457	7472	5601	1855	85407	5579	818	51176	1460	1499	7976	5331	5532	7855	9475	4772	22943	894	6885	89780	6423	5578	1856	6932	23500	9350	1487	64840	5328	54361	6424	83439	5879	5176	27130	815	2239	144165	5330	147111	7482	6425	51701	4609	817	4919	56998	27121	27123	387	50964	1488	595	7481	64321	7474	4040	7476	1454	5530	3725	5534	57216	11197	81029	4775	83999	896	166336	8324	8326	10023	5582	8325	11211	4776	6259	5535	23236	7475	80326	8061	6934	51384	1857
WP363	Wnt signaling	
WP4238	Flavan-3-ol metabolic pathway	
WP5202	Alstrom syndrome	80173	7840	28981	6811	23432	55968	6608	51668	26160	11020	5991	353116	7283	4645	7415	5989	7029	80124	128344	1874	5990	55330	5727	23557	55125	26052	84984	81	11159
WP3945	TYROBP causal network in microglia	375035	375387	64092	170954	951	79690	3142	10184	6039	864	10312	55803	4066	58191	3606	822	54518	202309	84695	3687	6776	54360	10257	3684	10577	718	64764	6696	51411	7046	10019	10261	920	23307	714	3071	2000	6195	10008	3689	3587	113277	1806	5341	7133	4688	678	54502	7305	9056	3059	3597	4094	26157	5996	6510	8832	654346	2876	29108
WP5063	FOXP3 in COVID-19	3570	3575	3560	50943	940	942	3572	6777	3569	3559	6776	6774	3561	941	3558
WP35	G protein signaling	9138	11217	6548	27115	5150	387	107	2790	2769	5576	5581	5583	10566	5144	10142	5575	2768	112	5588	8165	2782	11215	5567	2787	111	2770	109	801	5136	2781	2783	2776	2774	5590	5530	2775	6237	9465	3708	3760	5587	5582	2767	2788	9472	5568	2792	3845	2785	115	4893	2778	9495	5533	9630	5577	55970	11214	196883	3265	5142	5566	2786	2784	2771	2773	114	23683	9590	5141	5143	113	11216	94235	5137	5578	10270	10681	5580	10672	8852	2793	2791	5151	8622	5153	5331	51764	5573	5584	5579	108
WP4789	Multiple epiphyseal dysplasia and pseudoachondroplasia genes	4146	1298	1299	1311	1297	4148
WP3300	Dual hijack model of Vif in HIV infection	6921	865	6923	60489	8065	9978	106478911	7314	861
WP4331	Neovascularization processes	4318	7852	7422	5595	7043	5747	4791	5599	2048	54567	4090	3791	5601	5970	5971	5966	182	7046	2324	7042	5294	4854	4086	4790	2050	207	7040	4087	284	3091	4088
WP195	IL1 signaling	
WP4507	Molybdenum cofactor (Moco) biosynthesis	7498	10243	316	6821	4338	54996
WP5190	Creatine pathway	2628	1152	6535	4942	2593
WP4191	Caloric restriction and aging	10135	23411	5564	207
WP5178	Disorders of fructose metabolism	7167	3795	229	6652	216	2821	6514	5236	3098	5211	2203	132158	2538	6523
WP4846	SARS-CoV-2 and COVID-19 pathway	59272	43740570	43740578	43740576	43740568	51284	340024	6646	5045	1514	8829	56649	7113	43740569	43740571	43740574	43740577	43740572	949	43740575	43740573
WP4657	22q11.2 copy number variation syndrome	5894	5649	4942	84222	25786	150197	6097	7157	29102	5297	27037	2255	128989	23617	9978	6899	1013	8841	150209	5905	9127	7353	59	6517	60385	2814	5308	1365	70	8318	3280	10892	648980	64976	7625	6576	9993	54487	23752	113691	4099	29801	80764	5625	340665	1399	596	9681	6469	2296	6720	1592	5347	9611	56603	91179	26220	1813	1956	8218	8646	79680	6545	2263	421	65078	7514	284361	2815	85359	5077	7290	10298	5902	2260	266697	9076	8479	6721	2303	5430	2811	8359	10587	57142	8659	1482	10641	8131	7122	1312	100133163	642643	998	84861	8216	3842	3053	23176	2746	54584	23468	440799	3837	55752	2812	645348	7450	388849	8452	2928	9464	8220	3170	2637	373856	8854	101928891	1104	5901	25842	5071	100652736	9342	6722	100996435	51586	400891	400892	5500	8036	2253	406	728418
WP5441	Artemisinin inhibition of uveal melanoma	2475	208	10000	5294	207
WP5103	Progeria-associated lipodystrophy	4087	5965	4089	4088	5468	142	2339	4000	7486	3763	23463	84823	8815	83932	4001	10269	2200	5424
WP4224	Purine metabolism and related disorders	3251	10606	7172	353	5631	7498	5198	3704	158	100	3614	2618	1716	270	50484	2915	471	316	159	4860	5471	55034	4144
WP3933	Kennedy pathway from sphingolipids	55500	5130	9791	56994	10400	55224	10390	8879	81490	9468	5833	1120	1119
WP4016	DNA IR-damage and cellular response via ATR	7158	4361	6118	2237	51720	5883	22897	2305	2177	9656	1017	8493	672	11073	8318	55775	1196	4292	84142	2175	8924	5888	995	9521	5976	675	545	11200	7507	5893	5965	9401	8517	4193	142	604	5347	80010	4436	472	55159	7398	3014	6117	4683	79184	7157	7520	1111	5371	580	5932	983	6667	7156	5423	9400	7979	63967	9937	79648	7323	10111	7486	9156	50485	4171	353497	83990	55215	84126	5884	5111	1869	5591	8243	10155	6601	3364	79728	5810
WP2815	Involution	4318	1116	1869	7157	581	6774	999	3572	6777	9021	4609
WP691	Tamoxifen metabolism	1576	7366	7364	2328	1571	1558	1545	1559	1557	6817	1577	54575	2326	54657	1548	6783	1544	1543	1565	6822	54576
WP5112	Familial hyperlipidemia type 5	336	337	3949	116519	335	344	64788	338328	4035	4023	3990	1071	3931	5360	6400
WP5044	Kynurenine pathway and links to cell senescence	440275	847	23475	27102	688	6999	3620	196	130013	7157	7850	169355	8564	23498	7124	7099	3456	51166	1026	2308	125061	8942	3458
WP2943	Hypoxia-mediated EMT and stemness	6935	23405
WP4823	Genes controlling nephrogenesis	7852	5159	2253	7422	2263	8440	4853	1499	2138	8516	2297	2668	6928	3791	2118	6469	2296	6387	3237	23607	4868	2018	4690	6495	7827	3207	6943	3975	2737	3675	9353	7490	3688	5155	55243	948	54361	4010	2303	5979	6092	3611	5076	3913
WP4873	Peroxiredoxin 2 induced ovarian failure	581	10038	5602	7001
WP4480	Altered glycosylation of MUC1 in tumor microenvironment	7124	3551	8517	3569	5970	4792	4790	1147	4582
WP5394	UDP-derived sugars synthesis in fibroblasts	3099	5236	3098	2673	3101	5238	7358	2645	80146	2582	2821
WP5355	Metabolic epileptic disorders	3141	1373	6517	6470	226	5315	5214	3945	5232	2645	4190	28972	29968	5160	6518	1491	7498	51660	102724560875;	26227	2026	38	10166	27165	27304	5723	2628	2731	23474	5224	501	3101	6576	6513	275	1036	2597	5091	5230	8789	4338	5223	6514	6510	1892	92483	1738	6472	292	2203	58472	7167	2875	10243	10157	445	5009	2023	6515	686	3939	2639	3033	51166	48	5313	5105	4337	2805	54858	1737	94081	3098	2027	4191	6821	229	3948	2806	2821	25874	3099	6542	5213	5211	2746	230	2538
WP3602	Metabolism overview	
WP383	Striated muscle contraction pathway	7140	7139	4634	7111	71	4632	7169	59	10398	1756	4607	89	81	7135	7431	4621	4604	8557	7170	4606	7273	7137	1674	58	7138	7171	4703	4633	7136	8736	7125	7134	7168	70	4635	4624	4626	88
WP4905	1q21.1 copy number variation syndrome	5565	51422	2703	171423	4301	403228	644861	53632	2697	265	100873744	27134	403230	9414	5563	9557	26108	100506658	110806291	7082	2702	55243	51205	149013	2330	5562	100270895	50848	5571	2700	1499	403229	106479316	607	90780	644131	5564
WP4558	Interferon-mediated signaling	163702	56832	5578	3451	7297	3439	282616	3440	3459	3444	5290	3446	3588	6773	3447	3455	3448	282617	3442	3717	3456	3454	3467	3458	3716	3452	101180976	3445	3443	5295	3460	3441	10379	282618	3449	6772	338376
WP3888	VEGFA-VEGFR2 signaling	10525	3146	5654	91010	6125	10973	56907	83473	5710	6921	1267	9325	8813	8664	9578	10056	5784	9209	9114	91624	2746	4673	8665	71	84790	813	6142	2314	4343	7086	51309	9584	8867	4641	8974	26058	213	3998	51763	7024	7001	6729	55854	1200	8775	54505	8402	5757	23521	3939	11217	55692	2597	682	347688	3418	5496	5230	7111	4736	6301	7170	2035	4691	9659	23339	6624	1175	23597	23196	10963	8650	2335	8826	55379	3045	5226	6154	5954	29109	357	5499	9898	7114	1465	1981	391634	9100	6205	11080	9645	832	5515	9168	10130	5717	10574	6902	1192	8667	84952	811	9344	6747	10061	6181	1666	115098	1466	170506	6155	57326	9444	5034	4629	81567	81873	27044	2058	2926	160	83442	7531	3301	3320	7019	6732	9513	23189	378	6418	4646	781	1823	6129	1397	152273	6748	1982	22820	2130	26986	4952	8575	8985	23215	529	301	9588	29766	226	553117	5216	3491
WP288	Nod-like receptor (NLR) signaling	5970	3551	6885	8517	1147	958	5599	55914	2048
WP3613	Photodynamic therapy-induced unfolded protein response	10130	9695	440	468	22926	57761	4189	4677	51726	121506	7184	3309	1649	6783	7324	467	10018	7453	83939	7494	2081	4780	5611	9451	811	27113	23645
WP4686	Leucine, isoleucine and valine metabolism	64087	11112	3712	5095	3028	4594	4329	38	1629	587	1892	1738	593	594	5096	197322	23417	54511	549	27034	26275	56922	586	36
WP4963	p53 transcriptional gene network	53632	8795	126129	5563	3663	8408	94241	136	9706	23657	27113	356	57103	4292	10572	10379	54541	144455	406937	5429	55367	3383	51426	79923	64393	63970	27244	407040	5111	5562	1026	575	7832	898	407042	407041	6347	84335	5268	6303	83667	57521	8659	80328	6790	7057	2876	2810	5366	900	80329	6513	51422	2176	1017	1647	9618	55332	355	317	5571	4851	995	5728	4436	10879	27165	406985	2073	5371	50484	7520	64223	64798	9540	5565	2517	581	64065	8793	3976	9636	4688	6376	84129	4255	7249	9997	5564	56475	1643	7508	5054	2475	7124
WP5091	Frustrated phagocytosis leading to malignant pleural mesothelioma	
WP497	Urea cycle and metabolism of amino groups	445	5009	6611	5832	162417	2593	1158	5831	6723	4953	2628	1152	1373	383	4942	2746	65263	435	384	95	1757
WP5381	Smith-Magenis and Potocki-Lupski syndrome copy number variation	29109	3996	23026	84612	51422	8100	26959	9318	84229	84223	8741	85478	6738	140775	2119	26146	10400	2873	10890	56288	92749	1819	5584	6093	150737	51655	1408	7030	641	5728	116442	10018	51138	96459	80010	55255	10670	57560	5970	23059	6720	55090	105371564	28981	9020	2622	54472	983	3705	222235	7157	64223	11020	55081	10498	10743	581	90410	4218	10193	23426	10062	79018	6470	9575	374986	5564	1407	4289	54329	83450	84895	2475	23164	7124	8562	3553	50813	56912	23274	10987	140771	10980	222894	3170	115811	4659	80173	5187	25852	639	3394	1073	201164	8408	146691	51668	79989	60673	2538	4615	55502	406	57600	84288	3725	125170	7376	51098	10296	5105	10413	3984	2314	91647	6774	5071	693120	7942	1211	1213	10920	201163	7156	79781	2665	4620	64795	322	387	1212	26160	51168	10048	384	3169	4790	202500	8533	3939	203228	4609	54890	80232	56953	5562	25937	7099	116028	9821	9776	9101	351	23495	57521	64792	94274
WP4842	Mammalian disorder of sexual development	3640	1761	6736	23543	2516	50846	6662	2254	5600	5730	30812	268	2626	2018	5087	269	7490	10468	54361	668	284654	6715	1499	84733	2263
WP1559	Transcription factors regulate miRNAs related to cardiac hypertrophy	7040	207	50804	407021	5923	6774	5534	4790	208
WP2874	Liver X receptor pathway	6720	6319	1576	64240	1555	1581	6256	64241	2194	10062
WP391	Mitochondrial gene expression	
WP136	Phase I biotransformations, non-P450	3988	2098	5444	5446	8824	5445	1066	221223
WP2118	Arrhythmogenic right ventricular cardiomyopathy	81	3679	1824	3695	22801	27091	10369	488	8516	3673	59284	51176	71	778	87	59285	9254	1499	782	3680	784	1000	786	3690	3678	779	785	6546	6934	6443	5318	8515	1674	55799	2697	3685	3696	3694	6932	93589	1495	1756	89	27092	6262	29119	3688	775	6444	3675	83439	776	6442	3693	3908	3691	2010	59283	3672	781	3728	1829	783	88	4000	3676	3674	6445	60	10368	1832	1605	3655	1496
WP4944	Mitochondrial complex I inhibition leading to chemical-induced Fanconi syndrome	
WP5116	SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation	3661	57506	3456	23586	7189	9641	7187	29110
WP4673	Male infertility	5243	11218	4318	367	6470	9985	9575	55124	4780	904	57055	1191	140690	150280	4842	2100	55423	7508	27030	7124	27161	7520	4313	2346	8290	3983	3981	29968	56979	57119	6716	124404	905	5896	3159	5620	57135	355	124842	7320	675	7516	128153	30827	9194	5981	2033	3643	8476	54456	9319	56603	6948	51087	4522	5192	596	143689	1586	222229	440822	340719	6406	1728	55818	1543	23369	196	3817	4843	10400	2119	83844	7180	2099	4057	113235	283629	1617	58531	5726	9271	1387	140885	7518	23304	9101	5428	635	4548	339834	57054	8812	4438	116511	4846	158983	8359	2876	7057	346673	5423	26609	55170	2068	373863	5395	6660	8900	4477	10537	94240	4439	1025	23626	406	1618	57491	5619	343171	356	5444	7517	4292	676	84072	472	1106	54514	4524	4193	56154	2775	142	6648	83983	4552	3122	8787	338	2067	847	5445	135138	6649
WP4262	Breast cancer pathway	595	7481	472	6198	7474	7476	4040	142	26508	2248	399694	81029	3725	2251	10912	4616	2253	5595	3815	10023	8324	8326	8325	122011	11211	2353	5594	2249	6199	672	23493	7475	6934	80326	5925	8822	51384	1857	4855	54567	5295	208	2247	8817	54361	8202	28514	8823	6424	8648	83439	1026	5605	3714	2260	5290	51426	6464	7482	5604	4609	8503	2324	2252	5296	1871	8074	4854	7477	1452	1457	2932	7472	1870	1950	1855	369	10683	8313	3480	25759	675	53358	9965	3479	545	578	26281	51176	1956	5728	1460	2885	23462	5293	4851	5888	4853	4791	1499	7976	7855	3280	89780	2099	207	1647	26291	2064	1856	1021	6932	4361	10000	2246	23401	1643	2255	2475	6655	1019	3265	2100	673	5241	10297	1869	6500	1070	2535	388585	3845	581	10111	8312	1459	4893	7471	283106	2250	5894	8600	7473	6667	6654	324	4041	2254	27006	7480	4683	8321	8323	7157
WP466	DNA replication	990	4999	29935	5985	4175	81620	55388	5000	5111	5424	5426	4171	5422	4173	5557	6119	5983	5427	7311	5981	5558	8318	23649	8317	4998	5425	23594	1017	10714	23595	5982	5001	4172	10926	6117	4174	4176	7316	57804	51053	6118	5984
WP5280	Glucocorticoid biosynthesis	8644	6715	3290	1589	1576	1645	1584	6718	1109	873	1585	1646	3291	6716
WP2249	Metastatic brain tumor	406885	406888	4609	406887	23677	5295	1871	998	7157	406883	406881	406886	407021	407026	406890	1021
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	338	3949	335	344	4023	336	949	255738	302	19	26119	348	3990	4547	1071	3931
WP4397	Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors	692094	10664	729230
WP51	Regulation of actin cytoskeleton	8395	4893	3845	3672	57144	2250	5894	7414	2254	2256	6654	324	1133	2245	2909	1131	27006	22808	79837	23396	5829	5286	2246	55845	6655	5216	55970	2255	5062	28964	10297	673	8396	8394	9475	5063	5597	1398	138429	4628	2335	26291	8826	5881	7114	5962	1950	442775	10672	9965	26281	5159	7409	1132	6093	2263	2261	1956	5291	1729	4634	5293	5290	60	8936	50649	10787	2260	10298	6548	9138	4342	5604	26999	54961	8503	7429	2264	8074	10152	2257	7430	387	2252	5296	5154	5156	5294	5155	5295	9564	22800	624	5880	1072	5287	8817	2247	5747	1793	5605	5879	4638	2149	8823	30849	5305	998	9459	8045	929	2768	7454	1073	4478	8874	1128	5596	5594	2249	81624	5289	54434	10458	85464	4659	2147	8822	2258	10092	623	3984	1445	5058	10163	286472	23533	5288	6237	2248	56924	1129	2934	2251	4632	55740	2253	5595	2259	71	87
WP2332	IL11 signaling	3673	3589	6774	596	3572	6198	9021	6772	5970	5595	2885	207	5594	5295	332	6194	5170	3551	860	5781	8554	3590	3265	2242	3717	5605	3716	7525	1147	6714	2534	3383	1385	3381	10401	5604	7040	5894	466	5524	632	5296	6195	7297
WP5227	Thyroid hormone imbalance leading to neurodevelopmental abnormalities	
WP5474	Catabolism of skeletal muscle in cachexia	4089	3569	8517	3553	3551	7124	1051	3480	5970	8742	2475	57521	6774	84335	3570	3716	4791	5163	2660	3479	3554	4087	207	4088	84557	4790	1147	3552	64223	5294	7132	2309	114907	5971	51330	4792	92	5966
WP395	IL4 signaling	6198
WP4241	Type 2 papillary renal cell carcinoma	7030	405	253559	1729	1513	2033	112398	7422	8453	1026	7043	7428	1387	9915	79444	7942	5155	9978	54583	81578	7042	2271	2034	29072	6513	1856	112399	6421	3091	7040	7039	6923	6921	5546
WP5156	SARS-CoV-2 replication organelle formation	53349	5289	8678	55626	22863
WP2289	Drug induction of bile acid pathway	7421	1576	8714	123264	1244	9970	8647	6554	5243	1581	570	200931	8856	9971	10257	10599	6822
WP4255	Non-small cell lung cancer	6777	369	6258	6774	595	6776	6789	1870	1950	5291	1956	2885	5293	5582	5163	3718	5579	836	10912	578	4616	5595	5594	207	1647	1381	5925	1029	2064	5578	238	842	1021	5915	6655	1019	6257	3265	5335	10000	6256	1643	841	5295	208	54205	673	1026	1382	5605	1869	2272	7039	572	637	5894	5604	83593	27436	3845	581	5290	51426	4893	11186	5296	1871	2309	7157	5336	8503	6654
WP205	IL7 signaling	
WP3877	MYD88 distinct input-output pathway	7096	54106	51311	92610	7189	7097	3725	7099	7334	7100	3553	4615	7335	3654	10333	51284	81793
WP5424	Omega-6-fatty acids in senescence	23411	231	5743	240	3992	6916	6578	59344	1800	246	241	4056	64174	2678	5321	27306	4048	2053	8644	5742	54898	60481	2950	2876	2687	11283	239	247	9536	644914	5740	10257	9415	10
WP5277	Steroid hormone precursor biosynthesis	6715	1589	6718	3284	3283	1583	1586	6716
WP15	Selenium micronutrient network	4791	5970	4790
WP4742	Ketogenesis and ketolysis	1376	38	622	7351	788	6566	5019	6513
WP5362	TAR syndrome	3107	5174	142680	6613	3106	4116	653519	84265	5045	3134	200035	3688	129531	4233	7295	10623	10158	10621	8764	3135	2322	5294	8799	57805	10401	9775	9368	7329	3105	4790	2972	284615	114814	7852	1182	3458	148738	1956	128077	27246	116085	6774	9748	23786	54541	3932	9939	148741	10622	6583	1080	9855	8515	10628	3066	23411	84305	11126	10616	11216	463	9112	1759	3133	57817	919	5824
WP2436	Dopamine metabolism	1728	7299	5516	1312	5566	5568	5567	6647	1644	4128	7054	5515	4129
WP4861	Endoplasmic reticulum stress response in coronavirus infection	90673	81706	3309	5511	151242	5509	5610	84557	5501	8720	9451	84988	51360	79660	7494	89801	23368	5599	1649	54866	94274	4659	5499	22926	468	84152	55607	27102	54776	100996758	5500	23645	5514	2081	26472	26051	5507	648791	5510	5502	5504	5506	84919	596
WP5315	Sebaleic acid formation and metabolism	240	9415	3992	4051
WP3408	Evolocumab mechanism to reduce LDL cholesterol	3949	255738
WP4518	Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases	1800	26873	79017	2678	2937	2729
WP5119	NIPBL role in DNA damage - Cornelia de Lange syndrome	11335	9656	3014	472	545	9025	25836	165918
WP5097	CCL18 signaling	207
WP4290	Metabolic reprogramming in colon cancer	1743	10606	6888	57103	6390	5230	5223	3418	2597	29920	2539	4191	5315	6472	7086	2618	6510	2806	2821	6513	9123	2271	5226	5162	3101	8801	5831	229	3419	5723	2194	2746	47	2744	3939	5160	5211	50	29968	5471	2023	22934
WP3891	Benzene metabolism	4353	1571	2052	2944	1728
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	84674	639	4210	22900	3324	8767	55655	10980	842	331	50506	4792	834	10392	58484	114548	14	1147	147945	838	10910	840	4671	5879	22861	3606	5970	199713	3553	8517	51079	9447	3551	29108	91662	841	338322	64127	9744	55914	64170
WP4228	Vitamin B6-dependent and responsive disorders	11212	8566	55163
WP5347	IL26 signaling	836	4513	4312	3576	74614	20297	2042	6774	9021	6772	5970	16189	4353	12977	3588	4772	3605	55801	4318	18126	59	1673	81501	21926	1513	245972	1437	90865	1649	7124	3569	3553	100187907	77125	6364	16171	20310	6097	16163	53832	3383	581	12519	4087	3586	8600	7040
WP4539	Synaptic signaling associated with autism spectrum disorder	116444	6198	2932	5728	5291	2902	5293	5571	2904	5595	2906	2905	5594	207	8831	4915	51422	5563	6009	53632	9456	2475	3265	57521	10000	5295	208	775	116443	5564	7249	816	5562	627	814	4763	85358	3845	2911	5565	5290	4893	7337	5296	1978	23237	8503	2903	1742	7248
WP5398	NRXN1 deletion syndrome	2892	57502	2906	2903	1742	2904	116443	2902	54413	22871	2891	2893	2890	9378	57555	116444	2905
WP5352	10q11.21q11.23 copy number variation syndrome	55753	23451	999	8065	114548	1103	100422895	644168	196740	4086	9188	658	3299	2002	650	2073	55183	9031	4090	6924	58504	10514	5599	1738	6601	9241	5111	282966	8200	9575	1386	56478	3727	6598	8505	51548	170370	8467	1161	6572	4221	118461	23411	4093	657	4756	83737	143162	4641	57705	596	3297	55693	474354	57654	406	2074	285704	170371	7913	1743
WP5320	Male steroid hormones in cardiomyocyte energy metabolism	6817	1583	1586	3284	3283	1588	51171	8644	6715	6716	3293	3294	54658
WP4321	Thermogenesis	126129	5563	11343	1374	1376	8110	53632	6199	7350	111	109	6602	6598	71	10818	123096	2641	5568	9586	64764	1375	6198	5346	6599	8193	107	5600	5468	51703	5606	60	6597	9658	2260	1268	4881	112	3991	148327	55811	5562	2180	5567	57492	6601	6197	6603	84335	57521	6009	6300	8289	26291	63976	2181	6604	4217	51548	5592	152831	51422	55818	113	656	5571	2885	108	6605	353500	5603	2778	6195	64223	7248	84699	6654	57104	51780	10891	4893	90993	1385	5565	115	3845	788	5566	1386	5564	114	27330	7249	6595	3265	6655	2475	51412	196883	23028	155	5593	86	6194	6196	23305	2182	10488	1432
WP5088	Prostaglandin signaling	4283	8923202	9536	3553	3569	7124	29108	6347	6348	3592	374	7422	940	4318	3605	2919	729230	834	7040	5732	3552	114548	4790	3627	3439	3665	5294	112744	1435
WP4595	Urea cycle and associated pathways	4190	5831	8604	10165	2875	445	2806	5009	2271	2746	4843	4942	435	383	1373	162417	8659	10166	27165	4842	2805	4846	4191	3945
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	6300	4882	650	5600	6662	3549	2254	5594	5604	5894	5515	5745	1267	9474	5744	2261	5933	5605	1026	5595	652	5603	8817	6772	1432	6615	7067
WP206	Fatty acid omega-oxidation	1543	1544	1565	124	1548	131	127	1579	126	217	1576	130	125	216	1571
WP4804	Cholesterol biosynthesis with skeletal dysplasias	1595	1717	3930	10682	6309	50814	1718
WP2023	Cell differentiation - expanded index	4654	4209	406986	442896	406899	406956	860	407047	3195	407051	102465696	406915	406995	6657	3196	406935	4208	574411	3398	407013	407022	407016	406967	406937	7044	10637	5081	30012	406976	407007	406906	9314	406923	100271849	574457	406938	100313774	406947	407046	6722	10014	406982	406952	406951	407028	406942	406955	4205	442895	6774	574447	442894	406957	406989	406954	407008	645682	23416	2146	619554	407006	406977	406907	406904	407012	407015	406922	442890	406950	406996
WP5166	Glyoxylate metabolism	112817	54363	9380	3939	10861	2806	58510	5827	189	8659	1610
WP3644	NAD+ metabolism	23411	10135	23410	64802	51547	23408	65220	142	349565	952	22933	9048	51548	4907	203447	23409	23057
WP5174	Ulcerative colitis signaling	64127	4772	4790	2625	6778	3586	3567	7040	3596	50943	7097	3458	3565	4094
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	5588	8076	4026	87	4633	5595	4638	5747	3725	3685	7082	3690	7414	5594	1385	5829	3708	5335
WP5124	Alzheimer's disease	5700	4217	207	22943	3800	7846	4843	5693	6263	143471	22926	3552	489	5664	7186	842	1856	293	5705	1452	1457	2932	2902	441925	778	5293	29982	5331	7976	10213	355	7471	102	5894	7416	23621	805	3845	5602	4893	55102	7480	4311	8321	55626	27035	1139	2903	3553	5685	5719	3265	6622	10000	5692	51107	5599	4842	841	112714	7280	8772	5289	9706	5535	1965	348	801	8325	8408	3798	11211	5710	291	51384	1857	7475	10888	5481	1454	5530	10382	51806	3708	7481	5715	5689	3630	6868	347733	824	23385	100506742	2906	5595	2904	637	5604	10313	5330	823	4790	7417	9861	5296	27121	8471	4023	147700	292	3831	5694	54361	91860	10381	208	351	113457	83464	7494	5709	5663	177	9821	6424	30849	840	2597	79861	5701	9451	89780	7277	5691	7855	64837	468	7132	50507	5706	84617	5704	1855	5601	369	55851	8313	5970	23130	5609	7477	7472	10376	3643	1460	5291	5532	3416	1499	317	836	283106	572	7473	5718	7278	487	1147	8312	5610	1459	8323	83447	5332	5533	324	5684	4041	5686	7124	3551	2475	51807	1649	23401	3028	5713	442206	2535	54205	673	776	10297	5594	2905	60673	808	8883	779	3709	122011	5714	5702	80326	5688	5743	203068	8660	5707	23236	2776	1536	7474	7476	4040	488	7419	3799	90550	810	2081	84790	10023	8324	8326	81029	22863	5534	5683	55062	7482	10105	11047	5290	26100	27123	5682	5708	322	163688	5687	8503	1435	5695	7979	8678	3569	1020	3667	57142	3710	89953	10383	5295	775	9776	4035	4137	81027	347688	5690	5605
WP2816	Felbamate metabolism	1576	1571
WP75	Toll-like receptor signaling	7187	6373	23118	7100	7097	148022	2353	10454	4615	5594	3661	3663	6416	6351	114609	5595	3725	29110	51135	3576	6348	9641	3627	3440	5294	5600	7098	6352	3455	10333	5606	5604	3446	3444	23643	4790	54106	7189	257397	929	3445	5605	5879	3454	3456	7099	3654	3569	208	8737	7096	6300	942	3593	3451	958	6885	3448	207	1326	353376	5608	4793	3929	5970	6772	3449	8517	5601	5603	6696	3443	3441	5609	51311	3439	3665	4792	54472	3447	3442	5602	1147	3452	3592	8772	4283	3553	3551	7124	841	941	1432	51284	10000	5599
WP4220	Neurotransmitter disorders	7054	121278	6531	1644	6571	1312	1621	5409	7166
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	1964	8894	1983	3646	8665	1968	8661	8663	8664	8666	8669	8667	8662	10209	1965	8668
WP5221	2q11.2 copy number variation syndrome	51252	54910	285033	26504	93082	150771	26505	23397	151	56910	100422928	1844	81562	51239	1280	10865	9391	90342	23020	55683	55654	200539	431705
WP4751	HIPK2 in kidney fibrosis	6477	28996
WP4536	Genes related to primary cilium development (based on CRISPR)	123811	84100	166379	200894	79867	80817	55112	123016	51098	56623	10464	283643	57539	89891	132884	585	79989	79659	51668	7289	80173	79809	79600	163786	55125	91147		79583	80199	22920	55212	54903	23288	9371	51175	583	23322	80210	26160	65250	79770	64927	51057	137392	200728	11127	79598	11159	23059	57560	255758	60684	27241	57728	51134	132320	23552	150737	582	8655	8481	26146	79738	8195	27077	8100	26123	25776	57545	112752	22832	54585	55764	84984	56912	9742	57534	80178	22858	51626	51259	84314	10300	403	146057	2121	26005	79959	9731	79363	11116	9851	84455	90410	85459	6993	55081	11020	51715	129880	153241	85302	28981	51174
WP1530	miRNA regulation of DNA damage response	595	472	5893	4193	317	4616	27113	11200	355	836	545	896	10912	406982	5888	995	5981	9874	9134	894	207	2177	1017	672	1647	900	5883	8795	5366	842	1021	2810	4361	5925	6118	5810	9133	841	1643	11011	1020	5591	8243	25	3364	1019	84126	5884	891	1869	1026	54205	993	1027	898	63970	10111	581	1385	27244	637	4609	1111	406937	983	5371	85417	406948	55367	4683	3014	50484	7157
WP465	Tryptophan metabolism	38	169355	23498	8564	1738	259307	1892	64577	6772	11185	3033	51166	217	125061	15	8942	4128	1644	847	56267	1543	438	3620	26	2639	6999	316	883	121278	7166	130013	2806
WP179	Cell cycle	1026	5111	902	7709	891	991	9232	898	9088	4173	9126	8697	4171	9133	6502	1031	8243	10735	85417	5001	23595	1111	1871	7042	10393	51434	8379	29945	8900	4609	5885	4087	7043	896	10912	996	10274	4616	51343	7534	5933	472	595	3065	10744	25847	4193	4089	7529	9700	27127	4172	3066	5925	10971	9184	1032	29882	8881	4088	6500	1869	51529	1027	993	1022	10459	890	990	4999	9978	1019	64682	25	5591	7027	983	7531	7533	7157	5934	4998	8317	23594	7040	545	11200	7029	7465	7532	995	1028	1874	2033	2932	1870	4175	5347	5000	494551	51433	1030	1021	8454	2810	699	1029	4176	4174	10926	9134	1875	8318	1647	7272	1017	994	894
WP2513	Nanoparticle triggered regulated necrosis	7132	8737	8717	148022	11035	8772	7124	142	10524	5599	2512	841
WP3871	Valproic acid pathway	3032	54659	18	1962	1559	3712	116285	3030	1555	1548	36	3065	3028
WP4298	Acute viral myocarditis	7100	12487	842	5881	148022	3593	6443	1981	3552	54108	207	5594	5595	836	171558	7852	3108	835	4791	3458	79886	2932	595	6774	6772	142	663	596	959	7098	6654	27	1605	920	5294	839	2534	2021	60	4624	3689	1234	6445	3558	1385	4790	5921	114548	581	3611	3683	3586	3856	1232	7040	3908	6442	1982	840	4318	7099	26986	3716	3592	857	199	54205	6444	941	1906	598	5880	1604	1756	29108	25	8651
WP4931	Direct reversal repair	4255	221120	121642
WP5390	Pancreatic cancer subtypes	7033	83998	7031	6699	3866	286887	8581	9982	4640	10551	652995	6707	6318	4069	10170	3872	131177	7103	155465	23584	728113	84985	3960	84951	3855	11199	55808	54474	27290	1474	1510	51442	93273	8399	53836	6513	6317	1515	4680	79908	3853	6273	8796	7032	1551	119467	1015	374	79170
WP5130	Th17 cell differentiation pathway	6256	1432	5335	3559	2625	5599	6778	2475	6095	3662	3553	3569	246778	3717	916	30009	9575	51561	5588	3716	861	915	1407	3558	3320	4790	9572	7040	4087	50615	7046	917	5914	4792	920	7297	6097	50616	6774	6776	9021	6772	3932	59067	406	3108	50943	3725	3458	3565	149233	3570	4772	28755	4783	7535	919	3566	3605	196	3091	28639	2353	5594	27040	112744	5187	9466	3459
WP4785	Somitogenesis in the context of spondylocostal dysostosis	10683	3955	134701	28514	145873	4851	2043	6911	84667
WP28	Selenium metabolism and selenoproteins	10587	5970	1734	83642	2168	54952	2876	2878	2877	6670	348303	6415	60678	280636	51540	3725	22928	1733	51091	114112	2353	257202	85465	57190	58515	6414	2879	4790	54938	6156	51714	79048	140606	1390	51734	8991	55829	7296	1735
WP4484	Control of immune tolerance by vasoactive intestinal peptide	942	1493	355	940	3565	3458	3592	6962	3558	941	7432	3586	7040	3567
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	7528	207	11236	22926	5950	1622	10427	5563	23411	10483	1595	53632	26291	4191	3157	22937	3156	6396	6713	4047	5571	3949	84680	51586	51141	3630	31	5468	47	51128	1385	5565	9632	820	4023	5294	2194	949	6667	6721	4597	2224	25956	3638	9871	6319	23175	10484	5564	22872	8720	56681	5562	1024	10802	2993	51360
WP5303	Lacto series sphingolipid metabolism	8707	84002	8708	2525	2524	2523
WP4153	Degradation pathway of sphingolipids, including diseases	5660	2581	3988	10577	4758	950	4759	129807	2629	4864	10825	3073	3074	2720
WP5312	Metabolic pathways of fibroblasts	5723	5831	7358	283208	2264	387	9509	6513	7360	2260	29968	5033	10536	649	2746	2744	4015	5351	5832	6566	26227	10609	6510	5236	5335	8974	2645	1902
WP5365	4p16.3 copy number variation	7936	6654	10460	401115	867	2549	25920	152877	90459	7468	5594	100126332	118424	9793	617	92305	677770	5595	3020	353497	10818	2885	7884	2261	8218	5335	339983	5295	3954	7469	2247	51497
WP5169	Hemesynthesis defects and porphyrias	7390	1371	2235	3145	7389	212	5498	210	211
WP5194	Synthesis of ceramides and 1-deoxyceramides	53947	64781	29956	8877	2683	427	91012	1674	7357	253782	10715	7368	204219	2531	10558	259230	2583	79603	166929	127550	84002	8694
WP4927	COVID-19, thrombosis and anticoagulation	2244	2243	2147	5340	2165	2162	2266
WP5155	Arachidonic acid (AA, ARA) oxylipin metabolism	5743	2053	9360	6916	4015	5742
WP2870	Extracellular vesicle-mediated signaling in recipient cells	4089	7103	7474	4233	2475	3265	4240	1956	7049	1499	7043	7039	89780	4087	5894	7040	207	4088	3845	8312	3082	5294	27121	7042	324	2064	7046	8842
WP4532	Intraflagellar transport proteins binding to dynein	55764	28981	112752	83657	79659	140735	6993	51668	11020	89891	57539	1781	1778	1783	51143	1780	8655	55112	57728	51626	6990	57560	255758	83658	56912	64792	9742
WP1946	Cori cycle	5232	3939	2539	5214	3098	226	5230	5223	6888	2821	6514	6513	2875	7167	2597	3630	6517
WP167	Eicosanoid synthesis	246	873	247	9536	241	239	5740	2678	4056	80142	4048	8644	240	5743	5742	127281	1800	5730	6916
WP4940	15q11.2 copy number variation syndrome	114791	10844	2332	10426	85378	81614	729894	27229	123606	23191
WP5412	8q11.23 (RB1CC1) copy number variation	8408	60673	11345	23710	7124	4217	56270	7186	11337	5747	2185	9821	5925	7157	9776	55054
WP26	S1P receptor signal transduction	10000	208	5287	2771	2773	5595	5331	5597	5330	29127	6610	5598	1901	56848	9294	1903	5596	5594	8877	207	2770	23236	6300	427	53637
WP5031	Biotin metabolism, including IMDs	31	5095	32	5091	5096	3141	56922	64087	686
WP437	EGF/EGFR signaling	4846	4513
WP4030	SCFA and skeletal muscle substrate metabolism	100125288	2867	5697	5467	2865	6517
WP1541	Energy metabolism	5533	23410	2309	4208	100271849	5565	7019	1385	10891	814	4899	5468	8648	7351	3276	5562	5564	1386	2308	4209	10514	1432	6256	2551	5469	53632	2101	23411	5563	23082	7352	51422	5467	5535	5534	64216	2033	818	5571	5532	5465	3065	133522	2932	5530	51106	4205
WP100	Glutathione metabolism	3417	2944	2946	221357	2877	2730	2879	2678	2937	2878	2938	2952	2953	2876	290	2687	2729	2936	2539	26873
WP5181	Roles of ceramides in development of insulin resistance	5590	53632	389692	8660	7132	5610	5515	3651	207	55512	3630	6517	2180	3643	2081	5295	5599	3667	6198	1375	7185	7124	948
WP5434	Cancer pathways	652	836	3479	146849	8322	51764	1499	4914	4851	2263	2033	5291	9446	9002	6469	57121	3480	8313	5970	7185	10683	5601	1855	3572	6932	5366	2335	2064	5338	329	3560	1728	9475	113	1398	3448	89780	1869	10297	2773	816	2786	1441	54205	5566	388585	2535	4780	23401	9978	2246	54583	890	1019	10928	6655	196883	5337	324	4792	8031	5332	7157	4313	6688	1286	115	1147	2939	3447	3442	7473	572	5568	896	10912	3910	2788	3725	9252	81029	8326	4314	10023	810	3576	4259	5899	26508	4040	7474	1163	112399	3066	5743	2271	6923	5732	4088	4286	111	5594	1288	2787	5605	2846	5567	83439	2782	3454	7189	51561	3675	815	6502	7170	5295	4855	7849	28514	1630	1495	9817	8503	5336	2264	2034	5156	107	2790	119391	3446	374654	2940	2735	3595	1287	1282	4087	7482	23604	2323	355	5159	4791	5331	23462	818	7424	3441	1950	1870	2793	2932	3449	1399	10681	8454	1856	182	7186	6387	330	9134	1017	1647	4843	2099	8772	2737	3592	23365	1285	861	3597	2952	2938	3460	841	4824	3265	10342	26060	5292	7046	6667	8321	10125	11186	3082	3326	4893	5602	10235	581	2785	3728	6773	3913	27113	2767	356	5582	3815	7481	51806	3065	10161	6774	3600	3914	4089	331	1857	1613	7187	623	7048	3575	5898	11211	4258	8325	109	2770	5467	114112	8453	5879	840	8648	802	3596	7709	2277	2736	3714	898	3445	2308	2768	208	5155	3563	5335	5880	8202	54361	5915	2956	5731	4149	1910	7296	2324	1496	5228	2944	5296	7042	7423	387	7188	4257	51426	2260	8900	6608	5468	11040	637	2949	108	5579	675	317	4312	2941	3565	5888	3458	2885	5728	1956	2791	3443	7472	7477	596	369	8517	1021	238	1030	9826	3685	2057	1029	7704	6513	94235	3280	1439	7855	59345	5734	9618	894	114	9915	673	2784	3452	3827	5727	112398	1906	7478	3559	2100	2475	3551	1050	4041	5371	2778	8323	57449	3320	7484	1284	8312	7040	3911	2002	8324	3574	7483	1488	595	8030	4193	7476	6198	3915	2776	7015	23236	2783	6775	80326	2056	6934	867	2950	5747	2149	112	1487	613	3561	29119	5733	3569	1902	650	5914	3909	3481	163688	5154	5979	7175	3444	5290	64399	4609	27436	83593	23566	10319	7039	578	6093	3718	7976	2261	4853	221357	405	5293	51176	4436	10018	3912	1438	3673	7012	6772	10672	6777	842	7184	5578	5881	3451	2948	3593	2122	3459	115727	3566	354	2113	54331	862	207	2953	6500	9170	3717	2771	367	1027	3918	1643	6256	598	5599	10000	6778	25	55970	51684	2947	6654	3601	5900	2322	3439	7480	3558	999	22798	3845	7479	4254	805	284217	5894	2792	7471	5595	4616	7422	7043	653689	7852	3570	4292	3162	6776	4437	185	6258	7475	23493	2147	5925	51384	4485	6921	25780	6199	3091	1909	3562	3567	2353	3908	7428	1026	1387	1612	3594	3716	332	3688	54567	79444	1436	91860	6257	10587	4233	624	183	817	3655	8643	4854	2946	1871	3440	3674	4790	5330	3568	3455	5604	9138
WP2597	Secretion of hydrochloric acid in parietal cells	887	1128	3274	495
WP5053	Development of ureteric derived collecting system	23399	2625	7490	3688	51232	9353	5915	3730	2737	80144	23426	6299	3975	659	2736	26585	341640	4086	5076	2735	3611	168667	6608	2674	653	158326	4613	650	5914	5916	79633	6092	7042	80000	5979	2668	5087	7481	657	10736	2138	595	8516	6469	10468	2296	10252	2118	9620	652	57216	6091	1499	2263	3207	655	6495	10220	3237	2719
WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	2353	9817	3551	1548	7975	4790	4842	4780	4512	5743	4312	4097	4792	3725	8309	7422
WP2267	Synaptic vesicle pathway	160	440279	6855	774	163	6809	6844	161	8775	6571	6532	6857	10497	6854	23025	1175	22999	6507	26052	246213	2054	291	6616	57030	1785	4905	57084	6853	6581	6572	10059	11315	140679	81539	8224	112755	1759	6570	10815	5864	773	8218	1173	6812	477	1213	6804	1211	594855	10814	2055
WP715	Amino acid conjugation	
WP5428	FGFR4 p.G388R signaling	2264	6774	3586
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	920	5294	4792	1605	28632	3586	5604	5788	2534	3558	9402	1739	1147	4790	5588	915	940	5605	8915	10598	1019	9448	3551	7124	84433	1437	11261	54677	5335	3702	4690	7182	867	3567	207	9265	27040	2353	5594	64132	10892	925	7535	22882	3458	3565	2885	28745	8431	1493	3725	29851	5163	3937	9825	959	3932	8517	5601	2932	5609
WP2828	Bladder cancer	2064	7157	1029	1613	5925	4313	11186	5296	999	4893	6714	3845	4609	7380	5594	5604	5894	5605	1026	1869	7422	23604	9252	673	1612	4312	1890	4318	2261	1839	1956	5295	1950	3576	595	1019	3265	4193	369	7057
WP382	MAPK signaling	7867	4791	782	2261	283748	778	9344	355	11184	4296	5159	10369	2317	3164	5603	1399	1950	255189	1846	1844	6300	7186	26291	5578	5881	1647	8569	23542	786	994	6885	4217	207	4772	3727	3552	5608	115727	4915	1616	1386	80824	8550	3265	2255	55970	3553	5062	2318	2872	10000	4803	1432	5599	100137049	10125	27006	22808	3303	7046	9175	9261	57551	9020	6654	781	2250	59283	5894	409	5602	4909	10235	4893	3845	8986	5607	5921	2259	5582	356	3304	3306	7043	2251	120892	5595	784	5530	8911	6237	5778	3312	59284	2316	5058	8822	7048	123745	1852	23118	5535	25780	2249	2353	10454	3554	7786	4216	6416	6788	4214	785	100506012	5871	2005	2768	5879	5494	8823	5880	1848	93589	4149	8817	5155	208	22800	4208	51295	7042	777	5604	5606	23162	783	10746	2260	4790	5321	1843	59285	5532	2263	9254	4914	1956	2885	836	3310	9965	26281	5970	5580	5922	27091	369	5601	8517	5609	7850	1845	7132	3315	55799	1398	1850	1326	468	9064	5566	673	776	6655	27092	1649	8605	7124	3551	2246	4908	7157	2256	2254	5533	2002	7040	5598	5923	5906	1147	84867	6722	773	4775	5568	2253	9252	5536	3725	5534	8913	2248	6789	5924	2258	9693	8491	5801	5908	5594	3305	779	4137	408	7189	998	775	929	5605	627	51347	5567	9448	6197	11221	2247	3925	8074	2264	2257	51776	10368	2252	5154	8649	5600	5971	9479	51701	4609	774	5495	4763	1849	8912
WP2878	PPAR-alpha pathway	1019	2168	6256	6342	595	5465	1962	116519	30	1581	54600	10062	345	4609	376497	5360	55554	1622	34	335	1582	1374	1376	336	1579	983
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	6935	406984	406991	4790	3589	6774	3590	406985	5970	3572	3569	3717	406983	3718	3716	652995	3570	6659
WP4197	Immune response to tuberculosis	6890	3459	7297	6773	5771	3659	8519	4599	3455	3454	3434	3717	3437	3716	4938	3460	10379	8651	5696	3430	8554	6772
WP3942	PPAR signaling	336	8310	4023	335	3611	5468	51703	2169	345	1593	1581	2180	10062	6319	10999	2712	116519	30	6256	364	9415	23305	2182	2171	2173	6342	28965	3158	10580	6257	948	5170	2168	1374	1376	2713	1579	2170	126129	34	23205	1582	11001	5106	1622	2172	7350	2181	5467	376497	5360	81616	10998	33	8309	51	4312	9370	4973	51129	5465	1962	5105	4199	2167	1375	5346	6258
WP4148	Splicing factor NOVA regulated synaptic proteins	54386	23136	22854	8573	4756	2035	9568	5601	5909	57863	334	23332	2898	1600	2904	818	288	2902	10752	22883	1000	23705	5596	2566	3785	1946	2037	3778	23154	490	10243	5332	858	5590	6813	3763	2036	2054	22938
WP53	ID signaling	
WP4259	Disorders of folate metabolism and transport	5860	10797	441024	4548	10840	4524	4522	6472	10841	113235	471	160428	2348	6470	7298	6573
WP2509	Nanoparticle triggered autophagic cell death	81671	3630	64422	8408	7405	83734	9474	9706	55054	10533	9140
WP3299	let-7 inhibition of ES cell reprogramming	6657	5460	406890	406882	406881	406886	406883	1958	406888	406885	9314	406889	131405	406887	406891
WP3982	miRNA regulation of p53 pathway in prostate cancer	637	693129	406958	6767	407019	407037	64393	63970	581	100616323	64065	7157	192668	8795	842	5366	6477	4193	5054	100302270	9538	693128	472	841	143686	5728	317	100616330	836	27113	11200
WP5205	Clock-controlled autophagy in bone metabolism	3920	84557	1948	4086	8878	653	7040	8600	650	4041	1435	55626	121340	6096	84938	50964	7480	4862	55054	4090	2475	9140	8678	3569	1524	860	3952	5176	7415	57410	3717	9821	4318	659	9575	128338	7189	9776	8615	1513	5564	1407	1489	8408	4772	83734	79443	115908	56955	79365	10533	60673	3562	8553	81631	207	22943	5289	655	649	7475	9842	3146	5187	9975	64422	51384	5741	4093	10371	796	8792	4089	7474	596	3479	652	406	4982	4851	654	10507	8646	9474
WP408	Oxidative stress response	4128	4257	5602	847	4790	1543	6649	3726	2353	2953	1536	7296	54578	27035	79400	6667	1728	25828	50507	3162	4784	2878	4501	1432	50508	6647	10587	2936	2729	6648	2876	7498	4780
WP4685	Melanoma	369	3791	4193	5058	595	51806	810	1870	5291	5728	5293	2885	3815	25759	10912	5595	578	4616	5594	2353	207	808	4286	1647	801	2113	5925	2066	1021	80243	91860	1019	6655	3265	10000	5295	1643	208	673	5605	1026	1869	5879	572	2002	7414	5604	5894	805	4763	581	3845	51426	999	5290	1385	2913	4893	8859	1871	5296	7157	163688	8503	6654	8649	2903
WP5356	Affected pathways in Duchenne muscular dystrophy	1756	5328	5054	7225	185	6696	3569	1991	3708	2244	7222	2266	50507	7048	1536	6872	4353	7220	6261	6786	3313	1490	3586	2243
WP4906	3q29 copy number variation syndrome	100147766	348793	116211	8349	11158	83657	8503	7334	106481200	23077	255798	102	7040	4609	7629	200933	140735	6993	1739	123264	51626	106480695	54752	80235	9025	840	11116	84984	4771	5062	255812	22916	30061	55294	7018	83658	5829	4241	23411	26043	642892	106481777	1620	205564	375387	101927158	106481637	106480655	89891	3091	200931	106481386	57817	79659	165918	5130	4686	55112	6990	131540	3725	3077	8655	100302742	6777	7037	10445	106480509	2890	6776	54965	255758	9587	93183	9857
WP3594	Circadian rhythm genes	5730	90134	114781	55366	8454	23239	56339	5551	139135	7298	25942	2146	3727	9112	25819	85457	4843	355	10135	6496	9370	405	1408	1813	22871	2932	9611	8864	23596	6720	1141	6550	3192	1812	3398	121278	6097	5602	10891	10743	1453	5501	6500	26223	10062	3061	9575	1407	181	1471	7054	10514	9099	8204	5599	94233	5054	220202	5591	1374	9975	5187	26224	1644	4783	463	4804	9956	9967	3363	8945	406	3400	5500	5582	7311	7080	4297	2767	128674	4987	84432	3065	594857	7071	1454	1960	2673	8403	100	6096	4159	1390	1814	4862	8863	6233	1628	5468	7150	1406	60675	2691	3952	9456	6421	2155	3062	4669	23291	5499	135	9475	468	79365	2837	196	4841	83759	7153	134	1364	5465	4914	4916	5728	2033	1660	150094	129521	8792	9500	10887	5927	4544	5601	5371	7166	6839	7316	5936	7157	7337	1385	8914	1392	191	3399	112464	9915	8841	6440	687	3184	1019	55269	5593	4887	79723	54551	2776	3066	23411	5563	23373	551	1128	8553	5078	1655	10499	3725	6770	15	10419	4547	22809	6928	5971	3751	3778	9607	56938	8473	107	57805	51738	5629	9572	4543	5562	1958	10911	148523	2063	1859	23064	50865	6532	1815	6095	3569
WP2865	IL1 and megakaryocytes in obesity	2147	7097	7096	8991	4790	114548	7941	7077	3383	5290	1232	4615	3554	7076	3606	4318	2149	2205	6280	1839	3458	6347	3553	3654
WP5284	Cell interactions of the pancreatic cancer microenvironment	7040	729230	9531	1234	3627	6957	1435	6387	3122	942	6352	3791	1436	1438	10581	1437	941	6347	6955	2833	8829	3123	356	7852	7422	3902	355	1493
WP696	Benzo(a)pyrene metabolism	2052	1646	1543	1545	8644	10327	1109	1645	1576
WP481	Insulin signaling	5598	5602	50488	252983	57761	8986	5607	2319	3631	2931	2002	5894	382	9175	7248	9020	6654	2998	6195	6196	1432	5286	5599	2475	6655	3265	5781	3551	868	27330	7249	6517	30846	5770	6446	9064	1326	5608	5597	10938	10110	1398	4217	6885	207	5578	2992	5967	6009	6513	8773	2997	6300	6810	2932	6236	5609	3480	5580	5601	5603	5579	11184	4294	4296	25759	10211	5867	5584	53358	5728	5291	3643	6814	5293	2885	6464	5290	6844	10746	2888	5604	5606	5600	4293	11127	8503	5583	2309	115703	10487	5167	11183	2549	8471	6813	5294	1978	5296	5295	208	57381	9882	10580	9448	6197	5880	2889	3667	8651	5170	5605	5562	1958	5879	30849	7494	5588	5871	3991	10603	2308	7786	6416	4216	4214	2887	8491	375	5213	6199	5211	5594	2353	5596	5289	9265	5590	6616	8660	1977	23433	867	5563	23624	3799	5288	5506	3636	9021	4641	6198	6812	5595	9252	3725	6722	5792	4215	23678
WP80	Nucleotide GPCRs	136	140	5028	5031	5029	135	2846	10161	134	1241	5030
WP5447	GLP-1 in pancreatic islet cells	3630	2641	2740	6513	3569	6514	3570
WP5115	Network map of SARS-CoV-2 signaling	838	684	3592	3699	8807	6374	3717	916	5054	3553	350	6355	841	1437	1509	57007	7216	57534	5599	7018	90865	347	3543	51512	335	4939	6388	6289	3579	57617	5199	8519	2534	23367	3503	64135	3486	6731	6772	10394	55240	3126	7173	3273	7186	842	1974	6387	3451	537	11101	207	3538	3552	3557	5588	3716	3123	1294	6372	11119	5879	10410	3596	3240	286827	6403	84985	8836	5777	183	2811	84335	332	9133	6729	1369	1978	213	100187828	336	5910	9332	2537	914	1	1234	60	1843	6351	2011	7422	6359	22861	29110	54541	6237	3932	2934	10956	83737	3312	3429	10379	629	50616	7187	10010	3127	3122	3726	3605	4599	3091	2353	3567	3661	8408	7535	919	2963	3700	4283	10563	8554	6346	6288	715	3578	7124	64386	6194	10666	55922	2244	3559	6367	6356	10280	983	3603	3426	59272	3586	2920	1508	9540	4086	3565	3458	4914	836	3501	58191	3929	3577	59067	54663	796	7850	4884	708	1514	2335	1401	196	926	81631	3075	23586	3497	55937	8743	3675	7189	79572	6728	1235	10964	929	1958	3456	891	57506	3654	9868	3569	2247	116844	84433	1522	4090	6347	716	731	10850	920	2266	3627	8542	917	6352	8754	6364	6366	27248	2919	814	3500	23155	3043	114548	10344	71	4775	2921	3606	3434	3725	6241	8631	1051	3576	3574	5196	6348	5743	91754	3959	51156	4615	28639	55757	5104	1440	28755	2243	341	925
WP5470	Effect of omega-3 PUFA on Huntington's disease pathways	5571	2555	5293	1956	5728	5291	4294	836	4760	9619	1717	3157	5601	10018	1950	5609	6009	25942	207	146850	4155	64137	2567	51422	2554	2556	4915	2562	5564	1152	7249	2563	3158	2475	2561	7124	3553	10858	841	5599	5286	10000	64798	64223	7248	19	6667	9001	5894	2002	572	5602	1385	5565	2568	581	7376	5864	5595	2565	9252	57468	23533	5288	6198	22930	3156	3708	3065	55879	1977	3064	3066	5563	1595	53632	2560	348	2564	2566	2557	5594	6416	5978	6558	627	5562	840	5605	30849	54806	2559	3569	5287	208	84335	5295	4976	253260	5296	1978	664	5294	712	8503	6721	5604	2558	637	5290	2911
WP4216	Chromosomal and microsatellite instability in colorectal cancer 	7046	26060	324	5900	7157	387	5294	7042	51426	5602	581	3845	8312	4609	9423	572	4087	5604	5894	7040	1026	5879	10297	673	83439	54205	332	1643	208	10000	5599	1630	5880	2956	6932	5966	5366	842	5881	5743	7048	6934	122011	5898	1647	4088	5594	2353	207	836	7043	10912	27113	5595	4616	578	3725	1499	55770	51176	4292	2932	4436	10018	595	5899	1452	29110	8313	4437	5601	4089	369	596
WP5452	GLP-1 from intestine and pancreas and role in glucose homeostasis	6513	5122	3630	2641	5126	2740
WP5420	ADHD and autism (ASD) pathways	5567	6794	5562	9776	79581	6532	55065	9378	57521	9177	83667	1269	1815	6324	3741	4548	8564	5295	8678	1621	23284	148	8503	10243	471	1742	107	5156	253260	50944	5336	55788	2911	2565	58512	5568	2643	266751	266752	1645	4684	392636	249	15	217	5860	223	84105	6332	23464	282554	558248	2905	5594	3176	3360	7249	23426	5566	169355	55972	7124	158584	2561	79400	26047	64798	7157	7166	84557	4128	191	5021	2892	1491	2555	8942	5291	1499	25974	5409	221955	3614	873	27091	4522	3067	747	9454	2915	2694	6336	113	27430	83734	6570	6323	135	113235	55768	55191	30849	64802	6331	1576	351	6573	170572	5335	208	11280	3354	84335	10797	79109	2918	2185	10165	5296	1816	387	1268	9379	2558	31	2906	3815	1741	5582	4160	59284	2166	158	6804	2912	2917	64422	5590	6531	316	146	5092	246213	9231	6616	55034	3742	2744	140679	3363	5826	2566	557194	2557	5053	353	160428	6470	7054	4129	6014	11152	3704	121278	7248	8604	2891	56267	102	2752	5159	57502	3251	2902	10815	5573	51380	27165	2916	6335	57555	7298	55163	152330	2562	285242	2556	1036	4843	786	438	51629	1312	775	4143	79937	5575	6326	635	8566	6472	1605	3355	26100	10368	2017	5290	6855	27244	55062	5020	22863	1716	4524	8029	113278	2572	51293	2776	4552	2560	5563	3739	118788	867	2806	9787	53942	266750	10533	6649	60673	808	134864	2350	5564	116443	9369	6947	4594	6327	27092	27255	2475	2710	9140	5805	200909	55054	64223	2893	1557	154	4860	9228	8506	5579	3643	1956	5728	147	3458	59285	6948	1272	6328	116444	23130	5580	2628	159	9456	2550	50507	6334	6009	81693	25902	85445	22941	26	1636	9821	3737	4988	10840	3362	3743	3356	4846	6647	10327	27	23410	2326	5576	6844	2913	1739	2571	51166	2904	5595	6812	3738	5972	6697	2890	50508	185	6648	100	1786	2348	568126	6900	55879	80318	27232	23475	1644	8408	5289	908	3736	18	54413	166785	6857	6529	1565	10000	4842	6530	3352	80852	25	9229	2563	5067	3357	883	27035	22839	2903	5577	270	2346	1740	441024	55800	59283	1719	6999	3620	81034	7498	55312	9474	22871	4453296818;	102724560875;	5293	1813	1559	8644	8470	2914	27249	9455	10369	5578	57084	4204	231	2328	248	6330	2554	207	6329
WP3844	PI3K-AKT-mTOR signaling and therapeutic opportunities in prostate cancer	6009	253260	2309	5296	5294	64223	8503	4303	2887	207	572	4893	8408	5290	115482696	3845	9776	2308	5728	5291	5163	9821	7249	3265	2475	7942	4846	6198	2932	5295	79109
WP5406	13q12.12 copy number variation	26278	6641	338872	6445	6310	100506697	100874138	100313842	4099	1605	7186	6443	387	7188	7187	1837	5599	57142	55504	7185	2318	100874144	5601	387911	221178	1756	65078	4285	9370	5879	6442	84894	6444	6640	998	8082
WP4324	Mitochondrial complex I assembly model OXPHOS system	4726	4724	4701	55572	90871	4538	28976	4709	55863	4722	55744	80224	4713	4711	4694	4696	4719	4720	55101	4731	4695	4540	4708	4539	51079	51103	54968	4718	4725	91942	4536	51295	4715	4541	25915	4698	54539	137682	4705	4706	4723	4707	4729	4702	4710	55471	4716	4714	51300	29078	4717	25880	4535	55967	4700	4712
WP5269	Genetic causes of porto-sinusoidal vascular disease	57572	285203	695	4855	57514	54567	50508	1716	285556	1535	57708	79801	5879	653361	4688	5595	51523	51142	54106	4851	3782	998	25998	3516	84701	4790	2969	5594	79415	1536	4689	6667	51119	79631	51311	221336	3692
WP3869	Cannabinoid receptor signaling	2166	1269	5575	1432	5599	5601	5603	5568	5595	5567	221955	5573	1559	1576	5566	5602	135	222236	1543	1268	113	196	5594	5600	5577	747	1557	5576	6300	107
WP5294	Sildenafil treatment	2597	2932	4842	2982	208	5142	10000	5071	5144	155061	4846	7019	5592	2974	10891	4899	5141	2977	5143	2983	207	8654	4843
WP3584	MECP2 and associated Rett syndrome	6872	3481	6667	3185	2893	4208	2521	7337	5294	2530	126961	1385	4763	2571	2250	1869	627	1750	4354	9315	2289	5978	9126	6446	815	344	6194	11168	6670	2475	23435	2247	3187	54715	6890	4099	9129	4204	4661	6750	50937	2593	2146	25942	1465	8184	114787	1267	207	10664	4155	5454	2249	200424	3479	2570	80312	1749	4986	2892	2290	2894	2902	26084	5728	54790	1660	9611	604	728358	3065	2890	4904	2248	3480
WP2446	Retinoblastoma gene in cancer	891	5111	1026	9126	4173	898	5985	3925	6502	9133	3015	8243	2956	1111	580	1871	5984	10592	3275	407025	4609	6241	4863	896	5422	5931	5427	10733	3065	5947	595	1786	4193	8030	4172	3146	5877	54443	5925	8819	6595	1869	11124	5557	993	1027	890	5591	25	5928	1019	983	7027	3148	6117	7157	6839	407024	8317	4998	5894	1719	6596	10714	6240	7465	7153	7029	5426	24137	5983	4175	1870	5603	81620	1633	1021	7298	25942	4176	8318	2189	9134	994	7272	1017
WP2877	Vitamin D receptor pathway	7292	10125	387267	27035	8853	79963	1591	56262	9914	928	1027	838	6422	3592	4345	5653	6275	5243	251	1577	4773	6256	1565	112802	7056	8204	3397	4814	1647	1017	248	9926	1559	1493	5004	3484	3486	3684	6696	604	373863	820	126364	3860	387264	1305	7042	79789	9314	8027	6822	898	3123	3488	5588	151888	2308	1576	1026	1555	3117	976	3394	84766	5741	92737	623	215	3726	3091	5467	1032	2050	23581	4982	54210	6280	386675	3400	22997	78989	6279	154	7869	632	29785	4041	1050	85285	8600	113835	7040	8687	1045	4084	5744	3827	1673	283229	337879	6517	79689	875	4650	1029	26239	353137	1030	997	958	490	1946	5005	3868	727936	79104	5734	6304	1543	6546	147	4600	29923	64806	412	50486	55090	386672	25928	8074	100286963	7421	5368	219855	3965	6819	634	1469	4609	1992	54901	55503	7077	6699	6277	929	1581	6927	386676	11096	57167	3662	1031	11221	768	9075	639	240	353134	10568	22906	23274	7168	81037	9173	353323	400830	3663	1474	892	7078	168002	386679	654	200407	9365	3885	12307	1594	795	2539	56302	6273	7128	595	3294
WP5302	Neolacto series sphingolipid metabolism	8702	2683	2517	2527	84002	4668	4759	6484	8703	2523	2524
WP5171	Leukotriene metabolic pathway	1800	240	1666	26063	4363	4048	4051	64174	2678	4056	22949	2687
WP3655	Hypothetical craniofacial development pathway	9411	387	7020	56731	7043	8626	3664
WP4147	PTF1A related regulatory pathway	3516	3280	11317	256297	8850	5629	4851	4825	1499	3651	2255
WP4920	Mitochondrial complex II assembly	54949	644096	6391	6389	6390	135154	6392	57001
WP2840	Cytodifferentiation	8549	6868	3725	11197	8626	654	1991	26085	657	4089	1824	7474	3228	73075585294;	10468	404203	3880	27122	23581	94234	864	284110	947	55507	2353	55806	1523	5650	6929	3229	64919	25818	3488	147409	2736	2625	11005	1747	1959	43847	6657	27121	3866	337966	4790	1490	3479	652	2304	51176	1956	254950	9622	4851	3458	9355	25928	4487	8456	8842	85293	23560	4772	22943	26018	5653	6275	4345	337879	2908	22822	6422	1828	2354	4488	6662	6925	8321	10804	64065	4086	2619	3516	7040	80070	4254
WP438	Non-homologous end joining	7486	3981	27434	64421	7520	7518	27343	79840	5591	2547
WP3958	GPR40 pathway	5330	3710	23007	5335	113026	89869	5310	2864	23236	51196	5331	5336	2767	5333	5334
WP4970	Galanin receptor pathway	
WP4947	Nitric oxide metabolism in cystic fibrosis	54496	56341	3276	10419	55170	23564	10498	23576	4846	3275	4843	10196
WP5121	Sphingolipid metabolism in senescence	8560	1869	5579	2475	1019	2531	10558	166929	79603	53637	5925	2720	427	7357	5578	7015	1017	81537	8877	29956	5594	9294	9402	1901
WP5313	Carnosine metabolism of glial cells	6533	57571	121260	6565	55748	8140	84735
WP4462	Platelet-mediated interactions with vascular and circulating cells	7042	6352	7043	958	6401	7099	7097	6403	6404	7040	3553	959	6347	3383	7412	5196
WP357	Fatty acid biosynthesis	10449	79746	55268	55862	2194	47	1891	31	2181	51703	1666	6319	55902	2180	5091	3033	32	51102	55825	1892	2182	23305
WP2880	Glucocorticoid receptor pathway	5997	1907	11214	4240	6256	6347	7056	57007	5142	5552	2908	221079	11057	84951	9982	56262	7546	27063	3320	153218	10769	347902	1836	8436	79056	121512	6364	81706	54566	6591	8856	10252	644314	6397	387509	6286	7128	10560	3589	9792	8972	7049	51129	4791	1028	8507	10602	10728	1831	4616	9970	84002	3725	2040	3895	5375	8553	241	55224	330	80315	5272	5743	29103	5460	329	92737	221393	8454	89795	6337
WP4481	Resistin as a regulator of inflammation	5333	3592	5331	5293	5291	5595	5970	7124	3551	8517	3569	208	3576	3708	5335	1432	10000	5336	51196	5294	4792	56729	3593	23236	84812	5332	207	5594	5290	1147	113026	4790	5330
WP4912	SARS coronavirus and innate immunity	3442	3448	3455	59272	3447	6773	23586	3446	3661	3444	3440	3439	7297	9641	7187	3451	148022	7098	3449	6772	29110	10379	3441	3443	3445	3716	3452	57506	3454	64135	3456
WP2361	Gastric cancer network 1	4173	4851	11065	64094	3020	7153	64006	6790	1894	57122	22974	1063	55125	56992	286826	6286	86	4605	352954	8607	324	9585	54476	144455	11082	8209	121504	8900	54891
WP5224	2q37 copy number variation syndrome	9855	643905	100423043	64090	10267	2817	106481606	55502	80895	51281	375316	51540	11132	106480977	117581	389090	79054	50636	100616360	54576	79083	100873392	2637	406941	9208	79919	189	54578	79781	151176	106479670	10920	55355	51052	150681	51078	106480068	1841	404204	4705	55230	106480255	285193	391496	54574	10203	25992	23157	150677	64284	100533179	339766	23178	54658	57140	100616397	100616493	151171	100506749	54659	547	150678	106481601	100270937	1293	51665	23677	100379249	375318	26146	401036	285093	403275	101752400	9759	414061	100462787	5510	54573	54579	8864	6694	23192	2859	10123	54580	728294	54575	54657	100422942	100130450	100506723	151507	116987	8527	10494	84289	653437	140739	129807	100616417	339768	54600	3069	5133	377007	106481932	57007	666	54577	106480362	130916
WP5409	PAFAH1B1 copy number variation	6249	5049	5050	5048	81565	5649	7846	10726	1778	1641	7436
WP2018	RANKL/RANK signaling	
WP4754	IL18 signaling	4790	1147	6714	581	1994	1385	5894	637	2931	2002	4792	27035	6667	7157	12682231	6559	5599	1432	8837	5295	841	6194	7124	3551	4688	5562	54205	3659	353376	4776	207	5594	6885	5578	11	1447	3315	7132	55272	5609	6774	2932	1051	5601	3932	6198	4205	142	5580	5970	3725	32	2904	5595	653361	836	5579	355	5728	1499	356	2623
WP5440	EPAC1 and PKA reduction of retinal inflammation	5573	140609	5576	10411	3553	5566	5577	5575	114548	5567
WP5353	Macrophage-stimulating protein (MSP) signaling	632	4485	7422	1374	4318	6590	3456	121340	6591	7124	3586	3553	10891	4486	6935	9839	3381	55554
WP5274	Farnesyl to CoQ10 metabolism	
WP3874	Canonical and non-canonical TGF-B signaling	659	4015	84171	7046	7048	26585	5599	1432	4017	4087	649	7040	5601	4089	4016	4088
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	3710	5335	1385	3690	5594	6263	3725	3685	5595	5747	7134	5588	8076
WP4814	Somatic sex determination	268	2626	6662	2254	284654	5730	30812	54361	668	6736	2516	50846	1761	7490
WP4928	MAPK pathway in congenital thyroid cancer	8844	5605	238	5595	673	6654	3725	6655	4609	150946	2353	2002	5604	6464
WP3972	PDGFR-beta pathway	6722	3716	2885	5579	5595	3717	5159	3725	6778	6772	3265	6777	5295	6776	5335	6774	5599	5578	6654	2002	2353	5604	5894	6464	5290	5610	6416	4214	5921
WP2848	Pluripotent stem cell differentiation pathway	238	2056	7173	22943	89780	2249	3562	3630	652	7422	2253	1270	3479	2323	7043	3815	3570	4851	7477	3589	4907	1950	7472	7474	3577	6469	10468	3624	1435	4838	5154	3082	4909	7040	8600	10637	7471	7482	4254	8200	2246	7018	5155	2247	2255	3569	9241	1436
WP524	G13 signaling	85415	1072	6198	4608	23191	5216	10672	8976	3984	5291	10788	5293	1729	5305	998	5500	6093	4632	5879	397	11113	9138	57630	5585	4216	801	5602	7454	9475	5290	5063	1073	387	10188	5296	398	6242	8826
WP384	Apoptosis modulation by HSP70	8737	835	54205	3303	7132	355	840	836	842	8772	317	637	7124	841	5602	9131	839	4214	4790
WP5331	Autophagy in pancreatic ductal adenocarcinoma	3146	8036	7030	177	7157	4780	65018	3845	81671	6774	5071	10526	4790	4286	10533	8878	4193	8678	81631	7942
WP5191	Resolvin E1 and resolvin D1 signaling decrease inflammation	5163	1241	5293	5294	5291	2048	6011	2358	5290	207	1240	2475
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	9453	10654	3155	2222	38	3156	91734	3422	4597	4598	39	2224	3157
WP2806	Complement system	3707640	1369	2266	2769	155971	213	4153	5621	5329	3674	4036	4068	3383	2208	3381	4179	6401	1634	6403	3078	2220	7057	7295	1604	930	2357	6402	2859140	7097	11326	3915	2286	114131	3690	10332	729238	2243	5332454	3913823	933487	3238454	7454	5331889	85477	3913735	AAN47894	5340	718	1991	629	1675	1378	335	12393750	3911	5199	3818	720	3426	2703410	133	152185	717	409	27202	5331420	7448	2773	2219	730	2771	10877	729	5781	5648	5806	112476	2244	2859139	3573107	1380	2	2859231	708	269972	958	725	51727	1401	6404	2335	2859141	10747	YP_043213	3075	6223	966	727	9370	811	653509	710	5332074	6696	735	3673	1123177	3384	7264	3912
WP528	Acetylcholine synthesis	1103	10400	5161	1119	43	5160	5130
WP455	GPCRs, class A rhodopsin-like	8390	26692	2831	54329	57007	6751	3357	94233	8111	4991	3352	2865	3061	120776	26476	8843	2825	3579	10316	1237	81697	140	8387	1232	27198	390892	1812	158131	26538	4161	1131	26212	11251	1233	23596	26664	186	8383	2859	11255	3358	6915	126370	4986	283297	1813	64106	144125	8388	8590	26716	1238	680	2841	5028	9283	5729	26211	3354	3356	26333	2357	3362	5739	10886	624	2840	1910	5731	116511	3274	53829	4889	26659	4988	1236	1234	8386	1268	9934	64805	2845	57105	4159	1814	2850	338674	1816	23432	5540	2358	390756	10161	5032	4160	442186	2861	1129	185	4995	6755	7852	643	26188	81491	2835	3269	4987	56656	1909	3363	144124	10888	2829	886	146	623	2830	2833	135948	6753	611	155	1524	4993	2925	653166	10936	26701	283160	3360	2842	442184	554	27202	2847	6010	2826	56923	26189	2866	2864	2587	2857	10692	2852	2838	1241	1133	154	10798	2853	9002	3577	57121	51554	4544	153	79541	150	2150	5030	134	5021	1132	2848	887	147	26707	5029	23620	135	26658	3351	4992	6752	4985	553	2832	5734	11250	3062	2843	7201	719	5956	4886	53836	1815	26532	1269	2652	81797	5733	8392	5724	442185	2149	552	2844	2827	2846	10800	56670	2693	4158	3350	1235	2867	9248	2854	2862	5031	2151	729230	4543	8484	27334	152	4888	148	7932	135946	84636	1230	3355	26539	26696	9293	26531	151	4923	1240	2863	3973	29909	2828	8477	10803	9034	266747	4157	2834	5732	187	8811	81696	2359	5737	4142	3361	1128	136	6754	4829	4994	2492	4887	54328	442191	26493
WP3286	Copper homeostasis	538	54739	6647	540	79689	9997	84560	1317	4137	4493	2308	351	389160	5290	4891	4504	150684	9973	4502	4489	26872	5621	23621	102	8754	261729	324	4498	6667	7157	2309	4500	1353	55240	2932	4495	595	4501	4193	836	3725	6868	10063	4520	22823	1318	5728	4490	6649	6341	207	331	4494	4496	475
WP5238	Cholestasis	8714	64240	9414	3949	64241	8647	6554	2052	5244	9970	949	1244	6579	9971	6580	6256	5205	10257	3156
WP1591	Heart development	23493	3170	406904	9464	4772	27302	8553	5308	5594	4776	6910	4775	7422	2253	652	6722	4851	1499	7424	23462	657	2065	6469	2296	4089	650	2627	2303	406937	2626	4208	3670	7423	150572	406935	57057	4086	9421	659	8928	6899	1482	50805	6909	2255	5781	4773
WP5034	Mitochondrial complex inhibition leading to liver injury	
WP1544	MicroRNAs in cardiomyocyte hypertrophy	2626	9641	387	5294	5296	3084	817	8503	1025	5604	5606	5290	5330	4790	1154	5605	4638	5879	91807	183	2247	5170	5295	208	9734	5594	5596	10454	4776	1489	6416	406884	5595	5530	4040	7474	6774	8321	4041	9020	3976	5894	7040	5598	100302238	5607	406991	1147	2535	50804	1022	406990	2475	7124	3551	1906	1432	5599	4879	51564	89780	207	9475	5608	5592	5532	4878	2263	9759	406949	5320	1499	10014	5291	5293	5579	3479	8893	6093	3480	1855	3572	100302282	8517	407010	2932	1950	5609	1827
WP4760	PKC-gamma calcium signaling in ataxia	2890	3708	5331	5582	2767	773	2892	5163	6263	767	2911	5330	491	2891	2769	7222	2893	9630	9454	5332	23236	2776
WP3943	ROBO4 and VEGF signaling crosstalk	5879	7422	9353	6714	54538	3791
WP5065	SARS-CoV-2 altering angiogenesis via NRP1	5045	7422	59272	8829	3791
WP710	DNA damage response (only ATM dependent)	10000	5286	5599	25	6655	3265	1027	581	3845	8312	5602	4893	572	7471	7473	7040	324	6654	7480	7157	5934	7477	604	7472	638	2932	10018	5601	1855	596	578	5728	5291	3643	51176	2885	5293	1499	4791	6885	89780	207	894	5881	2064	6932	5366	1856	1029	6342	5295	208	5287	54361	5328	3667	5880	83439	30849	1026	5879	998	4790	6464	5527	5290	7482	4609	8503	387	5294	5296	2309	197259	595	472	7481	5529	4089	7476	6648	7474	5288	23533	4193	81029	5163	3725	896	27113	3949	10023	7161	356	4216	4214	901	847	5106	5594	2538	5289	4088	7475	3146	6934	8061	80326	1857	51384
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	54106	4938	7189	3716	7113	3454	7099	29110	6772	10379	51284	7187	285852	7297	9641	4939	3665	4940	7098	7097	3455	10333	59272	4615	5610	3661	6773
WP5431	FLT3 p.Gln640SerfsTer8 signaling	1234	1235	2322	6774
WP3666	Metabolism of dichloroethylene by CYP450	1571
WP5144	NRP1-triggered signaling in pancreatic cancer 	7046	5971	4313	7042	3082	4790	6714	91584	4087	5604	1490	5175	7040	2931	1003	5879	5605	5747	5361	55630	4318	1027	898	8829	208	9564	1278	10000	4233	5966	1105	7048	5362	9134	4088	1017	207	5594	5595	2321	7422	7043	7049	4791	1956	1950	10371	6615	1106	1277	6591	5970	3791	4089
WP3674	Tgif disruption of Shh signaling	7080	7050	6469	60436	4087	2253	2737	2290	4838
WP1425	Bone morphogenic protein signaling and regulation	10766	4086	657	4089	658	9241	860	10140	57154	659	650	4091
WP5215	Relevant molecular pathways and targeted agents in triple negative breast cancer	367	2885	5728	5595	5605	8821	7249	673	5163	3667	3265	142	6655	2475	369	6198	208	84335	79109	5295	10038	10000	57521	253260	79899	1978	64223	64798	9894	7248	6654	5604	207	5894	5594	4893	5290	3845
WP1584	Type II diabetes mellitus	2710	2475	3651	5594	3376	5599	5256	1154	6514	3643	6834	5590	3630	9370	6517	389692
WP3624	Lung fibrosis	5265	7015	3593	4204	655	3567	1440	729238	23250	3565	6351	653509	3479	6696	1051	3576	1950	796	3162	79991	5073	51750	6348	7012	4313	91039	1832	6356	5154	2252	3082	6352	7076	729230	4502	10144	1490	1232	7040	2920	57105	7039	2006	727897	26585	6498	4780	1215	4092	4318	3596	255520	5806	5328	2247	7124	3569	3553	1437	6347	1906	6440	5155	2246
WP4875	Disruption of postsynaptic signaling by CNV	1740	2911	1739	9379	5594	2905	22941	8831	2903	817	9456	23237	9378	9369	6262	57555	2332	6804	23191	9229	22895	7082	816	57502	7532	2904	5595	2906	818	22871	54413	815	2902
WP5078	T cell modulation in pancreatic cancer	7043	2191	1493	355	201633	383	79679	7422	7293	6361	64115	29851	3604	356	7424	4907	3958	959	80380	942	6387	953	958	84868	567	29126	5817	940	2277	5133	3956	941	10666	8744	3569	3965	5228	7423	6367	7292	7042	80381	3105	3620	3586
WP5090	Complement system in neuronal development and plasticity	7448	54205	27202	5359	6376	2219	730	733	5648	23418	715	729	1524	1191	1380	4240	841	714	10461	1378	56616	10584	84552	720	3426	7040	5199	717	581	966	2621	286204	727	3458	578	56288	64398	836	710	355	5584	317	3684	8512	7301	735	713	27429	64478	4140	84612	842	719	725	3685	10747	57088	4155	3075	3993	840	2220	4179	1604	843	731	716	721	9191	7042	10487	286410	712	4153	8547	728	637	3689	57048	5205	50855	57198	356	7043	2011	722	23513	78989	81035	718	3687	57194	1675	5627	629	9787	4139	331	5590	148229	732	558	3690	55061	10207	23250
WP364	IL6 signaling	
WP3926	ApoE and miR-146 in inflammation and atherosclerosis	406938	3654	6688	5970	7189	4791	348	7097	7099
WP4297	Thiamine metabolic pathways	60386	27010	4967	7086	10295
WP5028	Glycine metabolism, including IMDs	51218	23479	200205	6470	2731	55163	150274	11019	1738	388962	275	2653	51601	27247	387787
WP1992	Genes targeted by miRNAs in adipocytes	3784	58155	2697	3753	3479	3759	2078	7114	9759	610	10021	6722
WP4494	Selective expression of chemokine receptors during T-cell polarization	959	6348	3460	1233	2833	1437	6351	3565	3458	3592	3594	7852	7043	940	3567	1232	7040	729230	3595	3566	1234	1236	3558	8809	7042	1230	3459	920	3593
WP5380	5q35 copy number variation	6620	1581	2870	10083	79930	54540	5335	3092	5295	345456	4149	100302203	1329	580	27166	79184	3014	2549	5799	2264	10972	11285	29086	1212	9577	4609	7852	51428	1345	3725	7169	2904	10818	26262	84142	106479472	1350	22838	9377	9260	3635	1340	54825	25920	5741	84364	192286	4648	825	1627	5771	10636	114787	1327	1346	2770	8338	672	2771	2773	1337	375484	53841	6622	23119	5599	2246	1349	25	90249	8726	55294	53917	57104	6654	6569	257629	10960	1351	6714	5602	2161	102	9423	64324	51099	9026	80758	9965	2902	1813	2885	54732	51499	51491	285598	23197	5601	10959	57179	3480	9500	83463	51720	253314	23135	3101	107075310	23567	100422962
WP2035	Follicle stimulating hormone (FSH) signaling	
WP4341	Non-genomic actions of 1,25-dihydroxyvitamin D3	958	5578	3459	6300	7132	2113	207	5579	5291	5293	5331	3458	5333	4791	5601	5603	5580	6772	6667	84812	5332	4939	51196	51311	7297	6773	3845	5598	4893	9636	1591	4938	1673	5286	1432	10000	6670	5599	91543	6256	3460	64127	3551	7124	3265	7097	23236	113026	5594	5289	3725	8398	5595	5582	3576	959	6258	1594	23533	5288	8503	5971	5581	5583	5600	5296	3440	7421	4940	5294	820	5336	5330	4790	5290	3455	7099	30849	10964	857	3716	5588	5335	5295	6347	208	3569	5287	5469	6257
WP4288	MTHFR deficiency	56994	3176	438	1786	10400	1789	635	5130	4141	4524	1788	501	1312	2902	1119	836	79813	10919	55349	2906	842
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	9817	3939	5160	3091	31	54583	6194	4891	4780	8452	6513	5564	5571	7157	5162	5163	5161	5562	32	7422
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	7434	6844	79923	4790	30012	116	8929	4208	2624	721	5576	1390	3032	5979	6657	478	3356	9722	6507	5575	2625	6095	3569	2597	1958	627	3596	401	1387	3784	5567	5978	6331	3350	6532	1644	4821	551	864	6929	5053	11076	3091	8553	5454	2538	429	54738	6869	4133	9734	1374	6750	2697	6616	5354	34	6863	10971	361	4800	291	3576	10522	3065	6711	4904	4602	1129	1051	7529	859	55536	7422	3725	3329	2019	7161	7534	3570	4152	3757	3764	1385	7259	55800	10891	4128	1103	406992	720	3030	3586	1139	5577	6667	4010	121278	5316	7166	7531	7533	1746	226	7054	6262	4803	7018	6670	4824	6751	117	2100	3553	7124	2645	367	2784	6640	388585	5566	2908	2554	5452	3552	6330	3280	3557	4915	6752	406950	3359	10664	23171	2305	7184	4204	5460	2328	133522	7068	5087	7433	54862	1141	6550	4150	1143	1137	836	7532	4760	1499	4791	1889	5573	2902	2033
WP5105	Meta pathway lipodystrophy, dyslipidemia and hyperlipidemia	
WP688	Catalytic cycle of mammalian flavin-containing monooxygenases (FMOs)	2328	2326	2330	2327	2329
WP4159	GABA receptor signaling	1759	2572	161	6529	140679	163	2559	1175	9568	2571	223	11337	160	4905	10243	1173	29979	18	2550	6538
WP3935	Leptin-insulin signaling overlap	3953	6774	3667	9021	8525	5170	3952	207	8651	3717	8835	3630	8503	8660	5294	8471	3643
WP2064	Neural crest differentiation	5081	79885	7471	9421	127343	999	3516	10215	116448	8312	4086	6925	1280	6662	2670	1302	4488	7478	8841	388585	3975	167826	4155	1000	89780	27022	3280	2113	85416	3397	55869	1004	3198	1856	51564	8313	4487	1855	1005	10683	2932	8190	4851	2263	7021	9759	7976	1638	9355	4791	4853	10014	1499	2261	6663	388	9965	7291	652	64211	4609	5077	6660	283659	4790	2260	7020	2705	3670	4854	3196	8929	10013	28514	2247	54567	4855	3688	3211	7545	6911	83439	4286	655	429	3066	1857	4359	9734	23493	6591	4602	2637	4762	3065	6615	1488	83933	2253	5376	1749
WP368	Mitochondrial long chain fatty acid beta-oxidation	35	80221	6342	788	2182	55825	2181	3030	33	1374	3033	1376	2180	37	34	1962	1632
WP2813	Embryonic development	7124	207	7040	4609	595	3688	406984	999	3552	9839	249	6422	554210	7015	2066	3655	1364	406983	10718
WP5402	10q22q23 copy number variation	102	2838	10771	170425	8600	643161	5468	8382	5885	88	4790	92211	6457	27069	83853	5995	54462	11155	387695	23047	84332	650	112441434	10718	79812	1050	387694	27156	8243	94233	112476	149840	4143	84293	23409	83861	10459	221421	374407	9126	89765	81492	10974	340745	10939	2746	81619	4142	6623	56241	54537	345895	23244	2066	701	10262	442911	23063	26103	154865	143241	657	2894	10274	7422
WP4860	Hijack of ubiquitination by SARS-CoV-2	106478911	9978	8453	6923	79699	6921	9039	8883
WP4919	Neuroinflammation	5294	7099	3725	115482723	2353	207	2475	8923202	1432	5599	8923218	65125
WP4315	Malate-aspartate shuttle	8402	4190	2806	6507
WP4533	Transcription co-factors SKI and SKIL protein partners	4763	9113	26524	23314	7005	6788	3065	3622	7003	6497	7004	8463	6498	25942	8841	10461	10419	4204
WP2853	Endoderm differentiation	54799	8554	26610	10459	7478	10451	2908	63978	5744	6422	26986	29970	30009	3975	23168	115825	7473	7040	79668	56946	23682	5083	23181	1994	9760	23007	57690	7547	64864	9682	1789	23576	6925	3087	154091	6877	80155	324	27245	4838	2627	83881	6772	1844	1846	5087	724023	3251	51176	1499	22823	4851	51366	9646	23528	80312	22943	5090	8450	85363	55809	1601	406933	131405	2146	708	9350	5460	85416	79776	84295	6001	3198	6932	11169	121536	442918	9241	3227	2186	57669	6875	2308	351	2005	79035	140597	2736	8928	83439	7709	79577	5606	5077	27244	4087	58499	31	51701	3169	79923	54892	9044	6657	10128	2626	5916	494324	6928	1847	54623	4089	6478	9573	1488	8320	657	64321	27324	83595	57198	1112	23286	7080	3175	11190	55832	63035	655	79977	2131	4088	4830	51460	23373	6671	10973	5015	10153	3170	3720	123169	9425	11166	3915
WP2516	ATM signaling	4193	10928	8243	8517	8120	472	644914	993	7161	898	5888	995	1386	11200	3725	891	672	1017	1647	637	2177	9656	1385	10111	9874	7157	7158	3014	55367	4683	8738	4361	4792	1111	5883	983
WP78	TCA cycle (aka Krebs or citric acid cycle)	6390	8802	2271	1743	3419	3420	4967	8803	6389	3418	8801	3421	6392	4191	1431	1738	50	6391
WP236	Adipogenesis	8660	5925	4207	5618	4692	4088	7350	3091	5467	649	688	5106	8609	5933	5105	4616	10499	81029	3630	9021	1051	5346	6258	1675	6776	6774	2626	2624	4208	4023	2034	8471	8788	2303	650	1879	5914	1959	10269	5468	1052	26580	3977	4000	5008	3991	2308	4209	434	25937	1026	8648	6424	3667	6927	6095	3952	8651	3569	183	7025	442338	2625	6695	56729	196	1647	4282	1499	5465	1874	10135	652	2487	4154	3479	7291	355	9370	10658	6772	4205	6720	83881	1855	3572	6777	10555	56603	2971	9611	1592	5934	8321	55847	7480	1050	6667	3976	7040	1271	3159	9612	7471	10891	1385	651	64900	57761	6773	6319	23175	2908	123	1869	3399	1316	80339	10062	28999	6517	2688	1649	5054	6778	7124	6256	2662	9663	5740	8204
WP2911	miRNA targets in ECM and membrane receptors	6383	1292	3693	3910	7057	407049	7148	1289	22801	7058	1290	1281	1278	554210	1293	1291	407031	407032	50509	2335	3915	3694	3913	1282	3672	1284
WP1495	Glycine metabolism	6470	6472	4524
WP4504	Cysteine and methionine catabolism	2805	635	4548	2937	4143	1036	191	58472	1491	23474	51380	27349	102724560875;	4357
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	5535	1025	4776	4772	6827	3066	25920	55869	9734	4792	7936	5533	6667	51564	5530	5970	51497	10614	4773	7469	6829	3065	9759	57060	10014	5532	2033	8841	115482723	4775	5534
WP3996	Ethanol effects on histone modifications	217	83933	9759	10014	6573	1386	8841	125	220	10919	55902	126	8850	8854	4548	4524	3065	4143	3066	216	1571	7298	55140	55869	9734	10013	51564	8520	124	1719	191
WP5052	Nephrogenesis	80000	4853	3975	130497	84870	284654	26281	2253	182	89780	655	8854	54361	6943	5076	4211	10736	2297
WP4585	Cancer immunotherapy by PD-1 blockade	917	80380	6957	4772	7535	925	4790	29126	926	4776	4775	916	3725	3458	10725	5133	10538	915	6955	6774	5781	3932	4773
WP4725	Sphingolipid metabolism overview	427	7357	8560	130367	2629	57704	81537	8877	123099	64781	9517	259230	10558	8613	2531	56848	6609	57733	166929
WP2640	Aripiprazole metabolic pathway	1565	64816
WP5098	T-cell activation SARS-CoV-2	6775	3122	3605	27040	5594	4615	2353	64207	919	7535	149233	5595	3725	3937	3932	3708	595	253260	920	2309	917	3595	3455	5604	9402	4790	5588	3123	51561	915	940	5605	1026	3456	3594	3454	5170	84433	5295	57521	5335	1029	6009	8809	942	3593	207	10892	4772	3565	3458	5293	2885	5728	1493	29851	6363	5970	8517	2932	3125	7157	7297	4049	10125	64223	64798	7248	4792	6654	5533	5894	2534	5788	3558	1147	581	56477	3592	3717	8915	7249	916	3265	2475	3551	7124	941	598
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	4085	699	9126	9700	10274	324	991	701	9232	1062	5885	8243	9184	8379
WP5241	Mitochondrial beta-oxidation	1666	10449	33	2181	1962	1632	36	1892	3028
WP4156	Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine	15	1312	56521	5409	5805	2643	1719	438	1621	5053	6697	4129	7054	4128	5860
WP4545	Oxysterols derived from cholesterol	134526	112744	23600	27189	1582	2099	122970	641372	641371	3605	6718	3929	9420	8309	64806	11332	53342	7376	3290	1717	570	55856	80270	8856	9023	6820	133688	26027	10005	3291	1628	6822	1109	1880	1593	27190	1581	1576	2053	3638	10965	51302	284486	10858	23597	10682	2100
WP49	IL2 signaling	3265	3559
WP3591	Sleep regulation	5729	1814	4862	5730	4887	114781	2903	1812	3062	2837	1392	5020	2353	191	2030	135	8863	51738	117194	3061	6770	1813	22871	2691	10911	134	5021	3606	8911	4544	1141	3569	100	3356	1737	7054	1471	594857
WP2007	Iron metabolism in placenta	3658	48	7036	55240	4891	341208	57192	30061
WP5087	Pleural mesothelioma	8726	4771	1649	1019	2246	6194	23401	54205	961	285	2535	7249	1869	7473	1286	7138	64798	4313	7157	324	5332	2254	5420	1975	1855	5601	1005	3480	5609	5291	1460	4914	1499	2263	8322	3479	64405	89780	2305	1946	51422	166824	9675	9350	51513	6932	2335	960	1495	2247	9448	56034	57521	3710	2551	4209	9776	3675	1009	6401	83937	83439	5562	5605	1001	1282	7482	8314	1287	2919	28316	114548	4192	8379	5156	3627	27123	2264	8074	6352	7474	4040	3791	56924	5891	2248	6045	90550	1015	1839	4314	4215	8326	10023	9510	3150	23286	3725	7010	81029	9252	2253	3910	896	1288	5594	672	8491	115908	1942	122011	8061	11098	53632	9113	2872	57680	1285	8463	4085	3691	6374	3913	685	2250	57144	3672	5607	64403	581	10891	5602	5565	27006	3082	11186	58	8321	6667	9261	7248	1950	2932	80310	7424	22882	7004	1945	5159	4294	11184	2323	4217	1012	1017	70	60485	5608	5063	64132	6423	6387	1856	1006	8454	7186	8817	4149	54361	208	5155	84335	2308	5871	6424	2277	5606	9869	10298	3676	72	2260	147111	60	146433	27121	1008	7423	7003	5228	580	4293	2324	1496	3914	1454	7481	64321	3815	6351	27065	11197	3630	27113	55233	8945	2249	8325	6788	6416	4216	1016	11211	1002	1007	1857	8795	3146	6520	2475	5928	4908	9064	29128	5564	4318	59	80319	7040	5542	3586	2002	283106	3911	284	4194	8312	6714	1459	50488	1284	1385	5598	6015	64223	8323	4041	2256	596	4323	7477	7472	2885	3643	5728	1956	5571	648	26281	2321	9965	894	154796	1000	29126	1944	7005	28513	7855	4170	6513	6009	1029	171023	23043	3685	3054	467	3569	5328	6197	23512	1943	29119	1487	6347	8994	8045	11113	627	5747	1490	7039	6425	10319	83593	4609	5290	3689	5154	2252	8473	2257	50964	389421	3965	3481	1435	3909	7476	6198	4193	1488	595	472	71	8324	23012	6678	5163	10397	6259	9493	7528	1440	80326	2258	5563	1010	6934	7015	1825	3915	2255	5062	8140	5599	1432	4803	10000	6646	3918	1013	1437	59343	1022	1386	6422	55209	7471	3620	4254	284217	4909	999	6195	2322	29072	1969	7480	4920	6772	1452	3673	1457	3912	2971	26524	7403	5293	51176	2261	7976	578	4296	207	22943	84962	8569	4915	2146	26291	1004	1911	1436	4233	3688	64840	9770	58508	9821	3908	1003	1026	25937	5176	9686	5604	51378	10746	6464	5294	3655	4919	9532	5058	283349	10413	374	2259	92597	7422	5595	2251	83999	3690	9706	3091	6199	5281	4214	4804	1014	8408	4485	51384	8822	7475
WP3929	Chemokine signaling	7074	1237	3579	6375	2792	5894	1232	5473	4893	409	10235	115	5906	1147	2785	56477	6773	3845	6354	6356	6367	26230	7410	4792	6654	5332	6346	3265	10563	4283	6655	196883	3551	6370	1524	55970	10451	5829	2833	10000	2784	2786	2826	114	3717	6374	6376	2773	2771	673	59345	54331	1398	207	9475	113	94235	1794	6387	2268	6772	5580	5970	3055	1399	10681	8517	6777	2791	1233	2793	2932	51764	5331	4793	6369	2885	5293	5291	108	56288	5579	53358	6093	6361	3718	25759	7409	6363	58191	729230	5604	6464	1236	5290	4790	5330	10344	10850	2309	5294	2790	107	1230	5296	3627	6352	2185	6364	9547	6366	8503	5880	57580	10663	208	9564	5295	156	3702	408	112	998	1235	2787	2870	5879	5747	5567	2782	5908	2770	109	111	5594	6011	7454	4067	2868	2783	9844	5590	6373	2829	23236	399694	8976	23533	1445	2869	5196	6348	5058	6774	5613	6351	2921	5595	5568	653361	2788	10803	6359	643	7852
WP5348	11p11.2 copy number variation syndrome 	7157	920	284359	93010	93185	3655	9479	3340	7076	162540	977	3689	3676	81839	5978	9575	3675	3732	90139	143678	963	2737	931	9378	3688	930	2132	967	6386	3109	55343	51317	3122	2131	387763	3959	56981	8702	11041	60529	1839	1408	4166	51176	84680	406	8504	3108	221120	6469	8534	120071	10478	9537	9409	57586
WP3630	NAD metabolism, sirtuins and aging	200186	23410	10135	23411	2308	2309	6098	4790	7019	142	3091	5468
WP5397	Vitamin A1 and A5/X pathways	
WP2029	Cell differentiation - index	407007	30012	407015	10637	3195	407008	406989	406922	6774	406923	406996	6722	406947	407006	10014	3196	406982	7044	406952	407016	406937
WP5137	Linoleic acid oxylipin metabolism	246	240
WP678	Arachidonate epoxygenase / epoxide hydrolase	2950	9377	1559	1351	1573	2053	1558
WP5211	Glucose metabolism in triple-negative breast cancer cells	3098	5163	54704	3939	6566	5315	5214	6513
WP4210	Tryptophan catabolism leading to NAD+ production	23057	23498	23475	8564	27231	6999	349565	3620	51166	55191	64802	10135	8942	93100	125061	54981
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	5155	6469	3553	137814	55553	2247	7124	3479	1270	652	2736	6663	1267	6660	10215	4821	116448	2919	429	3976	2920	650	6662	4661	4099	30812	5354	4974	4340
WP4562	Canonical NF-kB pathway	4790	4792	1147	5966	3551	8517	5970	4794
WP5154	Docosahexaenoic acid oxylipin metabolism	4015	2053	8923202
WP5426	HDAC6 interactions in the central nervous system	84790	2078	2908	155871	4092	5879	627	7428	7415	8997	50943	8518	989	57634	3312	332	5460	5499	8842	9734	1536	55140	324	6667	10013	11315	7278	4627	1781	9636	7277	4615	2931	3320	1459	10133
WP1471	Target of rapamycin signaling	998	5571	5564	5879	5562	7249	54541	58528	2475	64121	6198	84335	79109	10670	3156	57521	253260	6009	79899	5563	1978	64223	7248	10325	25989	5578	53632	9706	115265	2280	207	55615	51422	5565	8408	3422
WP3953	mRNA, protein, and metabolite inducation pathway by cyclosporin A	6520	23657	468	6510	8140	4780
WP5061	Fatty acid transporters	2168	81616	10998	948	2167	2172	2181	2169	51703	2173	2182	1622	2171	646480	23305	23205	2170	10999	2180
WP5318	Female steroid hormones in cardiomyocyte energy metabolism	2099	6648	47	4547	4624	133522	3032	6513	6098	2626	34	5465	2101	6517
WP1604	Codeine and morphine metabolism	54658	54576	10599	1565	1564	8714	54659	1576	7364	54600	5243	54575	1244
WP5372	Involvement of -secretase in neurodegenerative diseases	207	1051	6772	6733	6418	23435	5641	4129	10000	4915	6622	208	351	5516	4137	627
WP5101	Congenital generalized lipodystrophy	26580	10555	2534	208	64900	9663	284119	3667	3091	84803	3691	8694	857	23175	84649	2885	5294
WP2879	Farnesoid X receptor pathway	6822	11309	10891	6256	9971	570	117283	10998	8647	6554	5244	8431	1581	9965	8660	2289	1576	7363	1582
WP5443	Effects of MFN2 mutation	23095	79969	89891	1778	1783	5865	79659	581	7157	1639	22906	4133	55288	841	6622	10567	10381	5864	7879	55112	836	9927	6856	1780
WP3931	Embryonic stem cell pluripotency pathways	4092	673	2535	2246	10000	3265	2475	93	2255	5781	2254	4041	2256	6654	324	3266	8323	8321	27006	7480	7484	5598	4086	5607	8312	7473	5894	3976	2002	7471	658	2250	26281	652	9965	5159	8322	1499	2261	7976	2263	5293	2885	5728	1956	1950	2932	7472	7477	3572	369	1855	1856	26291	6300	4091	4093	5608	5597	7855	207	89780	5605	659	8823	3716	4090	208	5155	6927	54361	2247	8817	9241	2257	2264	8074	5154	5296	2549	5156	2252	3977	2260	5606	5604	7482	2253	2251	3725	81029	8324	8326	2259	7481	657	6774	4193	2248	7474	7476	4040	4089	10097	7475	51384	8822	1857	90	2258	80326	6414	8325	2353	5596	2249	5594
WP4149	White fat cell differentiation	3662	6777	1495	1051	6095	6720	1649	6776	2625	2308	2908	10062	3630	28999	83439	23090	688	9314	5468	3661	1385	1052	7090	7480	10365	2122	2624	7026	1879	1959	5914	1050
WP3287	Overview of nanoparticle effects	207	7124	5294	596	3569	3162	4790
WP4900	Purinergic signaling	22953	53829	9127	2773	2846	5023	2771	134	5030	2767	5029	2779	346562	286530	24145	10161	2780	5032	5025	2775	27334	5024	5026	2778	5028	2781	5027	135	64805	9934	136	140	2770	5031
WP3391	Senescence-associated secretory phenotype (SASP)	3576	255626	474382	27287	8331	6774	5970	7324	1051	51433	8340	996	5595	8970	3725	7311	51343	3013	8342	3552	1032	128312	29882	1017	8338	8881	8345	2353	5594	3018	1021	3490	85236	79813	1030	121504554313;8294;8359;8360;8361;8362;8363;8364;8365;8366;8367;8368;8370;	30203021;	1029	30178339;8343;8344;8346;8347;	83508351;8352;8353;8354;8355;8356;8357;8358;8968;	126961333932;653604;	30128335;	6196	3015	890	64682	6197	94239	1019	3569	1031	10919	1026	51529	11065	7237908337;	1027	8348	8697	55766	6233	25906	119504	10393	5598	8900	4790	8334	29945	7321	102724334	27338	8341	3017	246184	7316	7314	8349	6195	3014
WP4949	16p11.2 proximal deletion syndrome	2908	8841	253982	283899	7189	10497	58508	22948	5518	5111	6911	83719	23025	6477	9961	8448	112476	2186	10694	226	10576	841	7430	3476	7157	57223	8479	143	146378	5531	57718	10423	55671	6693	5606	7290	5468	253980	79447	4790	79153	6950	5728	5516	124446	3486	5595	3835	9344	26470	151987	4150	11151	9989	79919	8030	653808	7203	10575	5966	7186	139420	10574	2099	8085	908	10693	22976	5515	5528	5608	4478	83723	23475
WP4292	Methionine metabolism leading to sulfur amino acids and related disorders	4143	1491	27232	4548	1036	875	191	6821	51380
WP2359	Parkin-ubiquitin proteasomal system pathway	6477	51807	55294	5719	10383	10381	6622	5713	5711	841	112714	113457	81027	5709	898	7280	347688	3308	5701	79861	5718	3313	56604	3311	118424	7278	9861	80086	25897	5708	3303	10273	7332	3309	7317	5705	2861	6478	7326	8573	5071	10382	10376	5413	7327	3312	3304	3306	84790	5715	51465	51182	9627	10213	347733	3310	7846	834	9246	7277	5700	5717	5714	5716	3305	5710	5702	203068	5707	5704	8454	84617	5706
WP229	Irinotecan pathway	54658	10599	9429	1066	590	4363	1576	54600	1244	1577	8824	54575
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	5294	268	5583	5578	5332	5581	23236	2492	5604	5894	207	5594	2661	4790	5330	3845	4893	409	3814	5290	5293	5291	3283	6770	5588	408	5331	5582	4318	5163	5595	84634	1583	5605	5579	3265	9210	5580	208
WP2586	Aryl hydrocarbon receptor pathway	11140	5925	1545	5743	84722	5894	5604	196	1017	4790	3845	1543	3320	4893	10728	4780	1956	405	1027	57491	7422	1316	1869	1026	7124	948	3265	9049	6346	5970	1544
WP3298	Melatonin metabolism and effects	1557	43	1545	23411	5187	348	438	4543	8863	1543	4790	9575	7189	1408	15	2308	1407	406	6817	112476	3654	889	4544	2932	1906	8864	1565	1544
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	1452	7477	7472	1457	2932	1855	8313	85407	100775107	406951	1460	51176	7976	1499	406950	7855	894	22943	89780	6885	6423	1021	6932	1856	2146	9350	110806272	100128881	85409	57680	23401	80319	10297	59343	2535	6422	8312	1459	55506	7473	283106	7471	4920	324	4041	3192	7480	8323	8321	1488	595	64321	7481	4040	7476	7474	1454	11197	283120	3725	81029	896	83999	8326	8324	10023	8325	11211	122011	6259	6929	7475	8061	80326	6934	1857	51384	1487	64840	467	54361	5328	83439	6424	5176	1024	7020	147111	3190	7482	407040	4609	51701	6425	56998	4919	27121	27123	50964	8607
WP4189	Mevalonate arm of cholesterol biosynthesis pathway with inhibitors	4597	3156
WP5233	Arsenic metabolism and reactive oxygen species generation	57412	7416	6648	6647	9446	476	28958	6389	7386	847
WP2447	Amyotrophic lateral sclerosis (ALS)	842	4744	5533	7157	4747	7132	847	5608	581	9973	572	637	4217	5630	834	836	5605	5868	5879	100506742	317	4741	5532	1616	10452	4842	1471	1432	598	5530	6647	57679	6506	2876	596	7124
WP4923	Autophagy	9474	9776	5564	5571	9821	22863	30849	5562	8678	2475	9140	57521	7405	84335	64798	26100	64223	55054	5563	79065	53632	55626	64422	81631	5289	10533	60673	8408	5565	51422
WP5407	15q11q13 copy number variation	6812	728498	23359	56160	8850	5970	197370	7082	23137	321	6804	871	130574	3065	653075	55719	25942	22909	727909	2697	4286	9578	161725	2177	112755	63941	54893	23268	406993	84250	55215	26287	51621	100820829	351	79677	1387	100506658	80036	25876	4308	493861	9892	27134	9414	6352	79608	1139	57165	1525	821	653073	29855	125111	286053	101059918	57530
WP496	Steroid biosynthesis	3294	3293	1586	51478	2165	3283	3284	3292	3295
WP5358	JAK-STAT signaling in the regulation of beta cells	9021	6772	2688	3265	1019	2475	6777	8651	3569	208	84335	3460	57521	10000	6776	6774	1154	3458	3570	3717	896	894	207	2305	2690	4893	3845	3459	64223	2056	5618	5617	8835	2057
WP3595	mir-124 predicted interactions with cell cycle and differentiation 	51804	55437	58190	5564
WP4541	Hippo-Merlin signaling dysregulation	1013	9978	3265	4771	5062	9113	3691	407054	3693	8463	5566	4893	999	64403	3845	57144	5501	3672	5577	5332	2322	1969	26524	3673	3684	3480	1005	3679	2321	64405	3680	5159	5573	7004	1499	4914	2261	2263	1956	3643	5063	60485	28513	7005	4915	3678	1642	154796	2305	84962	1012	1000	1004	1006	3685	5499	3688	5575	1436	4233	94274	1495	960	1003	5747	25937	1001	8451	5567	1009	3675	3689	28316	3674	2260	3676	3683	4609	3681	10298	1490	9686	2324	3655	389421	7003	5576	2264	5156	1008	3627	3687	5058	595	8516	3682	22801	3695	3791	56924	5568	5500	7010	10413	3815	1015	1014	1016	4804	6788	3690	9730	3694	3696	4659	1007	8515	4485	1002	1010
WP5285	Immune infiltration in pancreatic cancer	112744	6352	3593	3965	6387	6364	7042	27189	7423	3558	83998	56477	3605	2919	3567	7040	3586	7422	64806	7043	6374	4318	2277	3596	27190	3592	3565	3458	51561	53342	7424	6347	3576	1437	3956	7124	3569	3958	3553
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	27242	332	10451	308	7124	1495	2729	25	7057	5062	2149	4092	5747	840	1026	351	1027	4790	8312	79092	9616	8065	8878	8531	27018	2185	3309	3084	8767	10276	3065	3070	7431	7185	6198	9021	2065	3329	2081	2113	3727	207	5594	348	5585	8795	8454	3315	3575	26135	8870	1728
WP4186	Somatroph axis (GH) and its relationship to dietary restriction and aging	23411	207	2475
WP400	p38 MAPK signaling	4149	6772	1649	3265	1432	1386	2885	4209	3150	1616	998	9252	8550	5879	4217	6885	2002	4609	8569	6416	5923	4214	5321	6464	1385	5608	7042	8737	8717	3315	7186	7046	4293	9261
WP12	Osteoclast signaling	7965	5599
WP2876	Pregnane X receptor pathway	7266	6256	8204	10257	54658	8856	1548	8202	1555	27286	5705	1551	5243	66002	54600	8648	1244	10499	1577	1559	1576	2308	10599	6822	3320	10891	2939	6714	54657	54578	1557	8714	54659
WP23	B cell receptor signaling	
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	4056	284541	3248	239	2687	22949	246	66002	1800	51	8309	1579	8310	1962	240	30	145482	8529	4048
WP3845	Canonical and non-canonical Notch signaling	10683	28514	6237	27255	9794	4855	54567	65989	23462	51176	5663	4853	3714	4851	102	3516	3280	4237	84441	55534	8788	92737	5664	4854	182
WP4222	Phosphodiesterases in neuronal function	8654	2905	5143	5141	109	111	84152	113	5592	5149	135	5136	5137	5158	10846	5148	2890	2982	5153	1813	5151	2902	8622	2904	108	2906	2983	2977	115	27115	2974	5150	1385	107	5145	1812	2903	1139	5152	5138	196883	5144	5146	5142	5147	4842	5566	815	112	50940	5139	5140	55811	114	201626
WP4891	COVID-19 adverse outcome pathway	7113	3627	3569	183	3553	7124	3586	59272	6348	3559	3558	6347	1440	3574	3576
WP4146	Macrophage markers	9308	4069	2152	968	942	972	929	5880	9332
WP3851	TLR4 signaling and tolerance	3654	10928	29110	7124	3569	8517	51135	7189	100302736	257397	114609	4118	7099	3456	4615	10454	3661	4790	7187	7182	3665	23118	148022	3635
WP185	Integrin-mediated cell adhesion	3689	6464	3674	3676	823	3611	3683	3681	10298	5604	5606	3655	7791	7145	5296	208	9564	3688	5880	2889	10580	5170	5879	11131	1793	5605	5747	23473	998	857	3675	407042	8874	825	6414	5908	3690	5594	5596	85366	3694	3696	8515	726	1445	3687	5058	8516	3682	827	22801	3695	859	56924	11132	824	2534	5598	5602	5906	5607	6714	3672	7414	5894	7410	6654	9815	5829	10451	10000	3265	5062	3691	9733	3693	673	10753	6010	5063	5608	9475	5597	3678	1398	826	207	7408	5881	858	3685	6300	7094	3673	3684	369	3679	6093	53358	3680	2885
WP5114	Nucleotide excision repair in xeroderma pigmentosum 	7508	84464	9978	5985	6920	5887	5111	8451	902	5886	56655	10714	56949	51426	5984	5429	57804	6117	128710	5982	4331	142	7507	1069	5983	5981	3150	5427	3980	6119	57654	2074	5426	5424	54107	672	56852	7515	1642	5425	8450	3978	6118	7874
WP4946	DNA repair pathways, full network	2965	57804	7520	4683	4595	6117	404672	2071	5982	100526739	10714	3981	11284	9156	7486	57697	5906	10111	5887	1022	11201	4255	56655	4350	7508	5591	1643	2187	9978	79728	2966	201254	6118	4361	5889	22909	91442	7515	8450	5425	1642	2189	2176	5981	2175	5983	2072	6119	5424	25788	5426	545	54107	675	1069	7507	7398	10038	55247	4436	2188	5429	4913	2068	8930	5984	55120	27343	5395	3014	5423	4331	1111	64421	2178	51426	27301	5980	7518	55215	83990	8451	5111	902	5886	2956	2967	252969	2237	2067	1161	3146	672	2177	80233	3978	57599	23583	51455	5427	7374	4292	2547	3980	79840	2074	4968	142	4437	2968	7014	5893	328	472	6996	27434
WP2263	Androgen receptor network in prostate cancer	596	1399	6772	3292	2118	5347	4436	2885	5728	641	4312	11184	545	836	6690	11200	207	994	1017	6604	1398	3817	354	4361	3284	6009	1586	253314	842	8289	5591	51412	5781	3265	1019	2475	5599	86	24553	5829	841	2078	367	993	7249	1869	5894	572	2002	466	10811	5906	10111	3293	5921	581	3082	7157	6654	983	7248	4193	10252	10257	3294	595	5058	6774	472	6599	3725	5595	51478	5594	10397	2353	4088	672	5908	6602	2165	5925	3295	26073	2956	6601	2889	10253	6603	57521	3283	7113	3716	57492	1793	5605	4087	5604	4609	6597	5290	2549	1978	2185	1111	580
WP2826	Cocaine metabolism	8824	1576	1066
WP661	Glucose homeostasis	
WP712	Estrogen signaling	1147	4790	1432	5290	1385	207	3551	2099	2792	596	8517	2002	2852	2353	5601	3725	2782	6667	673	5566	2778
WP2456	HIF1A and PPARG in cardiac hypertropthy	84803	3091	5468	3939	948	6513	2597	7167	2819
WP521	Amino acid conjugation of benzoic acid	55902	10249	219970	92292
WP4844	Influence of laminopathies on Wnt signaling	2010	5468	2339	4000	8312	406884	122011	1052	3280	7480	6934	10269	324	23405	27161	1021	1050	6932	8091	860	6696	1051	6720	693120	7088	595	1452	2932	51176	23463	388585	1499	9370	6517	83439	26092	6895
WP3633	Caffeine and theobromine metabolism	10	1548	1544	7498
WP3604	Biochemical pathways: part I	
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	3123	916	3929	3501	3503	3569	3932	10394	55922	64386	3576	3543	920	3126	1401	3122	917	3127	28639	3500	926	5725029	914	7535	3497	919	925	2534	3538	28755
WP24	Peptide GPCRs	8484	728	4888	4159	4161	5540	1230	6870	1234	1236	10396	6865	1237	3579	7253	729230	2587	2532	1232	4889	552	3061	4988	2693	554	1235	2826	4158	2833	10663	2357	6751	624	6753	1524	1910	2925	6869	4887	680	3062	7201	719	4886	623	886	23620	6752	8811	2359	1909	4985	553	6754	4829	2798	2492	10803	643	7852	6755	5021	4986	887	4157	255061	4987	1233	2358	186	4160	4923	3577	185	3973
WP2643	Nanoparticle-mediated activation of receptor signaling	374	1956	2885	5293	5605	5747	5601	5603	3265	1277	1432	10000	3688	5599	5829	7094	6300	6654	5600	2335	5594	5894	5604	3672	3845	6714	5602	4893
WP4299	Lamin A processing pathway	4000	10269	23463
WP313	Hepatocyte growth factor receptor signaling	2185	6654	3082	2549	5290	6714	5906	5921	1398	3672	5908	5594	2002	2353	5604	5894	1793	5747	5605	5595	11184	3725	5728	2885	5829	5058	6774	5599	3688	4233	2889	3265	5781	1399
WP5396	Enterohepatic circulation of bile acids	8714	123264	28234	1244	6554	8647	5243	6555	200931	2172	10257	10599
WP5136	ALA oxylipin metabolism	246	240
WP4863	Host-pathogen interaction of human coronaviruses - autophagy	83734	89849	8408	84557	2475	10533	9140	5289	9706	55062	8678	64422	30849	9821	115201	9474	9776	55054	53349
WP4142	Metabolism of sphingolipids in ER and Golgi apparatus	81537	8879	8704	64781	57452	259230	2531	8707	166929	7357	130367	256435	7368	204219
WP3645	NAD+ biosynthetic pathways	8658	23475	3620	683	51548	6999	23410	143	23408	130013	23411	23409	10038	142	952	22933	80351	10135	64802	55191	51547	93100
WP304	Kit receptor signaling	
WP3651	Pathways affected in adenoid cystic carcinoma	26292	4613	1050	29072	55534	2264	2309	7157	284058	84159	5290	9863	4603	64324	5894	4609	8332	6595	8823	23269	1387	10933	5605	29128	58508	9223	10847	3645	1487	7994	8243	4149	5591	55294	54880	3265	27255	93986	2064	51742	8289	23135	9874	4781	23774	3008	207	672	23220	6605	221037	5424	63035	55783	5728	2033	7403	4851	54756	546	55914	9611	472	4602
WP5175	Disorders in ketone body synthesis	622	3158	38	5019
WP5329	Cholesterol biosynthesis pathway in hepatocytes	3157	3158	6720	9619	2182	29116	10965	9415	7376	6319	6785	54898	2180	1581	60481	39	2181	83401	641371	3992	1595	2194	19
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	5970	4191	142	3569	3553	3159	22933	2805	23057	10850	7157	23411	2806	10135	23410	9997	23408	4190
WP4942	15q13.3 copy number variation syndrome	10936	728498	1387	8850	106481770	51621	106479293	100507067	100288380	107080653	871	106478916	2916	390561	4308	101927579	283711	22909	6352	1139	727909	106480944	106479451	89839	54893	101059918	89832	2534	102725022	161725	106480705	2177
WP4157	GABA metabolism (aka GHB)	1800	137872	18	5446	27165	7915	4129	8574	2572	2571	2744
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	9648	9501	94121	94122	5873	5874	94120	23086	25924	79083	83874	84958	8567	22895	54843	201294
WP5472	Phosphoinositide 3-kinase (PI3K) family	5293	5294	5296	5291	30849	8503	5288	5287	146850	5295	5290	5286
WP4917	Proximal tubule transport	6524	117247	23428	9356	55244	6522	146802	6513	762	525	476	6519	6520	6550	64849	9376	481	6560	10257	6575	1244	51382	527	9429	10864	340024	9296	8671	6528	57393	55867	528	523	6569	6505	6523	51606	486	50617	65010	533	54716	529	348932	760	6582	245972	6514	160728	9550	9056	142680	5243	358	153201	11136	8992
WP4566	Translation inhibitors in chronically activated PDGFRA cells	5292	27250	8503	6195	5296	1978	5294	5602	5290	8986	5607	11040	5606	5604	5605	1973	5566	6194	5295	6196	208	1432	57521	10000	5599	2475	1974	5578	1977	1981	5608	6416	6199	5594	207	5595	5163	9252	5291	1457	5609	5580	1975	6198	5601	8672
WP3611	Photodynamic therapy-induced AP-1 survival signaling	10018	90427	5609	595	596	5603	602	578	355	3725	1839	356	3458	1956	4170	5608	8743	6416	3726	4217	2353	7186	1029	5925	7132	6300	8837	5599	598	890	1432	7124	3569	1026	7189	898	1386	4780	3320	3558	581	5606	637	2002	5600	7157	4313	5156	7188	2252
WP5422	IL19 signaling	29949	9655	8651
WP5093	Opioid receptor pathways	8411	26575	815	2902	1956	4988	1979	5331	5582	3725	5163	5159	5879	627	3791	3553	6777	6198	5601	3480	5599	6774	4842	2932	1978	5338	5590	2903	834	207	4843	774	1385	1234
WP4961	STING pathway in Kawasaki-like disease and COVID-19	3661	4790	3708	1147	114548	2152	5970	29110	3551	3553	8517	5966	2212	79671	4792	79792	340061	3456	9641	115004	4794
WP4524	Alternative pathway of fetal androgen synthesis	6716	8630	1586	5447	1528	1646	1109	3284	6770	3292
WP4485	Modified nucleosides derived from tRNA as urinary cancer markers	
WP4784	Proteoglycan biosynthesis	113189	124583	55790	11285	51000	1836	9469	26229	54928	22856	2131	2132	9060	347734	2137	64132	64131	126792
WP5376	17p13.3 (YWHAE) copy number variation	1621	27185	11258	1778	10671	1020	7529	1644	5515	7054	10540	10971	7533	51164	7534	7531	1639	81565	5048	7532	84516
WP2542	Sulindac metabolic pathway	1544	1545
WP58	Monoamine GPCRs	148	152	1812	1816	1814	3355	146	154	1133	1131	3351	3361	3363	1128	3360	1132	3274	150	1813	3350	3269	645694	147	3362	3356	3354	151	1815	3358	155	1129	153	3352	3357
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	11277	84153	23586	3661	10535	25939	4938	115004	6041	79621	57506	340061	64135	3456	8635	103
WP3980	Protein alkylation leading to liver fibrosis	
WP2328	Allograft rejection	3565	3458	727	652614	355	1493	836	3108	50943	6363	6772	735	59067	713	10376	2668	7431	3125	3126	3109	842	942	958	10578	5551	3593	6387	3552	3133	3592	5243	3107	730	4283	10563	729	7124	3553	3035	941	841	3559	23743	714	3115	6957	720	7040	3586	1459	3558	717	356	7422	120892	643	185	959	718	3576	50616	3118	3127	5590	6373	3122	732	3111	3605	3113	3567	3119	100507436	3123	3106	940	840	3596	1604	55825	2551	3117	6955	731	3112	3134	3135	721	5156	712	6366	3002	3105
WP1539	Angiogenesis	3791	2247	5155	1432	5335	405	2263	2321	7422	5747	4318	1387	7010	3091	4843	207	5594	7077	5290	4086	6714	4313	5156
WP5049	Glycolysis in senescence	7157	5230	5925	2539	3939	5315	5562	2597
WP2858	Ectoderm differentiation	25806	23229	2274	3975	79658	2737	29970	54898	57154	6785	1756	1896	1501	81576	4771	57621	5783	6016	7593	6622	23133	3148	8848	2627	5292	51592	8495	57476	5297	4920	7022	4926	157807	7471	7343	2534	3728	9687	54207	9924	170302	2263	406949	114815	1499	440193	22871	9079	652	8322	6469	2300	5420	56913	152789	54521	2720	57462	7704	8675	398	10486	54828	1004	55843	1006	4204	79776	7226	6907	8820	8345	4772	51422	5452	7855	5787	9935	407042	79731	6498	151613	3801	54806	83439	84809	10253	54880	10634	4061	6238	1487	6347	114822	5236	7026	8473	25987	6657	1496	91653	8835	11177	10013	51701	4609	56963	5077	54903	5150	5269	7020	5010	4982	83933	27324	1952	5080	7903	6781	4089	3853	657	27352	60401	51043	10257	50937	56899	6386	5362	460	4990	51762	3170	6929	51222	345557	5467	494323	166	8325
WP3927	BMP signaling in eyelid development	4086	4214	4090	2255	7039	5601	4089	3625	5308	6469	2296	3725	652	2303	5595	1956	27123	2263	4851	6422
WP5195	Disorders in ketolysis	38	622	3157	39	5019
WP5089	Kinin-Kallikrein pathway	1369	3818	2161	3827	710
WP477	Cytoplasmic ribosomal proteins	6198	6165	6232	6142	6124	6147	7311	6133	6202	6139	6210	6207	6199	6160	6193	6191	6125	6157	6164	6152	6138	6197	6192	4736	9045	6208	6159	6143	6141	6231	6233	23521	9349	2197	6224	6201	6203	6137	6158	6209	6171	6132	6173	6170	6122	6146	6144	6234	6217	6155	6181	6223	6230	6204	6206	3921	6189	6229	6176	6175	6205	11224	6154	6156	6167	6235	6228	6188	9801	6128	25873	6194	6196	6218	6135	6169	6161	27330	6129	6130	6123	6136	6134	6168	6195	6187	6222	6227
WP5399	NPHP1 deletion syndrome	2316	9564	23322	2317	5594	2318	261734	5595	2185	4867	27130
WP4538	Regulatory circuits of STAT3 signaling	1271	2151	3455	3595	3568	6714	3587	3977	5598	5602	80854	10401	5788	64223	53832	64798	11122	5156	253260	7297	3601	50615	5600	58985	10155	2475	3590	57521	1432	5789	3561	5599	3559	3563	84335	79109	3460	3925	1441	3716	4352	3454	2149	1387	3717	5594	5596	5597	1439	1489	3588	2690	3575	53833	6300	9180	3459	3560	9466	225689	163702	3572	5601	3581	5603	185	9021	186	9002	6774	1438	1844	1956	3570	5159	3718	5579	5595
WP170	Nuclear receptors	2103	9975	5916	2101	5914	4919	190	6097	7421	7182	7026	3172	2494	5467	2516	2099	5468	10062	9970	2063	5241	2908	5465	367	7376	7025	7067	6256	7068	4929	3164	6258	7101	6095	6257	8856	5915	2100
WP5064	7-oxo-C and 7-beta-HC pathways	122970	1593	641372	641371	3291	1628	10005	26027	134526	23600	4864	10577	10682	55856	570	23597	1717	10965	284486	2053	11332	3290	1581	8309
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	8801	4190	48	6389	4967	3419	5091	3417	1743	2271	5105	1738	1737	47	1431	5160
WP5389	DNA adduct formation leading to kidney failure	
WP1545	miRNAs involved in DNA damage response	442916	406886	407050	407011	407021	1021	664617	406948	3014	693122	7157	406979	442902	406991	406884	442917	407014	494336	1385	4609	406952	1869	406953	406982	896	1026	406949	993	1027	898	595	472	407010	574456	5893	442918	25	574506
WP5035	ACE2 inhibition leads to pulmonary fibrosis	
WP2882	Nuclear receptors meta-pathway	11182	64240	2258	5743	34	8660	23491	6337	6533	376497	6526	6524	6649	5375	29988	8553	10599	6538	8507	10602	51129	7049	79571	1839	25800	8850	10499	3725	23657	51	11254	8431	1831	6397	570	388662	2539	10252	595	91252	10257	4259	6286	7128	7421	81031	27173	6364	54578	79056	121512	7039	7546	131	4609	9982	153218	2940	27063	29986	6514	6532	7363	1958	1581	2950	7295	9817	2729	5997	1907	1544	2730	6342	54716	6347	8714	54659	6513	7364	5460	1728	329	1579	10486	5265	89795	22949	241	196	1543	80315	6527	5272	55554	3280	1956	2033	5465	1962	3458	2941	84002	6518	9965	2949	6554	873	644314	54566	1548	10560	2042	7922	125206	1557	874	218	5166	983	5055	54657	7040	5524	345	6594	8878	6714	2939	10057	340024	140809	10769	6528	3320	4780	30	221074	5552	2289	6517	66002	6536	6534	84951	27286	11214	6523	57181	1019	8884	5142	9588	4240	1582	55334	57678	92737	7048	114134	221393	1376	5244	1374	6531	114112	5467	3726	115482694	23764	1622	2678	4258	115584	11309	5105	66035	9970	57491	1244	6817	2040	55117	8647	221223	4616	2936	6591	8856	6774	3589	4199	56606	3162	347902	7042	2944	2946	1545	81706	336	64241	7296	3084	9152	1066	23054	51426	4257	64116	6515	6822	1576	2308	221079	177	160728	27190	8648	645	55630	11057	8243	1555	8202	54658	5052	5155	6540	29103	5226	8824	2948	3593	283375	8454	10998	2953	55224	5360	2099	29985	3895	3727	330	1028	10728	2495	201266	405	1559	4791	221357	60482	1551	5705	6720	23516	3337	9049	9792	8972	159963	7266	2878	387509	3082	11140	335	3326	1969	3303	26509	154091	211	6667	8436	1836	2947	2194	117283	6535	200010	9971	56262	144195	2512	10891	116519	348932	2908	1027	283848	3592	6319	10062	4097	1577	155184	54600	5243	2168	3553	54577	6530	28968	8140	2877	7056	57007	6529	8204	6256	2938	2952
WP5461	Primary ovarian insufficiency	157777	10734	9581	431707	3161	84168	3981	80067	9156	2176	79983	268	1586	113510	388649	239	2332	4486	857	78995	641	5888	55215	2175	367	654	9692	124045	54937	4292	1967	1352	1618	7516
WP4838	Regucalcin in proximal tubule epithelial kidney cells	5594	4217	4087	7040	5894	207	581	5741	9104	7132	7046	2475	56302	4089	89866	90550	796	836	578	317	673	59
WP1601	Fluoropyrimidine activity	1548	8836	2356	978	83549	4524	10257	6996	7517	51733	1890	7372	6241	7378	6240	1719	1806	2030	5471	151531	10864	1807	10057	23583	7083	9429	1066	7371	2068	7157	8714	7298	407026	8824
WP623	Oxidative phosphorylation	27109	517	4541	4698	3002	10632	4705	539	506	4536	521	10476	514	56901	4715	4728	4537	4716	4714	516	4535	4717	4712	4700	515	4723	4706	4704	4707	4729	4710	4702	126328	4697	4711	4713	9551	4508	498	537	4696	4719	4731	4720	4726	4701	4724	10159	4538	4722	374291	522	518	513	4725	4718	4695	4539	4540	4708
WP4922	Mitochondrial complex IV assembly	1353	285521	1351	25994	152100	1340	28958	389203	388753	4697	84987	1327	51241	107075310	80775	1347	1355	90639	9997	10063	1337	51204	1345	100131801	1352	6834	1329	100303755	116228	25953	9377	1350	1349
WP5026	Proline and hydroxyproline pathways	5625	4942	5831	8659	5184
WP4950	16p11.2 distal deletion syndrome	83985	1380	930	11273	7284	4773	3791	7185	718	975	3717	5868	3276	10806	5867	4352	3565	3732	2885	3643	6588	5350	487	8519	27040	84901	7410	7186	100616487	79874	25970	100289092	27342
WP2380	Brain-derived neurotrophic factor (BDNF) signaling	8517	3551	1147	23191
WP5300	TROP2 regulatory signaling	3717
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	5873	22808	5868	5595	5878	673	5869	9146	6237	3265	369	5594	3187	5894	10015	4893	3845	22800
WP4172	PI3K-Akt signaling	5294	3440	5296	1978	7423	2324	5519	5617	3655	5228	3455	5604	3381	4790	2260	3674	51378	3676	148327	3716	5008	898	3445	3908	5879	1026	2277	1436	4233	8817	4846	7057	208	5155	930	3688	3563	8822	1977	8515	9180	3575	5618	102723407	1311	7097	6199	3562	2538	3690	2249	63923	23035	4804	356	2259	57818	5105	3815	3570	5595	1388	29941	7422	8115	2251	3630	54541	5521	7058	3914	64764	3695	4602	1129	5529	10161	2998	1280	2322	3082	11140	3439	1969	27006	3326	7248	5520	6654	4254	284217	3672	3913	5894	2792	2250	4893	4909	3558	1101	22798	2785	3845	7448	1027	1386	6446	1285	1443	3691	9170	1297	3717	5525	1292	2688	3265	2255	55970	3918	598	10000	4803	1293	2997	1442	842	7184	131873	5578	3451	23239	26291	1017	3678	10110	54331	207	146850	2690	9134	3566	4915	5515	2261	5293	80310	7424	2323	1945	5586	3718	1298	5159	3449	55012	6696	3371	10681	3441	1950	10018	2793	3912	2932	3673	2257	2309	8074	2264	5156	2790	5154	2252	3909	1435	8503	3481	4609	10319	1287	23566	1282	7039	3444	3446	5527	5290	5522	100533105	3675	55844	627	2787	6794	5605	5747	7060	5562	2846	7099	5518	3456	2782	2149	3454	3667	1943	6850	5170	2247	1902	3569	117145	5295	57521	3561	56034	2783	28227	7450	5563	2258	2056	118788	3694	3915	3696	92579	672	1128	7059	5594	1288	1440	5106	1942	5528	256076	23678	2253	896	3910	2788	7010	9586	2248	4193	22801	23533	5523	3791	6198	3574	8516	595	7157	5934	64223	2256	2254	9623	84699	284	5526	3447	5649	3442	3911	572	2689	90993	3320	1286	1385	1284	1147	3452	2784	2786	285	1441	3693	7249	1019	2475	6655	3551	6194	1278	10488	3559	4908	2246	6009	3560	1291	94235	1021	253314	2335	1299	3685	2057	59345	1944	5585	1946	894	3448	4170	468	7143	5516	4914	51764	2263	3565	2885	5728	1956	5291	3643	2321	26281	3479	9965	3680	57121	7148	3480	5970	596	3679	8517	1975	2791	9470	3443	1277
WP4537	Hippo-YAP signaling	9113	4771	9448	26524	10413	8463	7004	5871	23012	25937	11184	10397	8491	7005	6788	60485	50488	11186	4485	3627	7003	23043
WP2857	Mesodermal commitment pathway	29072	6925	154091	92	3624	27245	4838	2627	7044	115825	7473	10637	9421	79668	56946	23181	4086	8312	9760	23007	7547	57045	1789	23576	5566	4780	6169	8463	29970	3717	54799	9113	8091	8554	93	4211	26610	6899	6926	80304	10451	4091	708	268	5460	85416	79776	84295	6001	11169	121536	22943	5090	55704	8450	89780	85363	55809	5308	3172	131405	5515	7855	7403	3251	51176	8646	5573	22823	51366	8322	652	23528	80312	83881	442895	2296	8313	1466	5087	6657	7003	5916	2303	27244	4087	7546	58499	31	343930	9314	203228	51701	84159	2260	3169	10124	79923	54892	2005	79035	8928	83439	659	6911	84667	10155	9241	28514	404220	5915	2625	2132	57669	3064	10973	90	3170	23499	3720	11166	688	655	79977	2131	4088	8553	8325	23373	27324	10413	57198	6722	11190	5080	2253	63035	4089	8030	1488	9573	6615	8320	595	8728	657	64321
WP5145	COVID-19 structural coverage map	83666	91662	9868	54834	7311	8829	26019	29960	64398	5976	28992	59272	10605	9636	55506	10454	340024	7314	7316	54625	9716	3508	140733	335	23070	9555
WP5151	Sialylation 	10559	54187	10020	55907
WP4150	Wnt signaling in kidney disease	8323	51384	1857	8321	80326	7480	387	4041	1856	7475	7473	7471	89780	7482	7484	5602	8325	7855	8324	1499	8326	7976	27130	2535	8322	81029	54361	7474	7476	4040	5601	1855	100532724	7481	7472	7477	5599
WP2646	Lidocaine metabolism	1544	1576
WP5417	Cell lineage map for neuronal differentiation	132625	388585	6536	3975	390992	4741	6506	2743	4488	6530	2741	1641	6529	7054	7166	2128	3763	4340	2627	6662	4010	4838	3266	2670	160	146713	8001	999	1740	10215	201456	1103	10763	4851	151871	2902	6663	51176	22871	7291	150	652	6091	2752	8825	4487	10369	8500	3371	83881	9568	9455	1464	10716	43	5460	4747	2550	9456	9454	57084	1000	4155	27022	3280	2742	3172	6532	3350	6862	28514	23025	441509	10381	2173	6507	10840	3688	2626	50944	27445	6657	152	1742	10243	3655	9314	9152	2571	5077	5175	6855	1739	85358	3866	79923	161	359787	5010	23504	100133941	2526	117581	1741	2904	8927	5080	6591	23085	64321	2572	151	4929	8573	6615	6616	361	57030	6285	9699	4133	54738	6531	6572	7168	2103	3170	3361	2249	2744	1267	947	4804
WP5076	Soluble ACE2-mediated cell entry of SARS-CoV-2	553	59272	6868	185
WP4495	IL10 anti-inflammatory signaling	3716	645	3586	3569	6772	3587	6773	6774	7214	644	3162	3588	3552
WP5083	Neuroinflammation and glutamatergic signaling	2890	6774	1737	2805	4089	2912	2900	2917	9021	5500	63826	7043	5595	1270	2904	2906	3570	26012	5582	7049	81539	801	6509	3588	5594	2905	2744	3554	2353	109	4088	23236	10645	7048	57030	6507	1738	1072	3569	2247	2918	3667	27185	56301	6472	3596	55144	627	815	80131	10991	3716	5330	4790	3587	2911	6515	4087	54407	814	817	7188	107	7042	7850	84230	27165	2914	116444	3572	596	6772	2892	2752	5579	3479	2897	3643	2902	26227	818	5331	3565	3458	4791	3566	3552	207	3593	57084	5578	5723	2915	6513	7132	5499	6511	3459	54795	23507	1610	4803	3460	4842	6506	3553	7124	6778	2898	816	6536	7133	4092	114	116443	3597	5566	3592	6470	92745	29968	1385	3976	3586	7040	5501	56262	5160	5332	2670	2899	2901	7046	2903	6505	2891	23237	2893	84254	4049
WP4874	CAMKK2 pathway	3600	142	3791	6198	3145	3162	6692	28959	5058	595	6279	3098	57205	5595	22861	3077	114625	200186	9970	10803	3091	57539	5594	3099	440	8638	8408	5106	8874	801	6402	5563	56907	23411	6373	10645	17748	8243	9817	10661	388581	57521	28232	898	2691	10964	4094	940	358	5879	6862	31	50614	23327	814	6005	3383	7412	51024	482	51316	6352	256691	8536	5970	6720	8611	854557	9759	2033	4600	56975	5208	7466	56269	10059	81631	1510	89874	932	6513	5209	2057	2628	4281	2475	4773	2645	7124	7103	4842	6194	9814	993	51327	6007	340348	4780	59341	28964	1371	6517	8878	6786	999	1385	92745	84557	1131	10125	1727	2194	7248	19
WP4918	Cellular proteostasis	10273	7411	3337	5201	5204	5203	10471	5202	3320
WP5133	Non-classical role of vitamin D	59272	5972	185	183	186
WP2431	Spinal cord injury	50507	6098	5578	4099	900	2236	5173	2212	4155	4843	1647	1017	8741	4282	9475	3552	1875	2902	1956	11202	727	3565	3458	5320	65078	388	836	713	3164	4321	7431	1464	2668	1280	176	7157	983	2670	1241	6662	9423	2920	7040	5542	2043	3558	64131	961	1027	2596	11025	63827	4318	7538	1869	3553	7124	1019	10673	4842	301	5362	5743	4050	361	5925	2697	6869	3554	2353	5594	2280	5786	5803	389	4804	383	8398	5595	3958	1462	5530	5322	595	328	3576	3627	387	2309	50515	4974	57556	56963	1282	6585	2919	4609	729230	1463	3383	199	998	6403	7099	7832	1958	6586	5879	358	627	3569	3952	57142	9353	6347
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	84823	4001	727	718	23463	9986	2339	1675	4000	629
WP3934	Leptin and adiponectin	5571	31	5564	3952	3953	5562	51094	1374	9370	79602
WP4223	Ras signaling	8844	123745	8399	25780	3363	4804	7535	801	5898	3815	5319	356	5582	64600	8036	2904	5595	6237	100271927	51806	5058	5296	9610	387	8437	27	2324	5604	283455	10298	4301	2260	4790	5321	6464	30814	50487	8315	5879	84647	5880	1436	91860	4233	22800	2114	5335	208	9771	10156	5578	5881	207	23179	54331	4915	2113	5063	115727	5293	283748	2902	5320	2261	22821	25759	5159	8681	10681	255189	2793	2322	10125	11186	1969	22808	5863	5900	6654	2903	391013	5894	2792	805	57144	5921	2785	3845	4893	10235	5602	5868	25	5062	55970	3265	598	5599	100137049	10000	9846	2783	5966	27040	5594	5908	808	2788	7010	5568	8398	3791	56924	399694	5322	5899	5924	810	6789	2549	5156	2790	5336	163688	2264	5878	8503	51365	4763	4303	83593	5290	998	5567	2782	2787	5605	81579	5295	94235	64926	5338	9462	84630	59345	8831	106821730	2885	5291	1956	3643	55770	51764	4914	2263	53358	2321	5579	5601	8517	5922	3480	5970	2791	51196	5869	5337	382	572	2002	7074	5906	1147	5923	5566	2784	2786	26279	8605	3551	5781	6655	10928	11145
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	7049	5595	5054	738	4089	860	185	2201	2022	2316	4053	1432	5599	7048	7182	7046	2200	4088	4052	5594	1490	4087	84467	6464	10631
WP1438	Influenza A virus infection	956534	596	956529	956527	956530	956535	956528	3802042	956531	956536	956532	956533	100289419	55193
WP3965	Lipid metabolism pathway	5346	10000	5575	593	208	5564	29923	5566	5571	5573	3991	55902	5567	5562	5568	47	51099	207	5160	31	5565	51422	5563	23205	5576	53632	57104	2194	5577
WP5043	Pentose phosphate pathway in senescent cells	7157	2539
WP1533	Vitamin B12 metabolism	4791	5970	2694	6947	6347	8029	6948	4036	4790
WP2034	Leptin signaling	
WP4830	GDNF/RET signaling axis	10736	7490	2625	186	2138	9353	2668	64321	6928	3227	2296	8854	10252	6299	652	3975	26585	5076	3207	3237	2303	6664	79633	6092
WP5346	8p23.1 copy number variation syndrome	83595	203074	55613	1475	1499	3329	5595	4482	10445	640	613209	346702	115004	7015	9107	7097	83656	2212	5594	606553	6910	649	3651	56955	3727	253012	2213	9103	7884	137075	613211	6517	79660	9258	7099	54984	8879	203076	1509	252969	2222	83648	4825	2626	83650	286046	90459	94137	9108	66036	5894	4926	7013	8312	6281	613210	1508	8658
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	3690	22943	7827	207	950	1759	1514	4868	7094	11346	10971	4690	3685	182	23607	5420	4040	81	3987	375790	7225	4643	7431	55742	1028	1499	4851	84623	5329	3856	7040	3913	7414	7471	3911	1287	4627	5076	3611	4288	2534	977	1286	50485	51196	1378	9076	4311	1605	64423	4010	4041	7402	2195	84063	3688	7490	5335	3664	941	1285	3675	1027	7448	5800	816	7099	5111	3691	1026	5747
WP5029	Amino acid transport defects (IEMs)	11136	57393	6520	153201	6505	9056	54716	340024	6519
WP334	GPCRs, class B secretin-like	799	2740	2692	23284	30817	2696	2642	7434	1394	5745	22859	10203	23266	5746	1395	7433	976	10149	117	6344	2015	64123	9340
WP61	Notch signaling	2475
WP4249	Hedgehog signaling	132884	1453	64839	894	50846	409	122011	2619	157	6608	339745	2735	4036	374654	64399	50937	8643	8452	23432	51684	91653	3549	11127	1455	1456	1454	6469	53944	596	595	1452	156	5727	2736	408	5566	5568	2737	8405	64750	2121	5567	57154
WP69	T-cell receptor signaling	
WP405	Eukaryotic transcription initiation	6908	5434	5436	5432	5438	171568	3611	2961	2959	5437	2963	2965	2068	25885	2071	5430	6883	6878	4331	6877	55718	2968	51082	51728	5431	6880	2967	64425	2958	55703	5439	661	5440	2966	2960	1022	5435	6884	84172	6879	902
WP4655	Cytosolic DNA-sensing pathway	3445	84265	9560	3452	1540	57506	3456	8772	5435	29108	10621	3551	10623	3569	843	3553	55718	9140	11128	90865	55703	841	3440	3439	3665	3627	9641	5441	4792	54941	6352	9636	3442	5434	9533	3447	4790	5437	1147	171568	3444	3446	9474	6351	4793	3606	103	79671	10622	9447	8517	51728	3449	51082	29110	5970	5440	11277	661	3441	3443	7706	115004	8737	3451	81030	340061	11035	8717	834	3448	23586	3661
WP474	Endochondral ossification	1028	249	85477	9507	9510	9759	654	2261	51719	3479	7422	2487	6777	5327	6696	3157	3480	6772	4921	657	871	1515	5741	655	207	579	801	864	7078	8100	2690	1300	5566	5727	5744	4318	2737	860	2247	55553	8817	5328	11096	2688	1473	7067	5167	1280	176	7042	4208	50515	3481	6662	3549	11127	445341	7040	54407	4256	5745	2260	4322	6660
WP3947	Serotonin and anxiety	2911	3356	2332	2554	5341	3358	2353	1392	5530	816	148	84812	5579	3350	7442	23237	5443
WP299	Nuclear receptors in lipid metabolism and toxicity	1591	5468	9971	5467	1580	407039	64240	7421	1571	8714	1582	5244	19	5914	5916	1579	693120	9619	1594	5915	8856	225	1555	1592	1544	1559	5465	1576	5243	8647	1581	1244	9970	5825	10062
WP3998	Prader-Willi and Angelman syndrome	4927	2796	6870	3972	51738	7175	5020	2558	8480	7334	6638	79023	81614	114791	348995	5122	1031	123606	627	101928840	23165	2691	3814	9638	4928	105370731	791114	9883	585	4692	692236	81929	5590	54551	5925	1977	2332	57194	23636	595	5903	9818	23511	8021	4193	9631	27229	3630	1749	338428	7681	25909	10844	4808	4194	283685	5108	653061	347686	338429	338427	10426	5443	7157	7337	2569	55706	4803	990	1019	57122	1081	200959	23191	1869	85378	53371	2488	9025	23279	55746	791115	2567	9688	10762	2562	51151	3653	4948	894	23225	1030	1021	129401	79902	2733	1029	9972	23742	6396	11097	4487	3358	2570	8086	692218	7299	8924	8926
WP5373	Osteoarthritic chondrocyte hypertrophy	8061	5578	3726	3091	2353	5594	207	3727	11061	2263	405	4914	2261	7422	5595	3725	5970	1734	4921	1051	6696	3791	1281	1277	6774	2264	2034	1280	176	2355	6662	5971	1490	3381	5290	2595	4322	4790	2260	1300	55004	7428	3717	2354	860	54681	208	10000	4803
WP4584	Biomarkers for pyrimidine metabolism disorders	6240	1806	1807	7084	51251	50484	7298	80324	1152	51733	1890	1723	7372	6241	30833
WP5442	Wnt/Beta-catenin signaling inhibitors in current and past clinical trials	57060	1499	8215	4040	4041	122011	64840	324	8312	3172
WP4724	Omega-9 fatty acid synthesis	79966	83401	2181	79071	10965	2182	9415	64834	6319	3992	54898	2180	60481	2194
WP536	Calcium regulation in cardiac cells	6001	2810	8786	490	5578	489	94235	2703	6546	113	2701	59345	6263	54331	64407	6261	2709	108	811	3762	5579	1132	7532	147	782	51764	5573	5331	480	3745	818	2791	57620	127534	483	57369	5580	8536	153	10681	11142	5577	10287	1131	10804	2778	7533	1133	154	7531	409	115	2785	10052	805	2792	114	816	2773	776	8490	2771	2786	2784	5566	9628	5996	6262	2702	2707	196883	55970	155	5590	2776	5569	2697	10971	844	2783	8787	2781	146	10636	3709	5350	491	801	779	2868	1128	5999	109	2770	111	808	6547	2280	784	8601	2788	7534	2767	5582	773	5587	26575	2869	3760	3708	488	2775	481	845	7529	1129	5998	817	777	57165	148	5583	309	5581	5576	482	2705	107	81025	5570	774	814	2870	2787	6004	5567	2782	492	112	408	5588	2700	84876	815	775	2706	5575	3710	5997	6000	486
WP5111	Familial hyperlipidemia type 4	3949	344	84649	335	116519	338328	64788	4035	4023	336	337	2646	355	2645	5360	64714	6400	3990	4547	3931	1071
WP5323	Fatty acids and lipoproteins transport in hepatocytes	255738	10948	949	344
WP2817	Pregnancy and lactation	1981	1977	139728	1447	5617	2066	2064	5618	1050	2099	8600	4609	7528	9914	1147	5770	1956	84876	2908	857	5241	3717	4782	6777	1051	51083	2065	2100	8792	595	598	2706	2001	23508	7392	7170
WP2849	Hematopoietic stem cell differentiation	3674	999	4601	11107	4778	2313	1997	11040	7040	23569	51701	4254	4582	1435	5292	406948	7539	7294	80342	90485	3071	6688	2624	4208	4005	10661	1437	2354	3569	3553	4773	10614	140628	285989	10320	2993	2149	863	79366	861	3131	406950	100125288	947	1440	3663	3552	2353	55502	3690	3567	4066	8780	3562	85474	2056	7173	126375	399	6776	1827	7481	84695	5087	407008	1950	4261	4602	91	28	124790	7148	7852	7409	51379	23650	51176	3757	116931	4851	2623
WP5473	Cytokine-cytokine receptor interaction	3577	51554	27178	3572	59067	5197	55504	8797	7850	8792	3565	3458	84957	652	64806	130399	6363	58191	55801	1439	656	8743	115650	6368	3560	392255	8809	282616	8771	7132	23765	2057	958	10220	23405	8742	4283	10563	10673	6346	1524	7124	3578	6370	2662	3559	8200	133396	94	2826	1441	7133	114799	8793	2689	2920	7040	8600	3586	6375	3976	651	5473	8764	4049	6362	6367	6356	6354	50615	3624	3626	92	2658	132014	269	3574	60401	3576	9573	6348	5196	282618	654	4055	26525	53342	2921	3623	10803	3604	3606	655	1440	27302	3588	90	944	4050	9466	2056	53833	163702	112744	6358	3590	3569	338376	2657	246778	943	84818	23495	6347	10663	3561	8744	51561	4352	9560	1235	3454	3456	3467	659	2919	729230	3595	653	10344	3977	3587	10850	3627	1230	650	6352	8718	608	6366	6364	56832	1435	6357	91	1233	1438	3598	8808	6369	355	7293	970	50604	6361	2661	9966	2690	3552	3557	3566	268	7173	3459	8784	51330	6387	3451	93	10541	3625	1896	9518	2688	284340	3460	6355	27242	1437	57007	4803	90865	3597	8807	6376	6374	3579	1237	658	1271	1232	282617	3558	56477	84639	7292	7046	386653	3601	4838	3600	959	3581	657	3589	50616	56300	4982	356	6351	149233	3570	29949	7043	1270	643	7852	6359	3605	3562	3554	3556	3567	3953	6349	83729	388372	4804	55540	3575	7048	11009	27189	6373	5618	2829	8795	27177	1436	9210	3952	6761	3563	8740	85480	6372	2660	10913	3594	27190	3596	3455	3568	6360	1236	146433	939	151449	1234	8995	6846	23529	27179	53832	7042	58985	9547	5617
WP5342	Pathophysiological roles of DUX4 in FSHD1	4609	5081	2100	10891	100288687	154	4617	114907	4656	5979	4654	2033	1026	7422	84676	391769	340096	5976
WP3601	Lipid particles composition	1071	3931	336	345	4023	348	335	344	338	3949
WP2526	PDGF pathway	6464	6714	6416	4790	1147	7074	5594	2002	23647	5894	7410	6654	387	5154	5295	5155	5058	6774	5335	8976	6772	3265	5595	5879	7409	5159	4513	6722	3716	998	2885
WP4630	Measles virus infection	3455	637	5290	3446	10399	3444	440275	4790	1489802	9641	3440	5296	4940	917	8503	3654	3569	5295	3561	1489804	25898	7189	3716	54106	898	915	3445	9451	940	57506	7099	4179	3454	3456	4599	1965	10332	2353	4615	4478	3305	3661	7187	23118	7097	8717	29110	10379	7128	51135	3312	6774	595	6776	356	1489805	7161	3306	3304	81607	103	27113	896	3725	3447	3442	283106	572	1459	5602	5610	3558	1147	6773	581	7297	7157	51209	3303	4939	3439	2523	3665	4792	1019	3551	6504	3553	30835	841	3559	598	5599	51284	4938	3592	3452	1027	54205	2213	8772	868	916	1017	27102	894	6885	8667	4948	3448	3552	9134	9367	23586	3560	842	1021	3451	3593	6772	3449	5970	596	6777	8517	5601	3441	1457	3443	4791	4793	5293	5291	1460	578	355	3310	836	3718	64135	317
WP5239	Lac-Phe pathway	10057	55748
WP430	Statin inhibition of cholesterol production	693120	6646	2222	3156	6713	4035	3949	344	116519	337	1581	8694	348	345	5360	3931	1071	341	3990	407039	4023	64240	338	335	19	64241	336	949
WP5092	Interactions of natural killer cells in pancreatic cancer	3500	102	4609	10052803222914;	3002	22914	2214	2624	9437	5551	6352	7124	10225	259197	6346	6348	6347	10666	1437	6351	2308	3458	648	374383	6868	201633	5817
WP107	Translation factors	1977	1983	3692	1933	1981	1974	8662	10605	1965	23708	27102	8667	8664	8666	8665	1967	8891	1938	23277	8893	1964	9086	8672	1975	1978	8892	3646	8894	10209	8668	8890	7458	1915	29904	5610	8637	1968	1917	1979	1936	1984	2107	1973	9451	1937	26986	8669	9669	8661	8663
WP4336	ncRNAs in Wnt signaling in hepatocellular carcinoma	5328	100302145	54361	64840	1487	5176	6424	83439	6425	4609	51701	9314	7482	147111	574412	50964	27123	27121	4919	56998	1454	7474	4040	7476	7481	64321	595	1488	10023	8324	8326	83595	83999	896	81029	3725	11197	6259	122011	11211	8325	407037	406996	51384	1857	6934	92140	80326	8061	7475	23401	57680	85409	6422	2535	59343	406953	80319	7471	283106	7473	1459	1994	8312	8321	8323	7480	4041	4920	324	85407	1855	1457	2932	7472	7477	1452	1499	406949	7976	51176	1460	406971	89780	894	22943	7855	9350	2146	1856	6932	6423
WP2889	Oxytocin signaling	5333	952	5021	2776
WP5382	TGFB / Smad signaling	7048	7040	1490	5054	7049	6678	7532	1265	10631	7046	25937
WP3585	Cytosine methylation	1786	3418	6996	4204	3417	80312	53615	54790
WP5446	GLP-1 secretion from intestine to portal vein	2641	2776	6523	442206	5122	6514
WP4217	Ebola virus infection in host	3115	7410	4864	3665	10461	5610	1508	57617	3672	7251	7074	432	3107	5868	684	8575	4240	30835	2318	3685	858	8826	3109	3385	10462	1514	3126	153090	708	219931	23586	3120	3133	9367	84868	3836	207	2060	27072	3678	3108	388	8655	100996758	1956	5291	2033	5293	3565	2621	8218	4791	3125	93978	3673	3384	26762	81	7301	3480	5970	2317	6772	5922	5971	8503	3655	4153	387	5296	3135	9641	65082	4790	3676	3105	7020	5290	60	1212	7150	7099	1387	5879	7879	3675	857	3106	64601	998	3123	3134	3112	3688	5295	3117	4734	339390	23339	2348	3122	11314	3127	5966	55823	27183	3661	3119	5594	3690	10332	1965	3113	558	389	3111	6868	5595	91937	87	85477	71	5058	3118	2316	10577	1213	2934	859	1211	29110	9021
WP1455	Serotonin transporter activity	4128	4842	3690	6804	3553	3554	10066	121278	7041	6532	5516
WP2583	T cell receptor and co-stimulatory signaling	7535	925	5921	4790	3558	2534	926	2931	207	641373	6957	4792	5578	10125	8445	5335	1452	2932	6955	3932	5530	5777	5163	1493	940	5133	1859
WP5408	15q25 copy number variation	6262	83640	26052	8120	646	53346	643707	57538	9789	64506	8731	7150	5894	85358	2911	9154	6457	10947	64282	50944	1176	28972	8943	9455	123722	4828	8867	9640	3708	1950	5151	54993	60559	123207	4829	84942	116986	6261	100505679	23478	2915	123720	6513	57188	53339	3064	100616404
WP2406	Cardiac progenitor differentiation	6331	7139	132625	140885	91807	6862	2247	9241	1432	1482	50805	6657	5156	4633	79727	3670	4208	2626	6656	4920	389421	3481	3624	7070	4838	3084	7040	145873	79923	57057	4624	4684	3815	4851	5080	55897	7852	3630	652	3479	83881	3791	2932	64321	5460	7137	3170	22943	6910	649	290	89780	70
WP5236	Markers of kidney cell lineage	3371	7474	6928	284252	3791	8313	8854	2138	10736	4907	2297	2668	5087	3815	4851	5972	1499	5159	84870	284654	2253	652	6495	9096	7827	655	6943	3172	4868	4435	2056	2018	1674	112399	182	5915	54361	6927	54583	7490	3195	4090	112398	338917	6422	59	1634	3975	6299	9423	5175	7040	163	4086	5076	2252	79633	5914	130497
WP3959	DNA IR-double strand breaks and cellular response via ATM	472	142	4193	7014	5893	3297	11200	836	545	578	317	675	5976	641	995	5888	7161	10413	6788	10524	672	9656	2177	842	5883	1029	4361	7158	86	9113	10155	8243	25	1020	5591	5111	1869	5884	9025	79035	7189	1386	9126	9156	581	10111	79648	637	55183	1111	64421	7157	11186	4683	3014
WP4521	Glycosylation and related congenital defects	29925	7991	22845	79868	54344	440138	8813	2683	1798	79053	9526	79644	56052	4351	5373	84061	8818	7841	79087	10195	85365	29929	79796	4247
WP2059	Alzheimer's disease and miRNA effects	5715	5689	3630	6868	824	347733	5595	2904	23385	2906	100506742	5481	5530	1454	10382	51806	3708	7481	5710	291	1857	51384	407026	10888	7475	5289	9706	1965	5535	348	8325	801	3798	8408	11211	113457	351	5709	83464	7494	177	5663	9821	30849	6424	5701	79861	2597	840	9451	292	3831	91860	54361	5694	10381	208	27121	8471	5296	4023	147700	637	5604	10313	5330	7417	4790	823	9861	441925	2902	29982	5293	778	5331	7976	10213	355	5705	1452	1457	2932	489	5664	7186	293	1856	842	4217	5700	4843	3800	7846	22943	207	5693	6263	143471	22926	3552	112714	7280	8772	3553	5685	5719	3265	10000	6622	5599	51107	5692	841	4842	7480	8321	4311	55626	407021	27035	2903	1139	102	7471	23621	5894	7416	805	3845	5602	4893	55102	2081	84790	10023	8326	8324	81029	22863	5534	5683	7476	4040	7474	7419	488	3799	90550	810	5702	5688	80326	5743	5707	8660	203068	23236	2776	1536	2905	5594	808	60673	8883	779	122011	3709	5714	775	9776	4137	81027	4035	5690	347688	5605	8678	3569	1020	3667	3710	89953	57142	10383	5295	5682	27123	26100	322	5708	5687	163688	1435	8503	5695	7979	7482	11047	10105	55062	5290	1460	5291	3643	5532	3416	1499	317	836	1855	369	5601	55851	5970	8313	23130	5609	7477	7472	10376	50507	7132	5704	5706	84617	89780	7277	5691	406921	7855	64837	468	442206	2535	54205	673	776	10297	3551	7124	2475	1649	51807	3028	23401	5713	83447	8323	5332	324	5533	5686	5684	4041	572	283106	5718	7473	487	7278	407024	8312	1147	5610	1459
WP134	Pentose phosphate metabolism	6888	5226	6120	2539	7086	22934	25796
WP4571	Urea cycle and related diseases	10165	1373	383	10166	27165	435	162417	445	5009
WP2596	Gastric acid production	6343	643847	2922	7432	4588	643834	5222	885	5225
WP3297	EV release from cardiac cells and their functional effects	6387	2066	406935	10365	6004
WP2507	Nanomaterial induced apoptosis	581	841	839	9131	596	317	836	840	355	8772	842	578	55732	356
WP138	Androgen receptor signaling	6013
WP5050	TCA cycle in senescence	5163	4190	673	54704	4199	2805	2271	57546	7157	4200
WP2846	PCSK9-mediated LDL receptor degradation	255738	3949
WP5275	Ether lipid biosynthesis	8504	5189	410	51555	7368	84680	387521	55711	23175	9409	64900	5191	9514	9663	8443	8540	84188	10390	79888	5824
WP3875	ATR signaling	5883	5810	1111	84126	545	144715	6119	6117	11073	6118	3364
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	7157	55662	5743	664	6513	2056	5366	5211	284	3091	597	5160	3485	3939	4843	637	7039	6515	4170	581	5230	6566	405	285	7422	578	7043	3484	3486	665	5315	5054	1906	332	598	3098	54583
WP5072	Modulators of TCR signaling and T cell activation	6923	8065	9616	4068	58490	6598	921	26523	9158	5094	677	84065	7128	10425	399	5777	1606	5922	8525	10672	4716	8651	53347	1027	4209
WP4674	Head and neck squamous cell carcinoma	27244	2260	4790	3845	4893	5290	5294	2549	5296	1978	64223	7157	253260	7248	5170	2195	9817	114788	3265	1019	2475	57521	10000	83667	3664	208	79109	5295	841	6194	4780	7249	1869	8772	6794	1026	5562	2280	207	406885	84962	6199	5563	7048	8452	5925	6009	329	1977	7187	2064	7015	1021	5966	8650	4089	54541	9794	3480	23533	5970	595	5728	5291	1956	1499	4791	2261	4853	4851	2263	8626	7422
WP727	Monoamine transport	3690	3554	6999	273	135	5934	114907	43	121278	6531	5819	6853	7124	6804	6530	3553	183	1621	11255	1432	7054	6529	4842	6532	10497	5516	4982	995	10066	7249	7041	60482
WP5489	Regulation of cytotoxic T cell responses by Malat1 - miR-15/16 circuit 	6693	596	919	378938	3558	939	6955	941	915	916	6957	917	942	940
WP722	Serotonin HTR1 group and FOS pathway	50818	10125	387	9261	2776	3339	5604	5606	5594	2353	2002	5608	1385	5290	5906	4214	5923	7867	6722	2005	5595	3717	5605	9252	673	5170	3356	3708	1432	6774
WP4815	Glycosaminoglycan degradation	3373	2588	3423	2799	2990	10855	60495	411	138050	4669	3074	3073	8692	2720	3425	23553	6448
WP2873	Aryl hydrocarbon receptor pathway	7040	2939	6714	51426	3320	4257	11140	26509	1545	218	54578	5055	54657	3553	54577	7124	8140	54658	1544	4780	1027	3592	27190	8648	54600	3726	196	1543	3727	3280	54659	1728	3593	23491	10486	9049	1956	10728	2033	3458	405	57491	3725
WP5400	6q16 copy number variation	3952	4160	4915	51738	3953	181	2693	6492	3643	405	5443	3630	4852	627
WP4666	Hepatitis B infection	5970	3449	6772	369	5601	6777	8517	596	5603	3443	3441	5609	5291	2885	2033	5293	836	5579	355	6554	317	64135	3718	537	3448	6885	1642	207	353376	4772	5608	468	23586	6300	842	5578	3451	6778	6655	3265	4773	7124	3551	841	1643	10000	1432	5599	10488	3452	1386	54205	8772	3717	673	4318	3447	3339	572	2002	3442	5894	7040	1385	5602	4893	90993	6714	581	3845	6773	1147	7297	3439	3665	7046	84699	6654	1960	29110	9586	4089	64764	7529	51135	3576	6776	7419	6774	5582	7534	356	7043	4775	5595	114609	100506742	1388	1654	3725	4088	4615	5594	10454	2353	4776	3661	6416	4214	7187	6775	10971	7048	23118	148022	7097	3654	843	3569	5295	332	208	7189	148327	3716	3445	5605	1026	5111	3456	3454	57506	7099	1387	4609	637	5604	4087	5606	3444	5290	3446	4790	9641	7042	5296	3440	7098	5600	8503	2185	1959
WP286	IL3 signaling	
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	5196	6348	3576	2215	29110	2921	3902	6351	23586	4928	84868	3661	4599	4088	8717	6387	6373	7186	7706	3066	7187	8737	10010	51284	1437	3811	6347	841	284340	7124	4283	10563	57506	3456	8772	6374	682	6372	3438	7189	23367	7020	6773	5473	3586	2920	8519	8480	7040	59272	2919	3579	3433	6352	7188	3665	3627	79132	7157
WP453	Inflammatory response pathway	7133	940	3458	3565	7448	1277	3561	3559	3912	1278	1281	3918	941	3932	959	3493	7057	958	3915	2335	942	7132	3560	3507	7535	3566	3558	3494	3911	7059	3567	3913	3568
WP3892	Development of pulmonary dendritic cells and macrophage subsets	2323	1435	3398	6688	3394	7173	6925	1437	6774	55509	860	3662
WP5292	Glycosphingolipid metabolism	2717	84002	57704	127550	2629	8703	9331	9514	57733	2581	2583	7357	410	10825	7368	129807	8869	53947	8707	9334	2683	8708	8702
WP5385	Growth factors and hormones in beta cell proliferation	208	3845	10000	1019	808	1017	2305	7040	207	2321	200186	5228	8788	2146	2308	5294
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	142680	56975	1026	9365	84876	249	2263	2261	4791	595	1758	1585	6696	1594	6569	5167	8074	6098	5741	2591	5251	4790	1591
WP127	IL5 signaling	5294
WP5095	Overview of proinflammatory and profibrotic mediators	3552	8741	3557	3448	55801	6387	3593	3451	6368	282616	3443	3441	3449	27178	6696	59067	5197	64806	6363	58191	4312	6361	50604	3458	3565	414062	6369	3558	5473	56477	3447	3586	6375	3976	282617	2920	3442	7040	10148	386653	4049	6362	6367	3439	84639	6354	6356	6355	1437	90865	4283	10563	6346	10673	3553	284340	3578	6370	7124	6374	6376	4318	3592	3452	1489	1440	3562	3605	3567	6373	6358	112744	27177	2056	27189	11009	3576	3574	56300	3589	50616	5196	282618	6348	3600	29949	2921	1270	7422	6359	3606	26525	4314	53342	6351	374	3444	3446	10344	6846	2919	6360	6352	9547	56832	1435	6364	6366	6357	10850	27179	3627	3440	6347	246778	3569	27190	3596	3456	3467	51561	85480	5008	9560	3445	6372
WP5189	Copper metabolism	1317	25978	540	538
WP4506	Tyrosine metabolism and related disorders	6898	2954	3242	3081	2184
WP4656	Joubert syndrome	2316	27241	472	27031	5148	6469	142	79598	1855	1069	8481	10464	56623	23090	582	123016	80184	79867	200894	468	26123	27077	79848	402	585	1068	65062	95681	10524	9094	22897	9786	5158	261734	5116	407	1857	6009	51524	4361	57545	5147	91147	2475	79600	9731	54806	80776	403	51259	27130	284086	79583	80210	23322	10111	203286	4644	583	6102	117177	4218	4646	54903	55212	5108	51684	200728	153241	129880	5145	65250	4867	51199	9738	387
WP4483	Relationship between inflammation, COX-2 and EGFR	5291	1956	5293	5595	673	4312	3265	5731	5733	1950	208	10000	5743	5294	80142	1588	51365	5594	5734	2099	207	5732	5290	4893	6714	3845
WP3858	Toll-like receptor signaling related to MyD88	3665	7096	51311	7187	9641	7097	148022	5971	54472	7098	5966	7100	5594	4615	10333	1147	4790	353376	3661	54106	4791	7189	7099	114609	8517	3551	29110	5970	3654	51284	51135
WP5258	ROS in COVID-19 endothelial dysfunction	7132	7124	3439	59272	27035	4790	3454	3383
WP3930	EDA signaling in hair follicle development	5727	4050	27121	115482723	10913	128178	5971	6469	649	22943	65125	2735	25928
WP3679	Cell-type dependent selectivity of CCK2R signaling	1268	23236	6262	885	887	6263	7220	6261
WP2363	Gastric cancer network 2	92140	54921	10153	7157	5984	51316	29089	1299	79075	962	27101	63922	4609	6277	55299	157769	25909	1956	3930	55593	8926	5983	55215	84823	1499	11065	5884	7153	1297	255488	29028
WP5149	Lipid metabolism in senescent cells	5743	50487	240	7157	283748	5319	123745	6578	84647	1026	8398	8399	26279	5322	3265	81579	8605	7941	255189	5321
WP5351	Kleefstra syndrome	84661	7403	58508	55777	57492	9970	6595	51412	6601	11091	6603	86	6256	6599	171023	79813	8289	5929	8314	79447	6604	6602	23054	6598	22976	9070	6597
WP1589	Folate-alcohol and cancer pathway hypotheses	10840	4524	4548	1385	1051	875	1571	128	216
WP5345	1p36 copy number variation syndrome	3872	9651	28514	388581	151888	4171	2782	6339	55052	81399	4087	5261	643988	118424	150684	26155	8995	55210	7188	163688	79906	441869	4089	3312	1743	8510	6497	92105	3434	57801	83756	116983	339456	4088	4593	142678	8452	27122	5590	65220	84069	5830	2563	9978	388585	7448	55174	56257	2898	51573	339451	9636	728661	1994	5193	126789	51150	5828	7292	8764	643965	148398	1855	83858	5192	375790	728642	984	126792	219293	199990	54991	64135	80772	7293	2099	339453	11079	4038	85452	84612	84808	729759	11126	7706	29101	8784	7186	64856	401934
WP22	IL9 signaling	
WP3303	RAC1/PAK1/p38/MMP2 pathway	79931	5970	5603	8517	6777	5601	4436	6774	5058	6776	1499	5888	10318	2885	10413	1956	5595	7010	1398	207	4843	5594	2886	4690	6300	842	2335	2064	738	3265	3551	5781	3925	4842	5829	5599	1432	2308	5879	840	5747	7075	4609	2888	572	4893	7108	51378	5921	1147	4790	3845	6714	581	4313	7157	1978	6247	5600	6654
WP4318	Mitochondrial fission and fusion	596	664	4976	55669	57534	581	51024	5337	9927
WP734	Serotonin receptor 4/6/7 and NR3C signaling	466	3363	5594	2002	5604	1385	3362	5906	6722	2778	2005	2908	5605	1958	5595	9261	3360	9252	673
WP5333	Enterocyte cholesterol metabolism	335	338	64240	64241	19	1595	6307	2169	51128	39	7108	4245	50814	29881	3422	4047	10999	3930	3949	51478	337	10654	8694	4597	1718	6309	4598	10682	948	1717	2224	3157	2222	4547	6713	3156
WP5193	beta oxidation 	6713	3422	3156	2222	10682	4598	1717	2224	3157	6307	4597	1718	6309	1595	10654	3930	3284	4047
WP5304	Cholesterol metabolism	338	64240	1595	5360	39	6307	9388	348	4018	3990	341	1071	50814	3930	3949	4047	9218	6770	51478	10654	8647	10577	4598	1717	3157	4547	6713	3156	335	4023	949	336	4864	4043	27329	27141	64241	19	255738	706	51128	7416	1593	345	2169	29881	3422	6272	7108	4245	3931	55908	344	114879	4035	10999	8694	1581	337	26119	10682	948	3988	2224	350	4597	6309	1718	29116	10948	2222	6646
WP2491	Diclofenac metabolic pathway	1557	1555	1558	1562
WP4211	Transcriptional cascade regulating adipogenesis	10365	2624	1959	28999	1050	1051	688	1054	5468	1649	6720	2625	1052
WP3969	H19, Rb-E2F1, and CDK-beta-catenin in colorectal cancer	1869	182	5366	1024	5925	1499	6659	1466	7289	999	595	1019	5469
WP4914	Adverse outcome pathway for mitochondrial complex 1 (C1) inhibition	
WP5146	Lung pathology of COVID-19	3661	6347	1437	51284	23586	4790	29110	4283	3553	3569	7124	7098	6373	64135	57506	340061	3606	51311	115004	3627
WP5222	2q13 copy number variation syndrome	100616165	150468	84524	100132382	5336	27179	5441	100874469	84639	25885	10461	5437	221830	129804	9533	5434	5435	100616370	30834	106479330	84910	64682	3553	106481552	100616341	100616499	27177	100270832	6574	727851	3552	3557	84269	284958	84172	150465	23550	26525	55289	64425	10018	56300	5440	10849	6772	51082	376940	27178	541471
WP2197	Endothelin pathways	1909	808	112476	23209	10203	6084	8517	1910	4846	6283	5609	427	10267	1889	22882	4852	790	91807	4513
WP3676	BDNF-TrkB signaling	2885	673	7249	627	3265	7225	112476	2475	5609	2549	9846	1978	6009	23237	7222	1742	7248	9456	207	3845	64132	4893	6464	1385
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	4088	207	4087	4790	3611	84557	253260	114907	4703	8892	5294	64798	64223	5337	3667	8976	8742	2475	7124	6198	2932	84335	79109	57521	3488	5564	5728	3479	5163
WP314	Fas ligand pathway and stress induction of heat shock proteins	71	54205	6709	4001	7867	84823	356	1616	317	3725	840	11124	355	836	397	4799	8772	5062	843	7124	5591	596	142	5058	5599	841	8837	5925	1676	58	8767	3315	842	9261	1677	6885	4214	6416	4000	60	839	3552
WP4580	Blood clotting and drug effects	
WP4752	Base excision repair	5425	7515	10714	23583	11284	27301	3978	4595	27343	2237	8930	57804	4913	5423	3146	142	4350	252969	6996	55247	328	10038	3980	5427	7374	56655	54107	5426	5424	4968	5111
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	30	6342	51	3295
WP2645	Heroin metabolism	8824	1066
WP4720	Eicosanoid metabolism via cytochrome P450 monooxygenases pathway	5468	66002	1579	2053	8529	284541
WP129	Matrix metalloproteinases	7078	8511	4322	7077	4327	10893	7076	79148	4324	4326	4320	4319	4313	6942	118856	7079	64386	7124	4321	9313	4323	4325	4318	4312	4317	64066	682	4314	4316	8510	56547
WP1403	AMP-activated protein kinase signaling	6720	1375	51094	5571	147	3643	1938	32	5568	200186	51719	6199	3953	51422	3172	126129	5563	5209	1374	23236	53632	10645	2475	3952	57521	79602	56731	3991	5564	1026	5562	6794	7249	891	6517	5567	55437	92335	31	5565	100271849	7157	84254	1978	7248	148
WP4747	Netrin-UNC5B signaling	6018	3791	1277	4756	57475	249	10413	54538	4617	3725	836	5595	4917	5594	116986	207	3552	5499	3635	5578	57650	5781	7124	1432	6347	219699	23365	81501	1612	6401	5605	5747	1003	3691	5879	56963	9423	3586	1490	5604	5894	5524	6714	59277	7412	5290	2534	3383	387	7157	2185	5519
WP5272	LDL- influence on CD14 and TLR4	3586	4790	1385	468	90993	6300	5294	5971	84699	5600	5966	3553	3569	64764	5603	5970	9586	1432	10488	6347	929	4791	148327	7099
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	666	2932	4170	208	10000	581	598	4609	83596	23786	597	637	2931	596	207	440603	578	79370	10017	599
WP1434	Osteopontin signaling	5594	3551	3690	6696	5604	5970	5328	1147	4790	3685	4318	9020	5595
WP4932	7q11.23 copy number variation syndrome	10477	6616	3066	5925	106479318	498	2969	8408	7462	2199	8326	83939	29914	1743	3306	5595	32	2074	442582	5313	23332	4641	1213	6804	8923211	91647	518	23636	3984	9076	79720	3014	135892	3084	10013	4609	31	63922	2006	6844	64756	106480090	2597	5111	9451	4967	516	7461	1072	8678	7122	5985	135886	1738	51085	8923188	8467	2200	106481520	693175	1365	9569	10516	114049	9246	7391	5592	468	7913	1499	1028	2885	100873491	137492	355	1364	7324	9275	83451	7472	513	26608	171022	539	506	9031	8468	107986809	5982	514	7251	23122	8878	3159	517	7458	84277	23451	51160	55048	8841	23426	23476	155368	9605	93343	695	3224	515	10514	155382
WP5036	Angiotensin II receptor type 1 pathway	7046	6667	50507	7048	2161	3727	10399	4088	59272	3091	4142	1490	7040	5594	59	22882	80310	1278	1277	3589	3590	185	4089	3572	5781	183
WP4787	Osteoblast differentiation and related diseases	80326	51384	23493	5590	7475	5289	5596	5594	2249	55502	8325	11211	5587	8324	8326	5582	81029	2253	5595	2251	7474	4040	7476	4089	2248	23533	5288	7483	7481	657	5296	5294	2252	4854	2264	5583	8503	5581	650	5600	7482	5468	2260	6608	5290	3714	2736	5588	30849	659	8817	2247	5287	860	28514	54361	4855	54567	4090	5295	6300	4093	5578	182	146850	89780	7855	5597	5293	23462	5291	1499	2261	4853	7976	2263	4851	5584	8322	652	5579	10683	5603	5601	54626	6772	5580	7477	7472	7480	8323	8321	4041	2254	6662	3549	7473	7471	658	2250	4086	7479	7484	3516	5602	5598	4654	2535	5727	390992	2737	5591	2255	2246	5599	5286	1432	7478
WP3635	Insulin signaling in adipocytes (diabetic condition)	6517	9882	6194	208	3643	6198	2475	3667
WP2038	Microtubule cytoskeleton regulation	4137	9212	998	5566	6010	11004	5879	7204	57509	7461	112476	25	1072	22919	3925	145624	5294	9261	983	324	2151	7074	90102	50855	6714	4914	4916	5728	1729	161742	818	2011	1855	2932	3984	6774	4139	11129	4131	11076	5594	207	1808	4915
WP5186	Vitamin K metabolism and activation of dependent proteins	84883	1728	29914	79001	2147	154807	2155	5624	2677	2159	2158	5627	8858
WP500	Glycogen synthesis and degradation	5525	5518	5836	5834	5260	80201	5837	5516	5256	3098	5236	5529	2932	5257	5521	5523	2632	5520	178	8908	5519	2997	3101	2992	2998	28227	5255	5522	801	5528	5515	3099	5527	7360	5261	2931	805	5524	5526	808
WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	6794	8398	80025	30849	9821	22863	7249	9776	9474	5564	1356	84335	10558	57521	23130	54676	2475	9140	23400	8678	11152	7248	64422	4204	6009	55054	26100	64798	64223	80347	79152	83734	2512	80067	8408	84557	31	10533	83636	60673	5289	55062
WP5108	Familial  hyperlipidemia type 1	5360	6400	3990	1071	3931	55908	3949	335	116519	344	64788	51129	338328	4035	4023	336	337	27329
WP4540	Hippo signaling regulation	3815	10413	1015	2767	5582	7010	5568	3791	5563	1002	1010	6934	4485	1007	2776	2774	53632	23236	5590	4088	6788	4804	1016	1014	998	5588	1009	83439	5567	5879	1003	5562	1001	25937	1436	4233	5575	5156	1008	387	5576	7003	2264	5583	5581	2324	4087	2260	28316	5330	51176	3643	1956	4914	1499	2261	5573	7004	2263	5331	5571	5584	5159	2321	64405	5579	1005	5580	3480	26524	5578	1006	6932	1004	23683	1000	1012	4915	7005	28513	51422	5566	5564	8463	2773	2771	9113	4771	2475	1013	2322	1969	2778	5332	5577	64403	999	5565
WP3938	miR-222 in exercise-induced cardiac growth	79618	28996	204851	1027
WP4659	Gastrin signaling	3725	7422	5595	3815	5587	4316	6774	595	5058	2520	3576	6198	7032	2776	25865	29984	5743	2353	5594	1958	1026	5747	5879	4209	2308	998	408	5588	5335	3688	332	5295	9564	960	3667	8503	1113	5581	5583	650	8649	387	1978	5296	4208	2309	9076	100271849	4790	5290	6464	5604	4609	6548	5468	9314	6093	388	836	4296	1956	2885	887	1499	2932	6550	5601	5970	5580	7082	51564	5578	302	182	3067	64283	329	1029	330	207	10524	1398	3717	5566	1386	1027	7525	1432	5599	598	6194	5829	5781	3551	5054	3265	6667	6654	4792	5055	6925	3845	6714	1147	999	1385	3558	409	2534	2002	572	5894
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	1499	8324	51176	6925	27122	1856	6424	324	9961	2932	8658	8325	1452	8312
WP1981	Thyroxine (thyroid hormone) production	65010	6528	53905	5894	5594	2002	1081	55107	7038	7253	7200	5595	50506	5605	107	7173	1184
WP5173	Disorders of galactose metabolism 	231	2997	6514	2992	2998	2592	5836	8908	6523	2582	2632	5236	2584
WP4479	Suppression of HMGB1-mediated inflammation by THBD	3146	7056	4792	4790	1147	5970	177	8517	3551
WP516	Hypertrophy model	467	3491	3554	102	11072	3475	6935	27063	3552	3727	1978	9948	4656	1839	1977	8013	3458	3606	7422	2660
WP4204	Tumor suppressor activity of SMARCB1	5977	5727	2736	57492	6605	2738	2737	3020	8726	51412	6603	23512	1019	5928	6601	6599	86	2146	8193	1029	5925	8289	8110	1021	3021	6604	6608	2735	6598	6602	6597
WP5123	Mitochondrial fatty acid oxidation disorders	3030	33	2181	55825	2182	788	6342	80221	35	3032	37	34	1962	1632	2180	3033	6584
WP34	Ovarian infertility	1618	3623	7249	1958	5241	11144	4292	5888	1027	8204	6609	7783	9611	2332	472	1051	3973	2100	2475	1019	23224	5618	7248	1588	7421	344018	2701	7784	1385	5732	894	207	2516	2492	658	2661	4088	4439
WP5311	Isoglobo series sphingolipids	10317
WP4233	Acrylamide biotransformation and exposure biomarkers	1571
WP707	DNA damage response	595	472	5893	4193	317	4616	355	27113	11200	5424	836	10912	896	545	995	5888	5981	9874	9134	207	894	2177	672	1017	1647	8795	5883	842	5366	2810	1021	4361	5925	6118	5810	9133	1643	11011	841	1020	5591	8243	25	3364	1019	84126	5884	891	1869	1026	54205	993	898	1027	63970	10111	581	1385	27244	637	4609	1111	85417	5371	55367	4683	3014	50484	7157
WP3924	Hfe effect on hepcidin production	148738	654	57817	164656	3077	3397	4092
WP4803	Ciliopathies	80776	30849	1406	23093	79583	84662	89765	2736	91147	202018	123872	83861	55036	51057	201163	23432	4867	6608	203286	23322	219844	26160	55212	83544	282809	54903	583	5311	23090	55130	79140	200894	55112	4750	79867	23247	7275	6101	352909	10733	166379	63917	25886	84100	51524	79659	9364	585	26005	54768	2737	22858	29922	374407	51626	84314	51259	146057	403	10210	8701	9742	51364	388939	153241	51684	114327	51473	4751	11020	1258	5310	9851	83538	582	168507	92749	8481	55624	146845	51134	57560	255758	339829	1063	27031	23639	27241	54585	161582	92002	84131	85478	27077	8195	26123	345895	26146	95681	54806	56683	27130	345643	112	7287	79809	79600	25814	139212	55172	200728	22954	65250	64446	374654	7546	6102	84140	56623	10464	55812	123016	23568	51098	157657	92482	388389	261734	8239	221322	83479	91754	9657	63929	220136	9094	132884	89891	57539	4117	2121	9731	221421	93233	284086	6674	4952	55857	5147	84984	1259	122481	2622	129880	94137	5314	28981	57096	124401	755	55081	51715	10309	132320	10806	347736	54919	80184	57728	167691	115948	27019	1768	27152	23059	7840	55764	22897	9786	57545	112752	79848	79738	65062
WP702	Metapathway biotransformation Phase I and II	54905	9955	4166	1645	4259	54576	79807	57834	8514	11185	1594	570	57404	7367	113189	373156	166012	266722	6718	3176	2950	1581	79799	1589	7363	1312	1544	9653	24142	54578	6819	1562	50515	83539	9027	119391	27233	2940	22977	3340	64816	2949	339761	1553	2330	2329	2941	57106	120227	1592	9446	89792	1548	8534	1585	2052	340665	113612	7366	2880	7364	79690	90161	1571	1558	54659	27284	2879	1543	1580	66002	9	2053	219970	10858	339983	4051	9951	122830	6820	54657	199974	57016	1557	29785	56548	2939	23563	10164	1593	26151	9420	6817	653689	285440	64711	9514	6783	11283	2936	64090	1595	126410	1582	1646	4258	9956	10720	445329	6818	1583	391365	1576	9348	222537	64579	51302	54658	10327	64377	1555	2876	2954	9486	2326	10249	1545	2944	2946	1588	8509	4257	6822	55501	1551	54490	8644	1559	221357	9196	8529	56603	10	2878	54579	2937	1586	10941	1584	4837	2948	7881	442038	6799	231	1573	2328	92292	1549	2953	9957	7172	54600	1572	9469	1577	574537	80218	79829	9394	2952	2938	55226	2877	1565	9953	9435	54577	2947	260293	54575	2327	8574	25830	1591	1109
WP5218	Extrafollicular and follicular B cell activation by SARS-CoV-2	9839	9168	2113	6402	639	3394	100885789	958	1401	6387	29760	9825	59067	973	718	5079	959	57379	3312	604	57823	6776	28395	3458	3565	720721;	171558	29851	6363	643	7852	3455	969	60468	9636	3586	1880	8519	4068	912	5788	283131	3689	3558	1236	1378	10148	3433	6366	10541	10673	10563	6850	7124	3662	3569	941	23308	1380	4240	930	613	51284	933	3732	7494	2308	151888	931	7099	30009
WP4496	Signal transduction through IL1R	7189	3725	3456	7043	7124	3551	3553	3569	5970	3656	3654	5599	1432	7042	3439	51295	9020	54472	4792	7040	5606	10454	6885	3554	4615	3556	1147	4790	3557	4214	5608	3552	11213
WP5367	Rubinstein-Taybi syndrome 1	2091	64425	1385	8092	4089	9188	8202	4097	1387	406	5111	3660	2308	9575
WP545	Complement activation	727	730	713	718	729	715	735	5648	1604	733	716	629	1675	731	721	714	732	712	5199	720	10747	717
WP5142	Calcium mediated T-cell apoptosis involved in inclusion body myositis	4209	2033	3066	5532	5533	824	4773	3932	3164	487	85450	5530	23523	5335	3065	801	7535
WP3672	lncRNA-mediated mechanisms of therapeutic resistance	644914	7475	7157	3091
WP4628	Aerobic glycolysis - augmented	9563	2023	23218	3098	226	1769	3939	5213	5315	2875	7167	2597	54704	189	51727	5230	5224	26227	132	6513	2821
WP322	Osteoblast signaling	5156	5155
WP4756	Renin-angiotensin-aldosterone system (RAAS)	810	186	51806	3708	8536	9586	1585	185	64764	57118	1388	5972	818	3709	468	801	808	2776	3284	3710	10488	91860	57172	183	1583	1215	816	1636	1589	148327	3283	815	1511	1386	1385	90993	5330	814	466	805	817	84699	163688
WP694	Arylamine metabolism	6799	54600	10	54657	1544	9	6817
WP1772	Apoptosis modulation and signaling	840	7189	332	9131	9448	3654	79444	843	8718	599	55367	664	839	2021	4790	9531	637	407025	27113	4671	3725	4982	356	835	5587	640	57448	8794	331	8795	837	8717	10017	7187	1676	597	3554	2353	4615	5594	834	7133	8772	1616	8739	54205	666	841	8837	598	5599	8567	5783	54472	4792	7157	56616	8738	3303	5414	8682	407024	581	8793	51651	572	355	836	578	317	84883	638	10018	8797	7850	27429	90427	596	842	5366	1677	8737	329	1029	8771	7132	4170	330	8743	4217	826
WP4925	Unfolded protein response	10628	7494	4780	9451	5366	8720	27113	8795	51360	1649	1965	596	3553	637	468	10018	22926	51493
WP4329	miRNA role in immune response in sepsis	406951	406947	407046	4791	6351	406900	51135	406984	407008	3934	3576	574447	6348	1991	5970	406985	406941	8517	5966	23118	406979	7187	406977	3663	3659	3552	406913	406963	406950	6885	10454	4615	406986	768212	406899	7099	7189	114614	406891	1432	51284	5599	3654	3569	7124	3551	407021	5971	406937	51311	3665	3303	3002	7412	3383	406911	406912	1147	4790	406991	406906	406976	100616173	3586
WP2290	RalA downstream regulated genes	5879	5881	998	55770	149371	4893	5898	3845	3265	8531	5880	10928
WP5276	Estrogen metabolism	51171	1576	1312	1559	8644	1577	574537	1551	412	51478	6783	3292	3294	1544	54576	3028	7364	1588	1558	51144	1545	3295	1557	54575	7923	3293	1543
WP5411	Phosphatidyl inositol phosphate pathway	5289	90809	113026	8898	9107	23236	3635	5298	55361	5288	5293	93492	5728	5291	5333	5331	55613	56623	3631	5330	55300	5290	8395	51196	79837	55529	5294	4534	5336	5297	253430	84812	5332	51763	9896	200576	5287	22908	5335	5286	23396	8396	8394	8776	4952	5305	8821
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	1634	4086	6750	4090	10018	650	7044	2308	4093	54361
WP410	Exercise-induced circadian regulation	7352	5813	6612	5187	9975	23118	10946	2120	11335	5281	7360	1408	5516	9218	3108	50486	406	1051	11030	9444	8864	5507	3312	26059	3301	8031	694	8341	2947	8987	2674	3422	10787	7341	4618	1407	9802	9575	51582	2950	1982	51663	5685	10140	9709	10381	687	7122
WP2113	Type III interferon signaling	10379	3588	163702	282618	6773	7297	3716	6772	282616	282617
WP5299	Ganglio series sphingolipid metabolism	3074	3073	338596	8705	10825	8869	6484	129807	6483	29906	2583	6489	6482
WP4936	Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins	57617	81631	1975	207	55607	23339	65082	23367	84335	8673	4077	55102	3920	55004	338	9528	115201	9821
WP4008	NO/cGMP/PKG mediated neuroprotection	2904	816	4881	4878	818	2902	815	4842	2982	10142	1261	1259	5970	4846	596	5593	817	842	706	1742	2903	331	1260	4792	4747	2974	1385	4790	1262	801	88	54714	2977	2983	1258	2905	572
WP47	Hedgehog signaling	
WP5182	Pro-survival signaling of neuroprotectin D1	581	841	330	7124	8717	11035	840	7186	836	842	8772	54205	7132	8737	5516
WP4396	Nonalcoholic fatty liver disease	4512	1351	4715	1050	7384	7386	54539	9971	2931	7040	5565	9167	581	54205	5564	4710	4702	126328	22877	4092	10062	6389	4707	1337	7385	1649	3553	100532726	3551	7124	4716	4714	6256	841	1349	10000	5599	1537	4726	51085	1571	4724	4701	170712	7132	7186	4709	1339	341947	4217	207	27089	4731	1347	4720	468	3552	51422	4694	84701	4696	6390	5571	5465	4695	4519	3643	5291	5293	355	836	578	4296	4708	9370	4513	6720	5970	51079	5601	374291	2932	10018	4725	5296	56901	4728	125965	6945	8503	4514	4698	637	5290	7412	4705	6391	4790	7494	998	4723	4706	4704	840	5562	5879	9451	4729	1329	3667	3569	10975	3952	4700	4712	5295	6347	208	55967	79602	4717	7388	8660	5563	4722	53632	1340	1965	1346	1327	4697	29796	4711	4713	3953	4719	356	2081	3570	27113	440567	7381	3630	5313	3725	1345	6392	9021	51094	83737	9377	1350	3576	4718
WP98	Prostaglandin synthesis and regulation	1909	4286	5734	307	1646	5732	5737	5729	5743	302	6916	5730	7356	9536	6915	873	133522	3248	306	10257	8644	3290	1645	5468	5738	10891	6281	27306	6277	5321	3291	6662	5617	309	5733	308	5731	1910	301	1906	5740	5739	1583	244	5742
WP4136	Fibrin complement receptor 3 signaling	3593	148022	7098	5966	3627	387	2266	6714	1147	4790	2243	5290	3689	3661	23643	4615	207	4843	83593	3456	7305	7099	3929	114609	2921	929	7189	2244	51135	6347	3569	8517	7124	3551	6850	5970	3656	3654
WP5235	Estradiol regulation in porto-sinusoidal vascular disease	6667	801805;808;	2099	6670	3782
WP2371	Parkinson's disease pathway	839	1644	9134	9246	11315	118424	7318	7317	842	6531	2058	5600	7345	6300	23208	65018	7314	7332	27429	5071	6622	7054	1432	5413	7327	5603	2861	7326	317	120892	6311	836	840	54205	835	51465	898	9627
WP698	Glucuronidation	7360	10720	5239	54657	10941	54575	54578	7367	7358	54659	7366	7364	54576	54579	7365	5236	55276	3098	5238	54658	54577	54600	574537	79799	54490	7363
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	3248	5740	6916	5468
WP3593	MicroRNA for targeting cancer growth and vascularization in glioblastoma	407035	23462	7424	7423	3091	55662	7422	3280
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	84678	126961	83740	8968	8356	8354	8358	8352	653604	55506	8357	3021	5594	9555	8350	2146	3014	3015	474382	474381	604	84759	8353	6045	8351	54880	333932	1848	94239	23512	8726	3020	5595	8355	55766
WP2203	Thymic stromal lymphopoietin (TSLP) signaling	
WP5283	Chronic hyperglycemia impairment of neuron function	4313	6616	6652	5590	4319	5583	5578	4320	5581	4324	79148	4326	23683	4843	4327	10893	4322	7442	4314	8510	5588	4316	5582	4317	64066	5579	4318	4325	5584	4312	4321	9313	5580	4323	8989	118856	64386
WP4816	TGF-beta receptor signaling in skeletal dysplasias	9372	6774	1950	5601	4089	407028	6696	2022	6772	10468	3725	23090	5595	652	51176	2033	7030	3458	6497	7049	1499	4054	864	9839	25805	2353	2280	4088	4052	3694	2200	7048	4093	4091	4090	860	9241	7057	7124	5054	3265	9719	1387	8928	4092	6498	7050	3716	4790	4086	7471	10637	3976	81794	4087	7040	3624	7044	7046
WP3915	Angiopoietin-like protein 8 regulatory pathway	5607	8986	50488	5602	55908	5565	5598	5894	2931	5524	2319	9020	6654	7248	2194	9175	6195	64223	7067	5599	1432	5286	6256	6196	2645	3265	6655	2475	6517	7249	10062	27330	868	143686	9064	5564	5770	6319	5597	5608	51422	1326	207	4217	6885	1398	6300	6513	51085	2997	6009	53919	5609	7068	2932	5603	5601	1734	9322	53358	25759	10211	4296	4294	11184	6567	2885	5293	3643	5291	5571	5465	10746	5290	6464	5606	5604	8503	6721	4293	64241	5600	1978	5296	8471	5294	10487	11183	253260	4023	2309	57521	208	79109	5295	1555	5170	2203	2889	3667	6197	9448	30849	5562	1581	5605	2308	1576	5871	4214	6416	4216	7786	23265	2538	5289	5596	5594	6199	8491	53632	64240	5563	867	23433	1977	8660	23624	6198	5288	9252	5595	5105	4215
WP4698	Vitamin D-sensitive calcium signaling in depression	3710	3708	6256	596	23028	2936	2729	2539	1594	793	492	3786	2904	2906	4780	775	2902	5816	2678	6546	491	55818	3709	2905	3339	3785	1593	1128	221656	493	121278	490	2903	23135	2915	7421	7166
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	1959	1785	9896	121512	3315	4359	4747	8898	8766	57111	79628	5865	10397	54332	23095	5376	5867	9927	7879	5864	26353	81846	9516	9230	53916	90678	10567
WP4195	Phosphatidylcholine catabolism	
WP3896	Dengue-2 interactions with complement and coagulation cascades	1378	714	721	336	1361	3998	728	712	5329	3818	2153	3426	2161	2159	717	462	3827	4179	730	2149	3053	729	715	1604	733	5328	5054	5648	2244	2158	716	7056	1191	1380	623	2165	7450	2	109821	7035	2147	719	2155	5345	5265	10747	3075	5104	5340	710	713	5327	5624	718	1213	735	2152	5627	1675	629	2157
WP558	Complement and coagulation cascades	1361	3998	728	712	1378	714	721	2161	2159	717	5329	3818	2153	3426	730	4179	2149	3053	462	3827	2244	2158	716	7056	1191	1380	715	729	733	1604	5054	5648	5328	719	2147	2155	5265	5345	7450	2165	623	2	7035	109821	5104	3075	10747	5340	710	5627	629	1675	2152	2157	5624	718	1213	5327	713	735
WP3658	Wnt/beta-catenin signaling in leukemia	3172	8312	3728	595	2932	122011	207	4040	862	5467	57167	5914	324	11197	5371	4041	7704	2322	607	861
WP4399	MicroRNA network associated with chronic lymphocytic leukemia	7535	406950	406948	4170	596	7157
WP3941	Oxidative damage response	713	7124	596	7185	715	5603	1380	716	727	1027	998	7189	1028	54205	7133	1026	836	578	5111	9530	317	51567	1647	572	5602	717	4214	6416	4790	4794	7187	721	714	10188	7186	842	712	4293	728	719
WP5433	PGK1, PKM2, KHKC/KHKA acting as protein kinases	9184	84335	6774	5315	5062	8678	5631	5163	30203021;	5230	8773	3014	4633
WP2536	Colchicine metabolic pathway	1576
WP3	Transcriptional activation by NRF2 in response to phytochemicals	1728	4094	4780	23657	5578	1051	2729	9817	3162	7965	5290	5599	2730	2048	2939
WP3981	miRNA regulation of prostate cancer signaling	596	8517	4193	2475	10000	595	2932	2308	2885	367	1499	1027	1387	5159	5605	1026	5604	5894	5594	572	4790	29968	3845	90993	5290	5154	7157	4792	6654	6932	842
WP5229	Nephrotoxcicity adverse outcome pathway	1317	6582
WP2525	Trans-sulfuration, one-carbon metabolism and related pathways	29958	6470	29947	153328	6472	6647	2876	2729	875	4548	1757	10797	635	2730	2877	23743	4143	1788	1120	1119	5337	9468	56994	64902	1719	2571	257202	191	1789	441024	29968	51380	26227	10768	1491	200895	4522	2936	6648	570	2878	2572	587	4524	2937	501	7298	2880	102724560	5723	55349	5833	6649	10390	55224	1036	2882	10400	25902	586	5130	27232	55500	1759	23382	275	27430	4144	2879
WP554	ACE inhibitor pathway	1636	1215	1511	623	10159	5972	3827	186	183	1585	7040	4846	185	624	4142	59272	4306
WP3879	4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression	5608	2872	5295	5290	8569	5604	5606	207	5594	7248	5595	5605	7249	8503	55872	5564	5293	5296	1978	5291
WP5279	Mineralocorticoid biosynthesis	1584	54575	3290	1589	8644	6715	1645	7364	1646	6716	3291	6718	1585	1109
WP5485	Post-COVID neuroinflammation	6356	3440	51311	2670	3146	7098	3586	5594	59272	3552	3558	7113	3592	3565	3458	3606	7099	7124	3553	3569	51284	3576	5045
WP531	DNA mismatch repair	3978	9156	10714	5425	5982	57804	6118	5984	6117	5395	4436	5985	4437	2956	5111	5424	5426	54107	56655	5983	5427	5981	4292	6119
WP247	Small ligand GPCRs	5724	8698	5729	5732	1901	9294	1269	9248	1903	1268	5739	5737	4543	1902	4544	5731	6915	5733	5734
WP5445	Hunger and satiety	5443	3952	5697	181	51738	2641	4852	4160
WP5117	Cohesin complex - Cornelia de Lange syndrome	113130	5885	5524	10734	5526	23383	25836	5515	5528	5527	151246	23244	23047	157570	23063	324	983	10735	55869	5519	27127	9700	8243	151648	5347	5529	9126	9212	5516	9985	5518	5525	114799	9232
WP5223	2q21.1 copy number variation syndrome	100616378	113457	653784	344561	50649	389043	130074	101927994	205147	90557	55041	445582
WP4753	Nucleotide excision repair	5111	2074	8451	5426	5424	5886	902	56655	54107	5983	5981	5427	1022	6119	2072	5887	1643	2966	9978	5985	7508	2968	7507	2967	1069	1161	2073	2071	5982	4331	6118	5984	2068	57804	2965	6117	404672	2067	3978	10714	1642	5425	8450
WP2868	TCA cycle nutrient use and invasiveness of ovarian cancer	3716	5595	6774	5594	1956
WP3873	RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis	55781	64223	5728	1956	2309	7157	253260	6135	10000	79109	5290	208	83732	207	2475
WP5273	Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists	29881	949	7421	5467	948	1559	8856	5465
WP4904	LDLRAD4 and what we know about it	7046	56937	4734	753	7048	55054	4087
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	5885	672	56852	9656	8243	4361	4683	9126	472	10111	22976
WP4519	Cerebral organic acidurias, including diseases	728294	2639
WP501	GPCRs, class C metabotropic glutamate, pheromone	55890	9052	2550	2915	2916	55507	2913	2914	2911	51704	846	2917	9568	2918	2912
WP2916	Interactome of polycomb repressive complex 2 (PRC2) 	8726	23512	5928	9967	2145	8178	23515	9774	2146	23064	5931	22823	3720	23087	121536	11329
WP2795	Cardiac hypertrophic response	817	9020	9641	5598	4790	5607	1147	3339	5604	1025	5894	5606	5879	5605	1022	208	5599	1432	2475	5170	4773	3551	9734	5578	51564	5608	5592	6416	4214	801	2978	207	5594	6885	5595	11184	5320	9759	10014	5587	2932	5609	4205	5530	8517
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	3315	2626	406979	967	3303	10611	407037	619556	3479	7099	4318	5728	1956	332	8470	1950	2114	6774	6647	3569	975	6696	3791
WP3529	Zinc homeostasis	7779	4504	4490	64116	7782	4502	4489	29985	148867	283375	55676	55334	7780	10463	4500	4494	4496	27173	4501	91252	4495	7922	7781	57181	23516	25800	64924	55630	4499	55532	169026	29986	221074	201266	4493	4520	84560
WP5172	Iron metabolism disorders	57817	7018	7036	55240	2512	4891	7037	30061	617	79901	7386	80025	3077	1356	2495	9843	148738
WP4945	Mitochondrial complex I inhibition leading to parkinsonian motor deficits	
WP1742	TP53 network	666	472	8743	581	4193	1647	4609	596	25	637	5366	8626	27113	1026	3486	1029	7161	7157	5015
WP45	G1 to S cell cycle control	4174	4176	5925	1029	6118	4661	1021	4172	1030	894	1017	1647	901	8318	9134	1032	6119	1028	5427	5558	7465	1388	7029	896	5426	4193	5000	595	1870	4175	472	1871	6117	7157	84699	23595	5001	983	4331	7027	23594	4609	8900	90993	23649	1385	4998	4171	1022	4173	5557	148327	993	898	1027	891	902	5111	1869	1026	1031	1019	10488	4999
WP697	Estrogen metabolism	7364	1576	54659	1312	414	1545	1728	2944	6817	412	54600	415	54658	6783	1544	1543	2938	54576
WP2875	Constitutive androstane receptor pathway	5524	23054	2939	10891	3320	6822	54659	8714	1557	211	54578	6667	1579	54657	1555	8243	54658	1548	6256	7266	2308	1576	1559	1962	10499	1577	6817	8648	1244	9970	5243	54600
WP692	Sulfation biotransformation reaction	6817	6819	391365	6818	445329	6820	9061	442038	6799	27284	6822	9060	27233	2936	25830	2539	6783
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	598	1788	2551	4170	6597	2553	3002	472	1789	596	4089	7543	1786	7014	2120	1387	2322	2033	5728	2309
WP5122	Prostaglandin and leukotriene metabolism in senescence 	4048	23411	10800	5743	3488	5925	240	5730	246	239	2770	3265	247	9536	241	4056	5321
WP5150	Spina bifida	1788	4143	23382	4524	27430	4548	1789	191	1786	4522	4552	6470
WP3596	miR-517 relationship with ARCN1 and USP1	7398	3397	644914	3398	372
WP4688	Serine metabolism	6472	6470	26227	7298	1719	5723	29968	63826
WP1600	Nicotine metabolism in liver cells	54600	316	54657	1548	2328	1555
WP2355	Corticotropin-releasing hormone signaling	9095	100506742	5595	3848	10499	3606	6770	2767	2081	10411	4929	3576	2775	142	2776	2697	2783	2781	5563	8061	5908	2770	3726	2353	5594	2870	1583	5747	7099	2782	1395	5588	408	1589	3283	815	5335	4846	10155	5336	387	6822	7020	4790	8912	1394	31	5604	5579	836	5584	1499	1889	2932	3861	1393	5970	5580	596	10681	3164	5601	842	1584	5578	3713	3284	3727	207	4217	673	2771	2784	5599	1432	2354	2355	4792	6667	2778	5443	6925	3320	157	1385	3558	409	3728	1392	7040	2002
WP4389	Bile acid synthesis and enterohepatic circulation 	6555	5594	2264	64240	3949	8087	8647	6554	5595	1581	9965	64241
WP4853	Linoleic acid metabolism affected by SARS-CoV-2	59272	9415	60481	3992	54898	10965
WP5293	Acute myeloid leukemia	6934	7704	6932	4353	3562	597	6199	5594	5467	862	207	5291	51176	5293	2885	3815	5595	5970	3684	369	6777	1053	6198	8517	8864	595	6776	6774	6688	1978	5296	5292	1050	5371	8503	5914	6654	4609	572	11040	5604	5894	5290	4893	3728	2735	3845	4790	8900	1147	861	929	5605	673	83439	2475	6655	1436	1848	3265	3551	5295	1437	208	10000	890	2209
WP3893	Development and heterogeneity of the ILC family	6927	6095	3600	3578	7124	3553	3569	2625	8320	50616	3592	85480	51561	3458	3565	374	3606	3596	30009	64919	196	3605	3567	4783	112935892	9760	2672	7704	3593	3398
WP4482	Vitamin D in inflammatory diseases	4790	1147	1843	4214	5608	4772	5606	4088	4792	7421	1432	6256	3551	7124	4089	3569	8517	5530	5970	9282	5534	2908
WP2533	Glycerophospholipid biosynthetic pathway	57678	5294	54675	1120	5833	253430	55361	346606	10423	10390	10400	56994	9791	137964	114971	8760	8443	8540	5290	5291	8394	5293	9489	5320	23175	2710	84803	150763	9663	2819
WP244	Alpha 6 beta 4 signaling	
WP5110	Familial hyperlipidemia type 3	3990	7436	1071	3931	5360	348	336	949	337	3949	335	4035	4023
WP5475	Hallmark of cancer: sustaining proliferative signaling	5159	2321	5293	2885	5728	1956	607	5291	3643	22882	2261	4914	2263	2932	8517	3480	5970	7704	9675	6009	51513	3172	4915	64132	862	207	673	7249	3717	861	10000	3551	6655	2475	324	4792	6654	5371	7248	4041	2322	64223	1969	64798	8312	1147	6714	3728	2002	27065	7010	5595	3815	3570	595	6774	4040	3791	4193	5966	8844	4804	122011	5467	9706	5594	5605	5747	2308	57521	208	84335	3569	57167	1436	150946	4233	5914	2324	5294	5156	4794	2264	2260	4790	6464	5290	5604
WP3617	Photodynamic therapy-induced NF-kB survival signaling	597	2920	3383	330	3552	3558	7412	1147	4790	329	4313	5743	7132	599	5966	5971	5970	7124	3551	3553	3569	959	3576	8837	1437	332	595	4314	4791	7189	112398	7422	6401	4318	4312
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	3565	4791	406938	7043	1493	406985	406984	407010	51135	6774	3560	7048	942	407012	406929	29126	406996	3566	7189	5133	406986	406983	3107	406930	7099	6778	8651	407018	6955	941	6347	51284	3561	3559	51311	3627	7042	6352	407013	407021	406994	406886	6957	407040	100616173	7040	10401	406992	4790	406991
WP197	Cholesterol biosynthesis pathway	4598	1717	3157	2224	6307	4597	6309	6713	3156	3422	2222	50814	4047	1595	10654
WP5158	Urotensin-II-mediated signaling		7018	5599	1432	6624	1649	7124	3551	5781	3569	3553	5111	3717	4688	8170	10911	7223	4318	1387	59	898	5566	3383	1385	7412	4790	1147	581	3339	4087	7040	2931	19	983	4689	4313	1280	387	1281	3162	2932	6774	1277	5970	596	6648	185	5601	1535	5595	653361	836	10014	1499	84883	4878	2033	3306	1956	5728	847	3661	5350	4088	1017	2837	207	5594	1536	842	9700	2335	240	50507	4879
WP3599	Transcription factor regulation in adipogenesis	3569	1051	7124	3952	3667	8204	5599	6256	3643	2308	2908	23175	6517	9370	7291	5468	5106	1385	10891	1052	8660	1050
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	7514	1984	10642
WP619	Type II interferon signaling	6772	9021	5580	4283	3662	5781	8651	3553	10379	4261	3460	5698	4938	3716	3458	3106	3660	3717	8370	3456	2537	9636	4843	3383	3659	5610	2633	6773	5967	6688	3394	3459	3440	3627	1536	6890	3433
WP2895	Differentiation of white and brown adipocyte	9325	1149	3224	655	63976	652	7545	650	253738	10205	27129	3225	51316
WP5289	Axon guidance	3897	56896	29984	6091	6387	6469	22885	25791	137970	1947	6714
WP3971	OSX and miRNAs in tooth development	442906	4854	50964	406935	693171	1834	100126334	6932	407021	406890	121340	406937	406882	407036	406881	406886	9314	407040	407025	22943	406885	655	407024	406889	406887	406993	4851	4853	1499	860	406888	80150	406987	406891	4855	1758
WP117	GPCRs, other	341276	53831	146	10888	2692	4935	26245	1909	3363	51289	4994	2492	144124	1901	5737	128674	393046	1952	4923	1129	9620	390756	5032	138883	1814	26492	3355	1951	401428	84539	23284	2532	1880	27239	1234	2911	1268	6608	54112	8392	53829	2149	26651	2840	26537	2918	64582	3356	1815	81370	441295	26211	9596	9289	8594	2841	11245	2837	26716	391632	2798	59350	135	26343	4992	59352	6752	887	26648	390885	29929	79541	59340	9288	3577	8389	1231	30817	154	1131	9290	26212	29933	84059	81050	3579	140	8387	57191	221395	9038	27202	9287	26494	84658	118442	283383	23266	83873	2925	2833	8390	56413
WP699	Aflatoxin B1 metabolism	2952	2052	1553	8574	1544	22977	2944	1576
WP2839	Hair follicle development: organogenesis - part 2 of 3	4041	344167	10804	8321	5154	5156	999	4790	2735	23560	6608	4609	894	3911	10913	652	8626	2736	2263	5727	4684	51176	2246	3688	6615	595	1896	6469	7474	860
WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	1903	7248	4790	207	56624	64781
WP5200	Dravet syndrome	7124	6328	2475	6327	1106	57526	79109	6326	6324	348980	815	3737	6812	55615	207	801805;808;	4790	55800	5290	6330	6323	64223	6334	2258	79899	253260	5578	5600
WP5314	Lactate shuttle in glial cells	256281	9123	760	762	6513	9194	6566	3098	8671	6515	6506	3945	3939
WP3849	MAPK and NFkB signaling inhibited by Yersinia YopJ	4214	1147	8517	3551	9448	7189	22882
WP2324	AGE/RAGE pathway	
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	3358	2002	5594	5894	5604	3357	3265	3845	5923	3708	3356	4893	10125	2005	6722	2626	2776	5605	9261	5595
WP186	Homologous recombination	5888	57804	4361	4683	5424	25788	675	10714	5425	5893	472	10111
WP2253	Pilocytic astrocytoma	6654	5609	673	4763	2885	5894	5594	5781
WP2374	Oncostatin M signaling	3091	7422
WP3413	NOTCH1 regulation of endothelial cell calcification	55553	10683	28514	2702	3672	54567	6303	813	249	2261	3714	145624	4851	7422	182
WP4486	Role of carnosine in muscle contraction	
WP2366	Butyrate-induced histone acetylation	207	47
WP4010	Liver steatosis adverse outcome pathway	
WP5368	Sulfatase and aromatase pathway	10599	11309	3293	3294	3292	6783	2100	353189	2099	412	28234	6579	28231	3283	1588
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	5601	56924	3695	5058	10413	71	7004	1499	11184	3690	70	8491	7005	6788	60485	5063	4485	10971	3694	3696	9113	4771	5062	1495	9448	3688	5599	259230	8994	8463	5871	59	3693	25937	3691	10298	57144	6714	72	3689	999	5602	60	11183	7003	58
WP2854	Gene regulatory network modeling somitogenesis 	84667	6911	2253	3280	89780	3955	134701	4851	2043	28514	145873
WP4565	Neural crest cell migration in cancer	23533	56924	5062	208	25791	2047	6774	5058	2048	10000	1009	2051	5293	5291	5879	4317	627	7291	4318	3725	30849	7204	7074	10298	57144	2151	375	207	2353	146850	5063	2050	2049	5290	57498	6272	4915	4804	4313	5294	387	8503
WP5414	IDO metabolic pathway	883	56267	51166	169355	8564	7124	6999	8942	2806	3620	3458
WP399	Wnt signaling and pluripotency	333926	85409	2535	5524	7471	7473	5602	7484	8312	8321	7157	8323	7480	4041	324	5520	10009	26190	5580	85407	8313	5601	1855	7472	2932	7477	7976	5516	1499	51176	2033	5579	8322	5584	6885	89780	27022	894	7855	5515	5460	6932	1856	5578	54361	5328	960	1487	5588	83439	1387	5518	4609	51701	7482	5527	29127	5522	79923	387	6657	5519	5581	5583	1454	5523	5521	4040	7476	7474	7481	5529	595	1488	10023	5582	8326	4316	8324	5587	3949	896	120892	81029	3725	5467	11211	6416	8325	28227	1857	51384	4800	6934	8061	80326	7475	5048	1500	5590	2103
WP4239	Epithelial to mesenchymal transition in colorectal cancer	3091	4088	1288	5594	7991	11211	8325	6416	94234	51384	11171	5318	7048	80326	7182	7475	9069	6591	4089	7474	7476	10686	51208	4040	7481	7483	6935	114793	5058	6615	5010	8324	8326	117581	7043	5595	6678	81029	4324	1287	56648	7482	5606	1282	4087	5604	5290	6464	5629	8828	9074	4854	9076	8788	7042	5317	5296	1832	5600	2303	8503	23512	54361	28514	7122	5295	208	9075	4855	54567	137075	3714	7189	4209	5605	149461	1365	23562	3678	89780	1000	2305	207	80224	9839	5608	7855	6300	2146	49861	3397	2335	182	24146	8999	9080	7082	100132463	10683	5603	2932	7472	26524	7477	9071	4851	4853	9073	1499	7976	53842	5291	5293	2885	56649	7291	64398	8322	1364	1366	5310	7471	7040	5894	7473	1284	999	1286	3516	7484	7479	3728	3845	26285	8321	4313	8323	7157	7480	7046	4041	3398	10016	6654	6655	5928	100506658	3265	9518	8726	92359	7478	1432	10000	5599	7448	58190	2535	1285	4318
WP530	Cytokines and inflammatory response	5154	16187	920	3593	1435	3122	6957	2920	3567	7040	3586	2919	3562	3558	1440	3552	3565	3458	3123	3438	3596	3456	3569	3553	7124	3600	3589	6955	3574	1437
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	1386	684	3725	5605	5595	4294	4296	5601	5603	596	6197	1649	5609	1432	5599	6196	3429	6300	6195	1977	5600	4293	5594	2353	5604	5894	5606	3726	4216	6416	4214	5602	5608
WP2338	miRNA biogenesis	5901	23405	57510	6895	29102	54487
WP1991	SRF and miRs in smooth muscle differentiation and proliferation	4205	93649	9314	4208	6722	894	4209	2002	817	100271849	1482
WP5336	Induction of autophagy and toll-like receptor signaling by graphene oxide 	54106	7189	4615	7124	3661	84557	148022	3456	7099	4790
WP5179	Biosynthesis and turnover of 1-deoxy-sphingoid bases	8877	9517	427	81537	4051	130367	10558	2531	56848
WP3937	Microglia pathogen phagocytosis pathway	7305	7409	5879	4688	653361	5293	5291	54210	2209	5286	27036	10451	5295	3055	6850	713	1535	5777	3684	5880	10095	5881	4689	8503	712	1536	7410	5296	5294	3071	714	5336	4067	2207	5290	3689	27040	5289	146850	54209
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	10379	5599	1432	51284	6772	29110	3551	8517	57506	3725	3454	64135	4938	3716	7189	5610	3661	1147	4790	6773	23586	3455	6885	2353	4615	4792	148022	9641	7297	7187	8737	4940	4939
WP4342	Vitamins A and D - action mechanisms	7421	10966
WP4357	NRF2-ARE regulation	23657	7525	3643	4094	4780	2932	7965	3162	2048	2730	9978	5599	9817	2729	1051	5578	1728	8452	5290	192111	2534	2939	6714
WP4788	Autosomal recessive osteopetrosis pathways	1186	7189	29887	10312	28962	7879	8600	3551	9842	8792	4790
WP2037	Prolactin signaling	5479	5617
WP5401	7q11.23 distal copy number variation	4191	136853	144404	83862	7783	22917	23136	10146	23604	5447	7532	114971	100616270	5894	51657	7784	677801	10749	4000	222183	2810	57414	3315
WP5143	GDNF signaling	
WP4400	FABP4 in ovarian cancer	2167
WP2369	Histone modifications	2145	114826	3020	8365	8355	4297	56950	8362	8367	8356	8354	8352	133383	8366	121504	8364	653604	8357	64754	79813	121536	79723	84193	8360	8350	84787	83852	54093	2146	8351	10322	8369	8353	333932	8363	8359	84444	6419	8726	8361	55209	10919	9739	58508	80854	126961	8968	8368	8294	6418	9869	8358	64324	387893	3021	26040	7799	51111	55870	9757	55904	6839	23067	29072	79918	150572
WP143	Fatty acid beta-oxidation	2710	1375	2820	35	23305	38	1892	1738	2182	1632	2712	3991	1666	1384	3033	55902	2180	2181	51703	33	3030	2639	788	8513	3990	34	1120	4023	37	3032	7167	1376	1374	57104
WP4317	Mitochondrial fatty acid synthesis pathway	27349	51102	51144	31
WP176	Folate metabolism	4791	7157	390243	6573	2350	2348	5970	113235	6347	2352	4790
WP2112	IL17 signaling	1052	4790	3605	207	10758	6885	5594	23765	112744	9020	6667	7187	27189	55540	2932	84818	6774	5970	1051	3551	132014	8517	3717	64806	5595	27190	3716	7189	54756	4793	53342
WP5033	Genes associated with the development of rheumatoid arthritis	23569	640	115352	3572	7185	3663	26147	4261	26191	3559	51744	3123	6775	1235	6583	1493	3685	958
WP704	Methylation pathways	7172	4837	4143	4144	27430	11185	3176	5409	1312
WP5360	KCNQ2-related epilepsies	5533	3786	9495	5578	288	5028	5514	5336	3708	1457	6324	801805;808;	23621	185	6804	624	3785	1128
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	59272	51548	114548	23586	4790	51295	7187	91942	28976	340061	27035	51103	7014	5245	183	3569	9868	54386	7189	79671	57506	3606	1636
WP3944	Serotonin and anxiety-related events	3356	1394	5530	5341	3358	2353	2906	5579	84812	23237	22871	3350
WP4018	Clear cell renal cell carcinoma pathways	5564	6470	57060	7249	2475	5315	5214	3945	5232	226	55276	64798	29072	64223	4190	7248	2194	7040	84969	8878	29968	1956	5728	26227	2033	80184	405	5159	2321	8536	2026	6513	9771	3101	6009	5352	5723	1012	207	79365	10993	5230	55193	2597	7428	6472	5236	57521	5155	84335	7042	5294	3759	5156	197257	146779	79605	7167	47	113675	8314	3939	31	126961	2023	5169	8082	5313	7043	7422	32	3791	2027	3098	6774	4199	6935	2821	8844	3948	229	230	5213	2887	5211	6019	3091	3099	8242
WP411	mRNA processing	11218	8731	8405	6427	3184	24148	6627	10594	22916	1479	4809	10978	10181	1653	8175	3192	1659	2521	3178	6732	23451	57396	57794	7307	10907	4670	1198	57819	56853	1478	9128	3191	10291	23283	8899	6428	6066	6628	1660	9785	8683	6733	6635	10658	6634	6421	6636	9129	23405	6430	55660	83443	56339	5094	10914	6429	8732	8106	84844	6629	1665	4841	29894	1477	23450	6434	53981	6633	5496	6426	3276	51362	3187	8243	6433	6431	10147	6626	3182	6625	51690	5430	9343	10421	10482	6729	10659	51692	6638	10972	9410	3190	8449	5725	3275	10236	10898	5681	1195	27316	11051	4686	10992	22826	6829	84991	10250	140890	3188	22803	9584	4904	10262	58155	10946	6637	10921	11129	10151	6632	3183	6432	3181	8559	1196	10772	11338
WP3646	Hepatitis C and hepatocellular carcinoma	3725	6241	4312	2487	7422	5595	836	2885	51176	3570	356	406947	6774	595	1870	3576	5420	4089	3577	407012	842	7345	5743	330	407048	207	4843	3091	4088	672	5879	840	1026	3716	598	5599	1432	332	960	5781	3569	407049	6927	100126313	6654	407013	7410	7046	26509	2017	7157	4790	1284	7040	407040	4609
WP5176	Disorders of bile acid synthesis and biliary transport	10257	80270	570	9420	8309	5243	8647	6554	1581	1244	5825	123264	10599	5205	200931	2172	1593	6718	1109	10998	6555	5244	23600	28234	3295	11001	1582	8714
WP4022	Pyrimidine metabolism	5167	318	955	654364	54963	5430	5434	5436	9533	10201	1635	221830	1807	1841	171568	23649	84265	957	30834	790	56953	55718	56474	55703	124583	246721	377841	139596	953	4830	129607	151531	5169	5422	5427	6241	978	51728	79077	7084	5440	64425	956	25885	5441	57804	50484	7371	4860	1806	9583	6240	10714	87178	5437	7083	5432	29922	5557	4831	4833	7378	1890	56655	10621	1503	10623	11128	7298	4832	30833	51727	1633	548644	1854	5425	5438	5558	51733	54107	1723	7372	84172	5424	5426	5433	10622	5431	51082	5439	661	4907	83549	221264
WP3963	Mevalonate pathway	4597	3157	2224	4598	39	10654	3156
WP1971	Integrated cancer pathway	4361	5925	7157	1111	983	580	842	207	4087	994	572	466	10811	672	1017	4088	4609	10111	581	571	5728	993	3716	641	4312	1869	11200	545	836	596	2956	4193	6772	1019	5347	4436	841	472
WP4225	Pyrimidine metabolism and related diseases	51251	50484	7298	18	5009	1373	30833	6241	51733	1723	1890	64902	6240	1806	4329	7084	27165	1807
WP2814	Puberty	2099	7076	4609	8204	595	6776	1950	7431	8061	374	2064	3725	5241	2335
WP2636	Common pathways underlying drug addiction	1815	2890	369	114	5595	5568	5579	5605	5567	2892	5500	5582	71	5566	2902	1813	815	60	1385	2911	5906	72	5908	5501	2770	814	808	5894	5604	5594	2903	1812	5578	2893	2891	107	5499	2915
WP5395	Glycosaminoglycan synthesis in fibroblasts	10090	2135	55790	11285	50515	54480	90161	113189	8509	166012	56548	64132	27087	64131	9956	266722	135152	26035	22856	3340	2131	9957	55501	9469	26229	55454	51363	9955	79586	29940	9348	9394	2137	126792	9953	2132	64579	8534	2134	9653	337876
WP4236	Krebs cycle disorders	51660	1743	2271	55526	8802	3948	8801	8803	2875	8050	3939	3945
WP4493	Cells and molecules involved in local acute inflammatory response 	3569	718	7124	729	3683	3676	3688	7412	3689	3383	3552	3576	727	3827	6403	6404	730
WP4806	EGFR tyrosine kinase inhibitor resistance	4893	6464	5290	581	6714	3845	4763	4609	5604	5894	7039	572	9542	3084	6654	8503	5336	2309	5156	2549	5296	5154	1978	3082	22808	208	5295	5155	6194	598	22800	10000	5335	56034	3265	4233	2475	6655	2247	5170	3569	3717	5605	673	3716	558	6199	207	5594	5578	2064	1977	1950	10018	9470	2932	595	6774	399694	6237	3480	2065	3791	596	369	6198	5595	7422	5579	3479	53358	25759	5159	2621	2261	5582	2263	2885	80310	5293	1956	3570	5728	5291
WP5085	Vasopressin-regulated water reabsorption	360	1778	109	551	79659	398	1639	361	4905	64764	9586	10540	6810	1780	51143	5568	8655	1783	359	1781	115	140735	6844	90993	1385	2778	51164	8766	396	84699	5869	5878	84516	10671	10488	9230	5566	51626	554	112	148327	5567	397	5868
WP5199	PtdIns(4,5)P2 in cytokinesis pathway	7430	5962	54443	11021	4735	9493	60312	4952	29127	4478
